Msigdb mapping v2.5 to v3
Jump to navigation
Jump to search
<a href="http://www.broadinstitute.org/gsea/">GSEA Home</a> | <a href="http://www.broadinstitute.org/gsea/downloads.jsp">Downloads</a> | <a href="http://www.broadinstitute.org/gsea/msigdb/">Molecular Signatures Database</a> | Documentation | <a href="http://www.broadinstitute.org/gsea/contact.jsp">Contact</a>
Gene set names are case insensitive.
|
v2.5 (old) |
v3.0 (new) |
| CMV_ALL_UP | ZHU_CMV_ALL_UP |
| CMV_8HRS_DN | ZHU_CMV_8_HR_DN |
| CMV_24HRS_DN | ZHU_CMV_24_HR_DN |
| CMV_ALL_DN | ZHU_CMV_ALL_DN |
| CMV_24HRS_UP | ZHU_CMV_24_HR_UP |
| CMV_8HRS_UP | ZHU_CMV_8_HR_UP |
| — | DER_IFN_ALPHA_RESPONSE_UP |
| DER_IFNB_DN | DER_IFN_BETA_RESPONSE_DN |
| DER_IFNB_UP | DER_IFN_BETA_RESPONSE_UP |
| DER_IFNG_DN | DER_IFN_GAMMA_RESPONSE_DN |
| DER_IFNG_UP | DER_IFN_GAMMA_RESPONSE_UP |
| IFN_ALL_UP | Deprecated |
| IFN_BETA_UP | Deprecated |
| IFN_ANY_UP | Deprecated |
| IFN_GAMMA_UP | Deprecated |
| IFN_ALPHA_UP | Deprecated |
| DER_IFNA_UP | DER_IFN_ALPHA_RESPONSE_DN |
| CALRES_MOUSE_UP | LEE_CALORIE_RESTRICTION_MUSCLE_UP |
| AGED_MOUSE_MUSCLE_DN | LEE_AGING_MUSCLE_DN |
| CALRES_MOUSE_DN | LEE_CALORIE_RESTRICTION_MUSCLE_DN |
| AGED_MOUSE_MUSCLE_UP | LEE_AGING_MUSCLE_UP |
| GOLUB_ALL_VS_AML_UP | GOLUB_ALL_VS_AML_UP |
| GOLUB_ALL_VS_AML_DN | GOLUB_ALL_VS_AML_DN |
| BRCA1_SW480_DN | MACLACHLAN_BRCA1_TARGETS_DN |
| BRCA1_SW480_UP | MACLACHLAN_BRCA1_TARGETS_UP |
| COLLER_MYC_UP | COLLER_MYC_TARGETS_UP |
| COLLER_MYC_DN | COLLER_MYC_TARGETS_DN |
| HG_PROGERIA_DN | LY_AGING_PREMATURE_DN |
| MIDDLEAGE_UP | LY_AGING_MIDDLE_UP |
| OLDAGE_DN | LY_AGING_OLD_DN |
| MIDDLEAGE_DN | LY_AGING_MIDDLE_DN |
| — | LY_AGING_OLD_UP |
| — | LY_AGING_PREMATURE_UP |
| HPV31_DN | CHANG_IMMORTALIZED_BY_HPV31_DN |
| HPV31_UP | CHANG_IMMORTALIZED_BY_HPV31_UP |
| AGED_MOUSE_NEOCORTEX_DN | LEE_AGING_NEOCORTEX_DN |
| CALRES_MOUSE_NEOCORTEX_UP | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP |
| AGED_MOUSE_CEREBELLUM_DN | LEE_AGING_CEREBELLUM_DN |
| AGED_MOUSE_NEOCORTEX_UP | LEE_AGING_NEOCORTEX_UP |
| AGED_MOUSE_CEREBELLUM_UP | LEE_AGING_CEREBELLUM_UP |
| CALRES_MOUSE_NEOCORTEX_DN | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN |
| HDACI_COLON_CURSUL_DN | Deprecated |
| HDACI_COLON_TSA_UP | Deprecated |
| HDACI_COLON_SUL48HRS_DN | Deprecated |
| HDACI_COLON_TSA48HRS_UP | Deprecated |
| HDACI_COLON_TSABUT_DN | Deprecated |
| HDACI_COLON_CLUSTER7 | MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7 |
| HDACI_COLON_SUL12HRS_DN | Deprecated |
| HDACI_COLON_SUL_DN | Deprecated |
| HDACI_COLON_CLUSTER8 | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8 |
| HDACI_COLON_CURSUL_UP | Deprecated |
| HDACI_COLON_SUL30MIN_DN | Deprecated |
| HDACI_COLON_CUR48HRS_UP | Deprecated |
| HDACI_COLON_BUT30MIN_DN | Deprecated |
| HDACI_COLON_TSA2HRS_UP | Deprecated |
| HDACI_COLON_SUL_UP | Deprecated |
| HDACI_COLON_BUT_UP | Deprecated |
| HDACI_COLON_CUR12HRS_UP | Deprecated |
| HDACI_COLON_BUT2HRS_DN | Deprecated |
| HDACI_COLON_CLUSTER10 | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN |
| HDACI_COLON_CUR24HRS_DN | Deprecated |
| HDACI_COLON_SUL16HRS_DN | Deprecated |
| HDACI_COLON_SUL24HRS_DN | Deprecated |
| HDACI_COLON_CLUSTER9 | MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP |
| HDACI_COLON_SUL12HRS_UP | Deprecated |
| HDACI_COLON_TSA24HRS_DN | Deprecated |
| HDACI_COLON_BUT48HRS_DN | Deprecated |
| HDACI_COLON_BUT16HRS_UP | Deprecated |
| HDACI_COLON_BUT24HRS_DN | Deprecated |
| HDACI_COLON_CLUSTER4 | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4 |
| HDACI_COLON_CUR16HRS_DN | Deprecated |
| HDACI_COLON_BUT16HRS_DN | Deprecated |
| HDACI_COLON_TSA12HRS_UP | Deprecated |
| HDACI_COLON_CUR_DN | Deprecated |
| HDACI_COLON_SUL16HRS_UP | Deprecated |
| HDACI_COLON_SUL2HRS_UP | Deprecated |
| HDACI_COLON_CLUSTER5 | MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5 |
| HDACI_COLON_CUR2HRS_UP | Deprecated |
| HDACI_COLON_SUL2HRS_DN | Deprecated |
| HDACI_COLON_BUT12HRS_UP | Deprecated |
| HDACI_COLON_BUT12HRS_DN | Deprecated |
| HDACI_COLON_TSA_DN | Deprecated |
| HDACI_COLON_BUT2HRS_UP | Deprecated |
| HDACI_COLON_CUR_UP | Deprecated |
| HDACI_COLON_CUR24HRS_UP | Deprecated |
| HDACI_COLON_BUT48HRS_UP | Deprecated |
| HDACI_COLON_CLUSTER6 | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 |
| HDACI_COLON_SUL24HRS_UP | Deprecated |
| HDACI_COLON_TSA2HRS_DN | Deprecated |
| HDACI_COLON_SUL48HRS_UP | Deprecated |
| HDACI_COLON_BUT_DN | Deprecated |
| HDACI_COLON_TSABUT_UP | Deprecated |
| HDACI_COLON_TSA30MIN_DN | Deprecated |
| HDACI_COLON_BUT24HRS_UP | Deprecated |
| HDACI_COLON_TSA48HRS_DN | Deprecated |
| — | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1 |
| — | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2 |
| — | MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_3 |
| PARP_KO_DN | SIMBULAN_PARP1_TARGETS_UP |
| PARP_KO_UP | SIMBULAN_PARP1_TARGETS_DN |
| NADLER_OBESITY_UP | NADLER_OBESITY_UP |
| NADLER_OBESITY_DN | NADLER_OBESITY_DN |
| NADLER_OBESITY_HYPERGLYCEMIA | NADLER_HYPERGLYCEMIA_AT_OBESITY |
| CORTEX_ENRICHMENT_EARLY_UP | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP |
| CORTEX_ENRICHMENT_LATE_UP | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP |
| — | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN |
| — | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_DN |
| DNMT1_KO_UP | JACKSON_DNMT1_TARGETS_UP |
| DNMT1_KO_DN | JACKSON_DNMT1_TARGETS_DN |
| SCHUMACHER_MYC_DN | SCHUHMACHER_MYC_TARGETS_DN |
| SCHUMACHER_MYC_UP | SCHUHMACHER_MYC_TARGETS_UP |
| AGED_MOUSE_CORTEX_UP | JIANG_AGING_CEREBRAL_CORTEX_UP |
| AGED_MOUSE_HYPOTH_DN | JIANG_AGING_HYPOTHALAMUS_DN |
| AGED_MOUSE_CORTEX_DN | JIANG_AGING_CEREBRAL_CORTEX_DN |
| AGED_MOUSE_HYPOTH_UP | JIANG_AGING_HYPOTHALAMUS_UP |
| BREASTCA_THREE_CLASSES | HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC |
| BREASTCA_TWO_CLASSES | HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2 |
| HOHENKIRK_MONOCYTE_DEND_UP | LENAOUR_DENDRITIC_CELL_MATURATION_UP |
| HOHENKIRK_MONOCYTE_DEND_DN | LENAOUR_DENDRITIC_CELL_MATURATION_DN |
| TGFBETA_ALL_UP | Deprecated |
| TGFBETA_C2_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C2 |
| TGFBETA_C1_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C1 |
| TGFBETA_C5_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C5 |
| TGFBETA_EARLY_UP | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 |
| TGFBETA_LATE_UP | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 |
| TGFBETA_C4_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C4 |
| TGFBETA_C3_UP | VERRECCHIA_RESPONSE_TO_TGFB1_C3 |
| — | VERRECCHIA_RESPONSE_TO_TGFB1_C6 |
| CALRES_RHESUS_DN | KAYO_CALORIE_RESTRICTION_MUSCLE_DN |
| AGED_RHESUS_UP | KAYO_AGING_MUSCLE_UP |
| AGED_RHESUS_DN | KAYO_AGING_MUSCLE_DN |
| CALRES_RHESUS_UP | KAYO_CALORIE_RESTRICTION_MUSCLE_UP |
| E2F1_DNA_UP | KALMA_E2F1_TARGETS |
| BRCA1_MES_UP | APRELIKOVA_BRCA1_TARGETS |
| KANNAN_P53_UP | KANNAN_TP53_TARGETS_UP |
| KANNAN_P53_DN | KANNAN_TP53_TARGETS_DN |
| GH_IGF_CHONDROCYTES_UP | Deprecated |
| HYPOPHYSECTOMY_RAT_UP | Deprecated |
| HYPOPHYSECTOMY_RAT_DN | Deprecated |
| GH_HYPOPHYSECTOMY_RAT_UP | Deprecated |
| GH_HYPOPHYSECTOMY_RAT_DN | Deprecated |
| — | ISHIDA_E2F_TARGETS |
| BUT_TSA_UP | DELLA_RESPONSE_TO_TSA_AND_BUTYRATE |
| HIPPOCAMPUS_DEVELOPMENT_POSTNATAL | MODY_HIPPOCAMPUS_POSTNATAL |
| HIPPOCAMPUS_DEVELOPMENT_NEONATAL | MODY_HIPPOCAMPUS_NEONATAL |
| HIPPOCAMPUS_DEVELOPMENT_PRENATAL | MODY_HIPPOCAMPUS_PRENATAL |
| HBX_NL_DN | WU_HBX_TARGETS_2_DN |
| HBX_HCC_DN | WU_HBX_TARGETS_1_DN |
| HBX_HEP_UP | WU_HBX_TARGETS_3_UP |
| HBX_HEP_DN | WU_HBX_TARGETS_3_DN |
| HBX_HCC_UP | WU_HBX_TARGETS_1_UP |
| HBX_NL_UP | WU_HBX_TARGETS_2_UP |
| LIAN_MYELOID_DIFF_RECEPTORS | Deprecated |
| LIAN_MYELOID_DIFF_TF | Deprecated |
| LIAN_MYELOID_DIFF_GRANULE | LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS |
| HOFMANN_MANTEL_LYMPHOMA_VS_LYMPH_NODES_DN | HOFMANN_CELL_LYMPHOMA_DN |
| HOFMANN_MANTEL_LYMPHOMA_VS_LYMPH_NODES_UP | HOFMANN_CELL_LYMPHOMA_UP |
| DSRNA_DN | GEISS_RESPONSE_TO_DSRNA_DN |
| DSRNA_UP | GEISS_RESPONSE_TO_DSRNA_UP |
| NAKAJIMA_MCSMBP_EOS | NAKAJIMA_EOSINOPHIL |
| NAKAJIMA_MCSMBP_MAST | NAKAJIMA_MAST_CELL |
| BRG1_SW13_UP | LIU_SMARCA4_TARGETS |
| HIF1_TARGETS | SEMENZA_HIF1_TARGETS |
| LIN_WNT_UP | LIN_APC_TARGETS |
| UVB_NHEK4_6HRS_DN | MURAKAMI_UV_RESPONSE_6HR_DN |
| UVB_NHEK4_6HRS_UP | MURAKAMI_UV_RESPONSE_6HR_UP |
| UVB_NHEK4_24HRS_DN | MURAKAMI_UV_RESPONSE_24HR |
| — | MURAKAMI_UV_RESPONSE_1HR_UP |
| — | MURAKAMI_UV_RESPONSE_1HR_DN |
| IGF1_NIH3T3_UP | Deprecated |
| INSULIN_NIH3T3_UP | Deprecated |
| GRAEBER_BETA2_INTEGRINS | Deprecated |
| CMV_HCMV_TIMECOURSE_20HRS_UP | BROWNE_HCMV_INFECTION_20HR_UP |
| CMV_HCMV_TIMECOURSE_16HRS_UP | BROWNE_HCMV_INFECTION_16HR_UP |
| CMV_HCMV_TIMECOURSE_1HR_DN | Deprecated |
| UV-CMV_UNIQUE_HCMV_6HRS_DN | Deprecated |
| CMV_UV-CMV_COMMON_HCMV_6HRS_DN | Deprecated |
| CMV_HCMV_TIMECOURSE_16HRS_DN | BROWNE_HCMV_INFECTION_16HR_DN |
| CMV_HCMV_TIMECOURSE_10HRS_DN | BROWNE_HCMV_INFECTION_10HR_DN |
| CMV_HCMV_TIMECOURSE_ALL_UP | Deprecated |
| CMV_HCMV_TIMECOURSE_24HRS_DN | BROWNE_HCMV_INFECTION_24HR_DN |
| CMV_HCMV_TIMECOURSE_14HRS_DN | BROWNE_HCMV_INFECTION_14HR_DN |
| IFNA_HCMV_6HRS_UP | BROWNE_INTERFERON_RESPONSIVE_GENES |
| CMV_HCMV_TIMECOURSE_8HRS_UP | BROWNE_HCMV_INFECTION_8HR_UP |
| CMV_HCMV_TIMECOURSE_20HRS_DN | BROWNE_HCMV_INFECTION_20HR_DN |
| CMV-CHX_HCMV_6HRS_DN | Deprecated |
| CMV_HCMV_TIMECOURSE_48HRS_DN | BROWNE_HCMV_INFECTION_48HR_DN |
| CMV_HCMV_TIMECOURSE_48HRS_UP | BROWNE_HCMV_INFECTION_48HR_UP |
| CMV_HCMV_TIMECOURSE_8HRS_DN | BROWNE_HCMV_INFECTION_8HR_DN |
| CMV_HCMV_TIMECOURSE_14HRS_UP | BROWNE_HCMV_INFECTION_14HR_UP |
| CMV_UV-CMV_COMMON_HCMV_6HRS_UP | Deprecated |
| CMV-UV_HCMV_6HRS_UP | Deprecated |
| CMV_HCMV_TIMECOURSE_18HRS_DN | BROWNE_HCMV_INFECTION_18HR_DN |
| IFNA_UV-CMV_COMMON_HCMV_6HRS_UP | IFNA_UV-CMV_COMMON_HCMV_6HRS_UP |
| CMV_HCMV_TIMECOURSE_18HRS_UP | BROWNE_HCMV_INFECTION_18HR_UP |
| UV-CMV_UNIQUE_HCMV_6HRS_UP | Deprecated |
| CMV_HCMV_TIMECOURSE_10HRS_UP | BROWNE_HCMV_INFECTION_10HR_UP |
| CMV_HCMV_TIMECOURSE_12HRS_UP | BROWNE_HCMV_INFECTION_12HR_UP |
| CMV_HCMV_6HRS_UP | BROWNE_HCMV_INFECTION_6HR_UP |
| CMV_HCMV_TIMECOURSE_6HRS_DN | Deprecated |
| CMV_HCMV_TIMECOURSE_24HRS_UP | BROWNE_HCMV_INFECTION_24HR_UP |
| CMV_HCMV_TIMECOURSE_4HRS_DN | Deprecated |
| CMV_HCMV_6HRS_DN | BROWNE_HCMV_INFECTION_6HR_DN |
| CMV-UV_HCMV_6HRS_DN | Deprecated |
| CMV_HCMV_TIMECOURSE_12HRS_DN | BROWNE_HCMV_INFECTION_12HR_DN |
| CMV_HCMV_TIMECOURSE_ALL_DN | Deprecated |
| — | BROWNE_HCMV_INFECTION_30MIN_UP |
| — | BROWNE_HCMV_INFECTION_30MIN_DN |
| — | BROWNE_HCMV_INFECTION_1HR_UP |
| — | BROWNE_HCMV_INFECTION_1HR_DN |
| — | BROWNE_HCMV_INFECTION_2HR_UP |
| — | BROWNE_HCMV_INFECTION_2HR_DN |
| — | BROWNE_HCMV_INFECTION_4HR_UP |
| — | BROWNE_HCMV_INFECTION_4HR_DN |
| ICF_UP | EHRLICH_ICF_SYNDROM_UP |
| ICF_DN | EHRLICH_ICF_SYNDROM_DN |
| ET743PT650_COLONCA_DN | MARTINEZ_RESPONSE_TO_TRABECTEDIN |
| HSIAO_LIVER_SPECIFIC_GENES | HSIAO_LIVER_SPECIFIC_GENES |
| — | HSIAO_HOUSEKEEPING_GENES |
| HOFFMANN_BIVSBII_LGBII | Deprecated |
| HOFFMANN_BIVSBII_BI | Deprecated |
| HOFFMANN_BIVSBII_IMVM | Deprecated |
| HOFFMANN_BIVSBII_BI_TABLE2 | Deprecated |
| — | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP |
| — | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN |
| — | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP |
| — | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN |
| — | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP |
| — | HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN |
| — | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP |
| — | HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN |
| PARK_HSC_VS_MPP_DN | PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN |
| PARK_HSC_VS_MPP_UP | PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP |
| PARK_MSCS_BOTH | PARK_HSC_MARKERS |
| PARK_MSCS_DIFF | PARK_HSC_AND_MULTIPOTENT_PROGENITORS |
| PARK_MSCS_LIN2 | Deprecated |
| SHIPP_DLBCL_CURED_DN | SHIPP_DLBCL_CURED_VS_FATAL_DN |
| SHIPP_DLBCL_CURED_UP | SHIPP_DLBCL_CURED_VS_FATAL_UP |
| SHIPP_FL_VS_DLBCL_DN | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN |
| SHIPP_FL_VS_DLBCL_UP | SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP |
| REN_E2F1_TARGETS | REN_BOUND_BY_E2F |
| POMEROY_DESMOPLASIC_VS_CLASSIC_MD_UP | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP |
| POMEROY_DESMOPLASIC_VS_CLASSIC_MD_DN | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN |
| POMEROY_MD_TREATMENT_GOOD_VS_POOR_UP | POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP |
| POMEROY_MD_TREATMENT_GOOD_VS_POOR_DN | POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN |
| MMC_RES_XENOGRAFTS_UP | Deprecated |
| RESISTANCE_XENOGRAFTS_UP | Deprecated |
| VLB_RES_XENOGRAFTS_UP | Deprecated |
| MTX_RES_XENOGRAFTS_UP | Deprecated |
| — | ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL |
| — | ZEMBUTSU_SENSITIVITY_TO_CISPLATIN |
| — | ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE |
| — | ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN |
| — | ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE |
| — | ZEMBUTSU_SENSITIVITY_TO_MITOMYCIN |
| — | ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE |
| — | ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE |
| — | ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE |
| VANTVEER_BREAST_OUTCOME_GOOD_VS_POOR_DN | VANTVEER_BREAST_CANCER_METASTASIS_DN |
| VANTVEER_BREAST_OUTCOME_GOOD_VS_POOR_UP | VANTVEER_BREAST_CANCER_METASTASIS_UP |
| BRCA_PROGNOSIS_POS | Deprecated |
| BRCA_BRCA1_NEG | Deprecated |
| BRCA_PROGNOSIS_NEG | Deprecated |
| BRCA_BRCA1_POS | Deprecated |
| BRCA_ER_NEG | Deprecated |
| BRCA_ER_POS | Deprecated |
| — | VANTVEER_BREAST_CANCER_ESR1_UP |
| — | VANTVEER_BREAST_CANCER_ESR1_DN |
| — | VANTVEER_BREAST_CANCER_BRCA1_UP |
| — | VANTVEER_BREAST_CANCER_BRCA1_DN |
| — | VANTVEER_BREAST_CANCER_POOR_PROGNOSIS |
| DORSEY_DOXYCYCLINE_UP | DORSEY_GAB2_TARGETS |
| ZHAN_MULTIPLE_MYELOMA_SUBCLASSES_DIFF | ZHAN_MULTIPLE_MYELOMA_SUBGROUPS |
| ZHAN_PCS_MULTIPLE_MYELOMA_SPKD | ZHAN_MULTIPLE_MYELOMA_SPIKED |
| ZHAN_MULTIPLE_MYELOMA_VS_NORMAL_UP | ZHAN_MULTIPLE_MYELOMA_UP |
| ZHAN_MULTIPLE_MYELOMA_VS_NORMAL_DN | ZHAN_MULTIPLE_MYELOMA_DN |
| DAC_BLADDER_UP | LIANG_SILENCED_BY_METHYLATION_2 |
| DAC_CGI_BLADDER_UP | Deprecated |
| DAC_IFN_BLADDER_UP | Deprecated |
| DAC_FIBRO_UP | LIANG_SILENCED_BY_METHYLATION_UP |
| DAC_FIBRO_DN | LIANG_SILENCED_BY_METHYLATION_DN |
| CMV_IE86_UP | SONG_TARGETS_OF_IE86_CMV_PROTEIN |
| UVB_NHEK3_C8 | SESTO_RESPONSE_TO_UV_C8 |
| UVB_NHEK3_C4 | SESTO_RESPONSE_TO_UV_C4 |
| UVB_NHEK3_C6 | SESTO_RESPONSE_TO_UV_C6 |
| UVB_NHEK3_C2 | SESTO_RESPONSE_TO_UV_C2 |
| UVB_NHEK3_ALL | Deprecated |
| UVB_NHEK3_C0 | SESTO_RESPONSE_TO_UV_C0 |
| UVB_NHEK3_C1 | SESTO_RESPONSE_TO_UV_C1 |
| UVB_NHEK3_C7 | SESTO_RESPONSE_TO_UV_C7 |
| UVB_NHEK3_C5 | SESTO_RESPONSE_TO_UV_C5 |
| UVB_NHEK3_C3 | SESTO_RESPONSE_TO_UV_C3 |
| INNEREAR_UP | ABE_INNER_EAR |
| HYPOXIA_REVIEW | HARRIS_HYPOXIA |
| HUMAN_TISSUE_PANCREAS | SU_PANCREAS |
| HUMAN_TISSUE_SALIVARY | SU_SALIVARY_GLAND |
| HUMAN_TISSUE_TESTIS | SU_TESTIS |
| HUMAN_TISSUE_THYMUS | SU_THYMUS |
| HUMAN_TISSUE_KIDNEY | SU_KIDNEY |
| MOUSE_TISSUE_TESTIS | Deprecated |
| MOUSE_TISSUE_KIDNEY | Deprecated |
| HUMAN_TISSUE_LIVER | SU_LIVER |
| HUMAN_TISSUE_PLACENTA | SU_PLACENTA |
| RADAEVA_IFNA_DN | RADAEVA_IFN_ALPHA_RESPONSE_UP |
| RADAEVA_IFNA_UP | RADAEVA_IFN_ALPHA_RESPONSE_DN |
| IFNALPHA_NL_HCC_UP | Deprecated |
| IFNALPHA_HCC_UP | Deprecated |
| IFNALPHA_NL_UP | Deprecated |
| STANELLE_E2F1_UP | STANELLE_E2F1_TARGETS |
| SARCOMAS_HISTIOCYTOMA_UP | NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP |
| SARCOMAS_SYNOVIAL_DN | NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN |
| SARCOMAS_GISTROMAL_UP | NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP |
| SARCOMAS_LIPOSARCOMA_DN | NIELSEN_LIPOSARCOMA_DN |
| SARCOMAS_LIPOSARCOMA_UP | NIELSEN_LIPOSARCOMA_UP |
| SARCOMAS_SYNOVIAL_UP | NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_UP |
| SARCOMAS_SCHWANNOMA_UP | NIELSEN_SCHWANNOMA_UP |
| SARCOMAS_LEIOMYOSARCOMA_CALP_UP | NIELSEN_LEIOMYOSARCOMA_CNN1_UP |
| SARCOMAS_LEIOMYOSARCOMA_UP | NIELSEN_LEIOMYOSARCOMA_UP |
| — | NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_DN |
| — | NIELSEN_GIST |
| — | NIELSEN_LEIOMYOSARCOMA_CNN1_DN |
| — | NIELSEN_LEIOMYOSARCOMA_DN |
| — | NIELSEN_SYNOVIAL_SARCOMA_UP |
| — | NIELSEN_SYNOVIAL_SARCOMA_DN |
| — | NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN |
| — | NIELSEN_SCHWANNOMA_DN |
| ADIPOCYTE_PPARG_UP | LI_ADIPOGENESIS_BY_ACTIVATED_PPARG |
| UVB_NHEK2_UP | TAKAO_RESPONSE_TO_UVB_RADIATION_UP |
| UVB_NHEK2_DN | TAKAO_RESPONSE_TO_UVB_RADIATION_DN |
| MENSSEN_MYC_UP | MENSSEN_MYC_TARGETS |
| GRANDVAUX_IFN_NOT_IRF3_UP | GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3 |
| GRANDVAUX_IRF3_DN | GRANDVAUX_IRF3_TARGETS_UP |
| GRANDVAUX_IRF3_UP | GRANDVAUX_IRF3_TARGETS_DN |
| TSADAC_RKOSILENT_UP | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A |
| TSADAC_RKOEXP_UP | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B |
| TSA_RKO_UP | SUZUKI_RESPONSE_TO_TSA |
| AS3_FIBRO_C2 | YIH_RESPONSE_TO_ARSENITE_C2 |
| AS3_FIBRO_C4 | YIH_RESPONSE_TO_ARSENITE_C4 |
| AS3_FIBRO_UP | Deprecated |
| AS3_FIBRO_C3 | YIH_RESPONSE_TO_ARSENITE_C3 |
| AS3_FIBRO_C1 | YIH_RESPONSE_TO_ARSENITE_C1 |
| AS3_FIBRO_DN | Deprecated |
| — | YIH_RESPONSE_TO_ARSENITE_C5 |
| ADIP_VS_PREADIP_DN | ADIP_VS_PREADIP_DN |
| ADIP_VS_FIBRO_DN | GERHOLD_ADIPOGENESIS_DN |
| PREADIP_VS_FIBRO_UP | PREADIP_VS_FIBRO_UP |
| ADIP_VS_PREADIP_UP | Deprecated |
| TZD_ADIP_DN | Deprecated |
| ADIP_VS_FIBRO_UP | GERHOLD_ADIPOGENESIS_UP |
| — | GERHOLD_RESPONSE_TO_TZD_UP |
| — | GERHOLD_RESPONSE_TO_TZD_DN |
| WELCSH_BRCA_DN | Deprecated |
| WELCSH_BRCA_UP | Deprecated |
| BRCA1_OVEREXP_UP | WELCSH_BRCA1_TARGETS_1_UP |
| BRCA1_OVEREXP_DN | WELCSH_BRCA1_TARGETS_1_DN |
| NF90_UP | KRASNOSELSKAYA_ILF3_TARGETS_UP |
| NF90_DN | KRASNOSELSKAYA_ILF3_TARGETS_DN |
| LI_FETAL_VS_WT_KIDNEY_DN | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_DN |
| LI_FETAL_VS_WT_KIDNEY_UP | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_UP |
| — | LI_WILMS_TUMOR |
| FERRANDO_T_CELL_DIFFERENTIATION_PATHWAY | Deprecated |
| FERRANDO_TAL1_NEIGHBORS | FERRANDO_TAL1_NEIGHBORS |
| FERRANDO_LYL1_NEIGHBORS | FERRANDO_LYL1_NEIGHBORS |
| FERRANDO_CHEMO_RESPONSE_PATHWAY | Deprecated |
| — | FERRANDO_HOX11_NEIGHBORS |
| IL1_CORNEA_DN | MAHAJAN_RESPONSE_TO_IL1A_DN |
| IL1_CORNEA_UP | MAHAJAN_RESPONSE_TO_IL1A_UP |
| WILLERT_WNT_NCCIT_ALL_UP | WILLERT_WNT_SIGNALING |
| BRCA2_BRCA1_DN | JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN |
| BRCA2_BRCA1_UP | JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP |
| PENG_LEUCINE_UP | PENG_LEUCINE_DEPRIVATION_UP |
| PENG_GLUCOSE_UP | PENG_GLUCOSE_DEPRIVATION_UP |
| PENG_GLUTAMINE_UP | PENG_GLUTAMINE_DEPRIVATION_UP |
| PENG_LEUCINE_DN | PENG_LEUCINE_DEPRIVATION_DN |
| PENG_GLUCOSE_DN | PENG_GLUCOSE_DEPRIVATION_DN |
| PENG_RAPAMYCIN_DN | PENG_RAPAMYCIN_RESPONSE_DN |
| PENG_RAPAMYCIN_UP | PENG_RAPAMYCIN_RESPONSE_UP |
| PENG_GLUTAMINE_DN | PENG_GLUTAMINE_DEPRIVATION_DN |
| MA_ATRA_EMP_DN | MA_MYELOID_DIFFERENTIATION_DN |
| MA_ATRA_EMP_UP | MA_MYELOID_DIFFERENTIATION_UP |
| ADIP_DIFF_CLUSTER5 | BURTON_ADIPOGENESIS_PEAK_AT_24HR |
| ADIP_DIFF_CLUSTER2 | BURTON_ADIPOGENESIS_PEAK_AT_2HR |
| ADIP_DIFF_CLUSTER1 | BURTON_ADIPOGENESIS_PEAK_AT_0HR |
| ADIP_DIFF_CLUSTER3 | BURTON_ADIPOGENESIS_PEAK_AT_8HR |
| ADIP_DIFF_CLUSTER4 | BURTON_ADIPOGENESIS_PEAK_AT_16HR |
| P21_ANY_DN | Deprecated |
| P21_EARLY_DN | Deprecated |
| P21_P53_LATE_DN | Deprecated |
| P21_P53_EARLY_DN | Deprecated |
| P21_ANY_UP | Deprecated |
| P21_MIDDLE_DN | Deprecated |
| P21_P53_MIDDLE_DN | Deprecated |
| P21_P53_ANY_DN | Deprecated |
| — | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 |
| — | WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53 |
| NELSON_ANDROGEN_DN | NELSON_RESPONSE_TO_ANDROGEN_DN |
| NELSON_ANDROGEN_UP | NELSON_RESPONSE_TO_ANDROGEN_UP |
| VEGF_HUVEC_2HRS_UP | ABE_VEGFA_TARGETS_2HR |
| VEGF_HUVEC_UP | ABE_VEGFA_TARGETS |
| VEGF_HUVEC_30MIN_UP | ABE_VEGFA_TARGETS_30MIN |
| ET743_HELA_DN | GAJATE_RESPONSE_TO_TRABECTEDIN_DN |
| ET743_HELA_UP | GAJATE_RESPONSE_TO_TRABECTEDIN_UP |
| TIS7_OVEREXP_DN | VIETOR_IFRD1_TARGETS |
| VEGF_MMMEC_6HRS_UP | WESTON_VEGFA_TARGETS_6HR |
| VEGF_MMMEC_12HRS_UP | WESTON_VEGFA_TARGETS_12HR |
| VEGF_MMMEC_ALL_UP | WESTON_VEGFA_TARGETS |
| VEGF_MMMEC_3HRS_UP | WESTON_VEGFA_TARGETS_3HR |
| MKK6EE_UP | Deprecated |
| IGFR_IR_UP | MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP |
| IGFR_IR_DN | MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN |
| STEMCELL_COMMON_DN | RAMALHO_STEMNESS_DN |
| STEMCELL_COMMON_UP | RAMALHO_STEMNESS_UP |
| STEMCELL_NEURAL_UP | Deprecated |
| STEMCELL_EMBRYONIC_UP | Deprecated |
| STEMCELL_HEMATOPOIETIC_UP | Deprecated |
| HSC_EARLYPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR |
| HSC_HSC_ADULT | Deprecated |
| HSC_MATURE_SHARED | IVANOVA_HEMATOPOIESIS_MATURE_CELL |
| HSC_LATEPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR |
| HSC_LTHSC_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM |
| HSC_HSCANDPROGENITORS_ADULT | Deprecated |
| HSC_HSC_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL |
| HSC_MATURE_FETAL | HSC_MATURE_FETAL |
| HSC_LTHSC_ADULT | Deprecated |
| HSC_STHSC_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM |
| HSC_LTHSC_FETAL | Deprecated |
| HSC_LATEPROGENITORS_ADULT | Deprecated |
| HSC_EARLYPROGENITORS_FETAL | Deprecated |
| HSC_INTERMEDIATEPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR |
| HSC_HSCANDPROGENITORS_FETAL | Deprecated |
| HSC_MATURE_ADULT | Deprecated |
| HSC_HSCANDPROGENITORS_SHARED | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR |
| HSC_INTERMEDIATEPROGENITORS_ADULT | Deprecated |
| HSC_LATEPROGENITORS_FETAL | Deprecated |
| HSC_STHSC_ADULT | Deprecated |
| HSC_EARLYPROGENITORS_ADULT | Deprecated |
| HSC_HSC_FETAL | Deprecated |
| HSC_STHSC_FETAL | Deprecated |
| HSC_INTERMEDIATEPROGENITORS_FETAL | Deprecated |
| IRITANI_ADPROX_VASC | Deprecated |
| IRITANI_ADPROX_LYMPH | Deprecated |
| IRITANI_ADPROX_DN | Deprecated |
| IRITANI_ADPROX_UP | Deprecated |
| — | IRITANI_MAD1_TARGETS_UP |
| — | IRITANI_MAD1_TARGETS_DN |
| JNK_DN | HAN_JNK_SINGALING_UP |
| JNK_UP | HAN_JNK_SINGALING_DN |
| LINDSTEDT_DEND_8H_VS_48H_DN | Deprecated |
| LINDSTEDT_DEND_8H_VS_48H_UP | Deprecated |
| LINDSTEDT_DEND_DN | Deprecated |
| LINDSTEDT_DEND_UP | Deprecated |
| — | LINDSTEDT_DENDRITIC_CELL_MATURATION_A |
| — | LINDSTEDT_DENDRITIC_CELL_MATURATION_B |
| — | LINDSTEDT_DENDRITIC_CELL_MATURATION_C |
| — | LINDSTEDT_DENDRITIC_CELL_MATURATION_D |
| — | CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB |
| INOS_ALL_UP | ZAMORA_NOS2_TARGETS_UP |
| INOS_ALL_DN | ZAMORA_NOS2_TARGETS_DN |
| TPA_SENS_MIDDLE_DN | Deprecated |
| TPA_RESIST_LATE_UP | Deprecated |
| TPA_SENS_LATE_DN | Deprecated |
| TPA_RESIST_EARLY_DN | Deprecated |
| TPA_RESIST_MIDDLE_DN | Deprecated |
| TPA_RESIST_EARLY_UP | Deprecated |
| TPA_RESIST_MIDDLE_UP | Deprecated |
| TPA_SENS_MIDDLE_UP | Deprecated |
| TPA_SENS_EARLY_UP | Deprecated |
| TPA_RESIST_LATE_DN | Deprecated |
| TPA_SENS_LATE_UP | Deprecated |
| TPA_SENS_EARLY_DN | Deprecated |
| ASTIER_BCELL | Deprecated |
| ASTIER_FN_DIFF | ASTIER_INTEGRIN_SIGNALING |
| ZHAN_TONSIL_PCBC | Deprecated |
| ZHAN_TONSIL_BONEMARROW | Deprecated |
| ZHAN_MMPC_PC | Deprecated |
| ZHAN_MMPC_EARLYVS | Deprecated |
| ZHAN_MMPC_SIMAL | Deprecated |
| ZHAN_MMPC_SIM_BC_AND_MM | Deprecated |
| ZHAN_MMPC_SIM | ZHAN_V2_LATE_DIFFERENTIATION_GENES |
| ZHAN_MMPC_LATEVS | Deprecated |
| — | ZHAN_EARLY_DIFFERENTIATION_GENES_UP |
| — | ZHAN_EARLY_DIFFERENTIATION_GENES_DN |
| — | ZHAN_LATE_DIFFERENTIATION_GENES_UP |
| — | ZHAN_LATE_DIFFERENTIATION_GENES_DN |
| — | ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP |
| — | ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN |
| — | ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP |
| — | ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN |
| NAKAJIMA_MCS_UP | Deprecated |
| HOGERKORP_ANTI_CD44_UP | Deprecated |
| HOGERKORP_ANTI_CD44_DN | Deprecated |
| HOGERKORP_CD44_DN | HOEGERKORP_CD44_TARGETS_DIRECT_DN |
| HOGERKORP_CD44_TEMPORALLY_DN | HOEGERKORP_CD44_TARGETS_TEMPORAL_UP |
| HOGERKORP_CD44_TEMPORALLY_UP | HOEGERKORP_CD44_TARGETS_TEMPORAL_DN |
| HOGERKORP_CD44_UP | HOEGERKORP_CD44_TARGETS_DIRECT_UP |
| HOFMANN_MDS_CD34_LOW_RISK | Deprecated |
| HOFMANN_MDS_CD34_HIGH_RISK | Deprecated |
| HOFMANN_MDS_CD34_LOW_AND_HIGH_RISK | Deprecated |
| — | HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP |
| — | HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN |
| — | HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP |
| — | HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN |
| — | HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP |
| — | HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN |
| IFNALPHA_RESIST_DN | TRACEY_RESISTANCE_TO_IFNA2_DN |
| — | TRACEY_RESISTANCE_TO_IFNA2_UP |
| OXSTRESS_BREASTCA_DN | CHUANG_OXIDATIVE_STRESS_RESPONSE_DN |
| OXSTRESS_BREASTCA_UP | CHUANG_OXIDATIVE_STRESS_RESPONSE_UP |
| RETT_DN | TRAYNOR_RETT_SYNDROM_UP |
| RETT_UP | TRAYNOR_RETT_SYNDROM_DN |
| OXSTRESS_RPE_H2O2TBH_DN | WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2 |
| OXSTRESS_RPETHREE_DN | WEIGEL_OXIDATIVE_STRESS_RESPONSE |
| OXSTRESS_RPE_H2O2HNE_DN | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2 |
| OXSTRESS_RPETWO_DN | Deprecated |
| OXSTRESS_RPE_HNETBH_DN | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH |
| GNATENKO_PLATELET | GNATENKO_PLATELET_SIGNATURE |
| GNATENKO_PLATELET_UP | Deprecated |
| PLATELET_EXPRESSED | Deprecated |
| GILDEA_BLADDER_UP | GILDEA_METASTASIS |
| SHH_UP | INGRAM_SHH_TARGETS |
| P53GENES_ALL | INGA_TP53_TARGETS |
| METHOTREXATE_PROBCELL_DN | BRACHAT_RESPONSE_TO_METHOTREXATE_DN |
| CISPLATIN_PROBCELL_UP | BRACHAT_RESPONSE_TO_CISPLATIN |
| CANCERDRUGS_PROBCELL_DN | BRACHAT_RESPONSE_TO_CANCER_DRUGS_DN |
| METHOTREXATE_PROBCELL_UP | BRACHAT_RESPONSE_TO_METHOTREXATE_UP |
| CAMPTOTHECIN_PROBCELL_UP | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP |
| CANCERDRUGS_PROBCELL_UP | BRACHAT_RESPONSE_TO_CANCER_DRUGS_UP |
| CAMPTOTHECIN_PROBCELL_DN | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN |
| METASTASIS_ADENOCARC_DN | RAMASWAMY_METASTASIS_DN |
| METASTASIS_ADENOCARC_UP | RAMASWAMY_METASTASIS_UP |
| O6BG_RESIST_MEDULLOBLASTOMA_DN | BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN |
| O6BG_RESIST_MEDULLOBLASTOMA_UP | BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP |
| CHAUHAN_2ME2 | Deprecated |
| — | CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP |
| — | CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN |
| KLEIN_PEL_DN | KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN |
| KLEIN_PEL_UP | KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP |
| NI2_MOUSE_UP | MCDOWELL_ACUTE_LUNG_INJURY_UP |
| NI2_MOUSE_DN | MCDOWELL_ACUTE_LUNG_INJURY_DN |
| UNDERHILL_PROLIFERATION | Deprecated |
| YAO_P4_KO_VS_WT_DN | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN |
| YAO_P4_KO_VS_WT_UP | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8 |
| — | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9 |
| SMITH_HCV_INDUCED_HCC_UP | SMITH_LIVER_CANCER |
| ELONGINA_KO_UP | YAMAZAKI_TCEB3_TARGETS_UP |
| ELONGINA_KO_DN | YAMAZAKI_TCEB3_TARGETS_DN |
| H2O2_CSBDIFF_C1 | Deprecated |
| H2O2_CSBRESCUED_C2_UP | Deprecated |
| H2O2_CSBCOMBINED | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6 |
| H2O2_CSBRESCUED_UP | KYNG_RESPONSE_TO_H2O2 |
| H2O2_CSBDIFF_C2 | Deprecated |
| H2O2_CSBRESCUED_C1_UP | Deprecated |
| — | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP |
| — | KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN |
| BRACX_UP | HEDENFALK_BREAST_CANCER_BRACX_UP |
| BRACX_DN | HEDENFALK_BREAST_CANCER_BRACX_DN |
| HEATSHOCK_OLD_UP | VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP |
| AGEING_LYMPH_DN | VISALA_AGING_LYMPHOCYTE_DN |
| HEATSHOCK_YOUNG_UP | VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN |
| — | VISALA_AGING_LYMPHOCYTE_UP |
| ROME_INSULIN_2F_UP | Deprecated |
| ROME_INSULIN_2F_DN | Deprecated |
| — | ROME_INSULIN_TARGETS_IN_MUSCLE_UP |
| — | ROME_INSULIN_TARGETS_IN_MUSCLE_DN |
| MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN | MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN |
| MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP | MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP |
| MAGRANGEAS_MULTIPLE_MYELOMA_IGL_VS_IGK_DN | MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN |
| MAGRANGEAS_MULTIPLE_MYELOMA_IGL_VS_IGK_UP | MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP |
| FERRANDO_MLL_T_ALL_UP | FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP |
| FERRANDO_MLL_T_ALL_DN | FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN |
| YE_INTRAMETASTATIC_HCC_UP | YE_METASTATIC_LIVER_CANCER |
| TPA_SKIN_UP | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP |
| TPA_SKIN_DN | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN |
| BENNETT_SLE_UP | BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS |
| ADIPOGENESIS_HMSC_CLASS1_UP | Deprecated |
| ADIPOGENESIS_HMSC_CLASS2_UP | Deprecated |
| ADIPOGENESIS_HMSC_CLASS3_UP | Deprecated |
| ADIPOGENESIS_HMSC_CLASS5_UP | Deprecated |
| ADIPOGENESIS_HMSC_CLASS8_DN | Deprecated |
| — | NAKAMURA_ADIPOGENESIS_EARLY_DN |
| — | NAKAMURA_ADIPOGENESIS_EARLY_UP |
| — | NAKAMURA_ADIPOGENESIS_LATE_DN |
| — | NAKAMURA_ADIPOGENESIS_LATE_UP |
| YAMA_RECURRENT_HCC_UP | IIZUKA_RECURRENT_LIVER_CANCER |
| ICHIBA_GVHD | Deprecated |
| — | ICHIBA_D7_GRAFT_VERSUS_HOST_DISEASE_UP |
| — | ICHIBA_D7_GRAFT_VERSUS_HOST_DISEASE_DN |
| — | ICHIBA_D35_GRAFT_VERSUS_HOST_DISEASE_UP |
| — | ICHIBA_D35_GRAFT_VERSUS_HOST_DISEASE_DN |
| TARTE_BCELL | TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN |
| TARTE_PC | TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP |
| TARTE_PLASMA_BLASTIC | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN |
| TARTE_MATURE_PC | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP |
| NUTT_GBN_VS_AO_DN | Deprecated |
| NUTT_GBN_VS_AO_UP | Deprecated |
| — | NUTT_GBM_VS_AO_GLIOMA_UP |
| — | NUTT_GBM_VS_AO_GLIOMA_DN |
| HINATA_NFKB_UP | Deprecated |
| HINATA_NFKB_DN | Deprecated |
| — | HINATA_NFKB_TARGETS_KERATINOCYTE_UP |
| — | HINATA_NFKB_TARGETS_KERATINOCYTE_DN |
| — | HINATA_NFKB_TARGETS_FIBROBLAST_UP |
| — | HINATA_NFKB_TARGETS_FIBROBLAST_DN |
| TNFALPHA_4HRS_UP | ZHOU_TNF_SIGNALING_4HR |
| TNFALPHA_ALL_UP | Deprecated |
| TNFALPHA_30MIN_UP | ZHOU_TNF_SIGNALING_30MIN |
| AS3_HEK293_DN | ZHENG_RESPONSE_TO_ARSENITE_DN |
| AS3_HEK293_UP | ZHENG_RESPONSE_TO_ARSENITE_UP |
| OSAWA_TNFA_HEPATOCYTE_UP | OSAWA_TNF_TARGETS |
| VHL_NORMAL_UP | Deprecated |
| VHL_RCC_UP | JIANG_VHL_TARGETS |
| RCC_NL_UP | Deprecated |
| HYPOXIA_NORMAL_UP | JIANG_HYPOXIA_NORMAL |
| HYPOXIA_RCC_NOVHL_UP | JIANG_HYPOXIA_CANCER |
| HYPOXIA_RCC_UP | Deprecated |
| — | JIANG_HYPOXIA_VIA_VHL |
| FERNANDEZ_MYC_TARGETS | FERNANDEZ_BOUND_BY_MYC |
| HTERT_DN | LINDVALL_IMMORTALIZED_BY_TERT_UP |
| HTERT_UP | LINDVALL_IMMORTALIZED_BY_TERT_DN |
| CHEOK_MP_DN | CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN |
| CHEOK_LDMTX_MP_UP | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP |
| CHEOK_MP_UP | CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP |
| CHEOK_HDMTX_DN | CHEOK_RESPONSE_TO_HD_MTX_DN |
| CHEOK_HDMTX_UP | CHEOK_RESPONSE_TO_HD_MTX_UP |
| CHEOK_LDMTX_MP_DN | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN |
| — | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP |
| — | CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN |
| SMITH_HTERT_DN | SMITH_TERT_TARGETS_UP |
| SMITH_HTERT_UP | SMITH_TERT_TARGETS_DN |
| RIBAVIRIN_RSV_DN | ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP |
| RIBAVIRIN_RSV_UP | ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN |
| TSADAC_HYPERMETH_OVCA_UP | Deprecated |
| TSADAC_HYPOMETH_HYPERAC_OVCA_UP | Deprecated |
| TSADAC_HYPERMETH_HYPERAC_OVCA_UP | Deprecated |
| TSADAC_HYPOMETH_OVCA_UP | Deprecated |
| TGZ_ADIP_UP | RUAN_RESPONSE_TO_TROGLITAZONE_UP |
| TNFALPHA_ADIP_UP | RUAN_RESPONSE_TO_TNF_UP |
| TNFALPHA_TGZ_ADIP_DN | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN |
| TNFALPHA_ADIP_DN | RUAN_RESPONSE_TO_TNF_DN |
| TNFALPHA_TGZ_ADIP_UP | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP |
| ADIP_DIFF_UP | Deprecated |
| — | RUAN_RESPONSE_TO_TROGLITAZONE_DN |
| YAGI_AML_PROGNOSIS | YAGI_AML_RELAPSE_PROGNOSIS |
| YAGI_AML_PROG_ASSOC | YAGI_AML_SURVIVAL |
| YAGI_AML_PROG_FAB | YAGI_AML_FAB_MARKERS |
| — | YAGI_AML_WITH_T_8_21_TRANSLOCATION |
| — | YAGI_AML_WITH_INV_16_TRANSLOCATION |
| — | YAGI_AML_WITH_T_9_11_TRANSLOCATION |
| — | YAGI_AML_WITH_11Q23_REARRANGED |
| NEMETH_TNF_UP | NEMETH_INFLAMMATORY_RESPONSE_LPS_UP |
| NEMETH_TNF_DN | NEMETH_INFLAMMATORY_RESPONSE_LPS_DN |
| UVB_NHEK1_C3 | DAZARD_UV_RESPONSE_CLUSTER_G3 |
| UVB_SCC_DN | DAZARD_RESPONSE_TO_UV_SCC_DN |
| UVB_NHEK1_UP | DAZARD_RESPONSE_TO_UV_NHEK_UP |
| UVB_NHEK1_C4 | DAZARD_UV_RESPONSE_CLUSTER_G4 |
| UVB_NHEK1_DN | DAZARD_RESPONSE_TO_UV_NHEK_DN |
| UVB_SCC_UP | DAZARD_RESPONSE_TO_UV_SCC_UP |
| UVB_NHEK1_C1 | DAZARD_UV_RESPONSE_CLUSTER_G1 |
| UVB_NHEK1_C6 | DAZARD_UV_RESPONSE_CLUSTER_G6 |
| UVB_NHEK1_C2 | DAZARD_UV_RESPONSE_CLUSTER_G2 |
| — | DAZARD_UV_RESPONSE_CLUSTER_G5 |
| — | DAZARD_UV_RESPONSE_CLUSTER_G24 |
| — | DAZARD_UV_RESPONSE_CLUSTER_G28 |
| SCHRAETS_MLL_UP | Deprecated |
| — | SCHRAETS_MLL_TARGETS_UP |
| — | SCHRAETS_MLL_TARGETS_DN |
| CROONQUIST_RAS_STROMA_UP | Deprecated |
| CROONQUIST_RAS_STROMA_DN | Deprecated |
| CROONQUIST_IL6_STARVE_UP | Deprecated |
| CROONQUIST_IL6_RAS_UP | Deprecated |
| CROONQUIST_IL6_STROMA_UP | Deprecated |
| CROONQUIST_IL6_RAS_DN | Deprecated |
| — | CROONQUIST_IL6_DEPRIVATION_UP |
| — | CROONQUIST_IL6_DEPRIVATION_DN |
| — | CROONQUIST_STROMAL_STIMULATION_UP |
| — | CROONQUIST_STROMAL_STIMULATION_DN |
| — | CROONQUIST_NRAS_SIGNALING_UP |
| — | CROONQUIST_NRAS_SIGNALING_DN |
| — | CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP |
| — | CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN |
| GUO_HEX_UP | GUO_HEX_TARGETS_UP |
| GUO_HEX_DN | GUO_HEX_TARGETS_DN |
| P53_BRCA1_UP | ONGUSAHA_TP53_TARGETS |
| — | ONGUSAHA_BRCA1_TARGETS_UP |
| — | ONGUSAHA_BRCA1_TARGETS_DN |
| MOOTHA_VOXPHOS | MOOTHA_VOXPHOS |
| HUMAN_MITODB_6_2002 | MOOTHA_HUMAN_MITODB_6_2002 |
| PGC | MOOTHA_PGC |
| TCA | MOOTHA_TCA |
| MITOCHONDRIA | MOOTHA_MITOCHONDRIA |
| ROS | MOOTHA_ROS |
| — | MOOTHA_PYR |
| — | MOOTHA_FFA_OXYDATION |
| — | MOOTHA_GLUCONEOGENESIS |
| — | MOOTHA_GLYCOGEN_METABOLISM |
| — | MOOTHA_GLYCOLYSIS |
| GALINDO_ACT_UP | GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN |
| LVAD_HEARTFAILURE_DN | CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN |
| LVAD_HEARTFAILURE_UP | CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP |
| FSH_HUMAN_GRANULOSA_UP | SASSON_FSH_RESPONSE |
| DAC_PANC50_UP | SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 |
| TSADAC_PANC50_UP | SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER |
| TSA_PANC50_UP | SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER |
| DAC_PANC_UP | SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1 |
| OKUMURA_MC_LPS | OKUMURA_INFLAMMATORY_RESPONSE_LPS |
| HYPOXIA_REG_UP | LEONARD_HYPOXIA |
| REOVIRUS_HEK293_UP | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP |
| REOVIRUS_HEK293_DN | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN |
| PARK_RARALPHA_UP | Deprecated |
| PARK_RARALPHA_MOD | Deprecated |
| — | PARK_APL_PATHOGENESIS_UP |
| — | PARK_APL_PATHOGENESIS_DN |
| — | PARK_TRETINOIN_RESPONSE |
| — | PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION |
| — | PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION |
| DISTECHE_XINACTIVATED_GENES | DISTECHE_ESCAPED_FROM_X_INACTIVATION |
| UVC_HIGH_D9_DN | GENTILE_UV_RESPONSE_CLUSTER_D9 |
| UVC_LOW_ALL_UP | GENTILE_UV_LOW_DOSE_UP |
| UVC_HIGH_D4_DN | GENTILE_UV_RESPONSE_CLUSTER_D4 |
| UVC_LOW_C2_DN | Deprecated |
| UVC_HIGH_D5_DN | GENTILE_UV_RESPONSE_CLUSTER_D5 |
| UVC_HIGH_D2_DN | GENTILE_UV_RESPONSE_CLUSTER_D2 |
| UVC_HIGH_D7_DN | GENTILE_UV_RESPONSE_CLUSTER_D7 |
| UVC_HIGH_D6_DN | GENTILE_UV_RESPONSE_CLUSTER_D6 |
| UVC_LOW_A2_UP | Deprecated |
| UVC_HIGH_ALL_DN | GENTILE_UV_HIGH_DOSE_DN |
| UVC_HIGH_ALL_UP | GENTILE_UV_HIGH_DOSE_UP |
| UVC_HIGH_D1_DN | GENTILE_UV_RESPONSE_CLUSTER_D1 |
| UVC_LOW_C1_DN | Deprecated |
| UVC_LOW_C3_DN | Deprecated |
| UVC_LOW_ALL_DN | GENTILE_UV_LOW_DOSE_DN |
| UVC_HIGH_D8_DN | GENTILE_UV_RESPONSE_CLUSTER_D8 |
| UVC_HIGH_D3_DN | GENTILE_RESPONSE_CLUSTER_D3 |
| LAMB_CYCLIN_D1_UP | LAMB_CCND1_TARGETS |
| LAMB_CYCLIN_D3_GLOCUS | Deprecated |
| NI2_LUNG_DN | CHENG_RESPONSE_TO_NICKEL_ACETATE |
| VERNELL_PRB_CLSTR2 | VERNELL_RETINOBLASTOMA_PATHWAY_DN |
| VERNELL_PRB_CLSTR1 | VERNELL_RETINOBLASTOMA_PATHWAY_UP |
| DAVIES_MGUS_MM | Deprecated |
| DAVIES_N | Deprecated |
| — | DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP |
| — | DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN |
| MUNSHI_MM_UP | Deprecated |
| MUNSHI_MM_VS_PCS_DN | MUNSHI_MULTIPLE_MYELOMA_DN |
| MUNSHI_MM_VS_PCS_UP | MUNSHI_MULTIPLE_MYELOMA_UP |
| BROCKE_IL6 | BROCKE_APOPTOSIS_REVERSED_BY_IL6 |
| KRETZSCHMAR_IL6_DIFF | KRETZSCHMAR_IL6_DIFF |
| HYPOXIA_FIBRO_UP | KIM_HYPOXIA |
| ADIPOCYTE_BRCA_UP | IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS |
| TAVOR_CEBP_DN | TAVOR_CEBPA_TARGETS_DN |
| TAVOR_CEBP_UP | TAVOR_CEBPA_TARGETS_UP |
| EGF_HDMEC_UP | ZHANG_PROLIFERATING_VS_QUIESCENT |
| ZELLER_MYC_DN | Deprecated |
| ZELLER_MYC_UP | Deprecated |
| MYC_TARGETS | Deprecated |
| — | DANG_REGULATED_BY_MYC_UP |
| — | DANG_REGULATED_BY_MYC_DN |
| — | DANG_MYC_TARGETS_UP |
| — | DANG_MYC_TARGETS_DN |
| — | DANG_BOUND_BY_MYC |
| YEN_MYC_WT | Deprecated |
| YEN_MYC_MUT | Deprecated |
| — | ELLWOOD_MYC_TARGETS_UP |
| — | ELLWOOD_MYC_TARGETS_DN |
| BYSTROM_IL5_DN | BYSTROEM_CORRELATED_WITH_IL5_DN |
| BYSTROM_IL5_UP | BYSTROEM_CORRELATED_WITH_IL5_UP |
| WERNER_FIBRO_UP | Deprecated |
| WERNERONLY_FIBRO_UP | Deprecated |
| WERNER_FIBRO_DN | Deprecated |
| OLDWERNER_FIBRO_DN | Deprecated |
| WERNERONLY_FIBRO_DN | Deprecated |
| OLD_FIBRO_UP | Deprecated |
| OLDWERNER_FIBRO_UP | Deprecated |
| OLDONLY_FIBRO_DN | Deprecated |
| OLD_FIBRO_DN | Deprecated |
| OLDONLY_FIBRO_UP | Deprecated |
| — | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP |
| — | KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN |
| — | KYNG_NORMAL_AGING_UP |
| — | KYNG_NORMAL_AGING_DN |
| — | KYNG_WERNER_SYNDROM_UP |
| — | KYNG_WERNER_SYNDROM_DN |
| INSULIN_ADIP_INSENS_UP | SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP |
| INSULIN_ADIP_SENS_DN | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN |
| INSULIN_ADIP_SENS_UP | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP |
| INSULIN_ADIP_INSENS_DN | SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN |
| — | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP |
| — | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN |
| EMT_UP | Deprecated |
| EMT_DN | Deprecated |
| DFOSB_BRAIN_8WKS_UP | MCCLUNG_DELTA_FOSB_TARGETS_8WK |
| CREB_BRAIN_2WKS_UP | Deprecated |
| CREB_BRAIN_8WKS_DN | MCCLUNG_CREB1_TARGETS_DN |
| COCAINE_BRAIN_5D_UP | MCCLUNG_COCAINE_REWARD_5D |
| DFOSB_BRAIN_2WKS_UP | MCCLUNG_DELTA_FOSB_TARGETS_2WK |
| CREB_BRAIN_8WKS_UP | MCCLUNG_CREB1_TARGETS_UP |
| COCAINE_BRAIN_4WKS_UP | MCCLUNG_COCAIN_REWARD_4WK |
| CHEN_LUNG_SURVIVAL | CHEN_LUNG_CANCER_SURVIVAL |
| ABBUD_LIF_DN | ABBUD_LIF_SIGNALING_1_DN |
| ABBUD_LIF_GH3_UP | ABBUD_LIF_SIGNALING_2_UP |
| ABBUD_LIF_UP | ABBUD_LIF_SIGNALING_1_UP |
| ABBUD_LIF_GH3_DN | ABBUD_LIF_SIGNALING_2_DN |
| BRENTANI_IMMUNE_FUNCTION | Deprecated |
| BRENTANI_CYTOSKELETON | Deprecated |
| BRENTANI_SIGNALING | Deprecated |
| BRENTANI_REPAIR | Deprecated |
| BRENTANI_TRANSPORT | Deprecated |
| BRENTANI_CELL_CYCLE | Deprecated |
| BRENTANI_ANGIOGENESIS | Deprecated |
| BRENTANI_DEATH | Deprecated |
| BRENTANI_CELL_ADHESION | Deprecated |
| BRENTANI_TRANSPORT_OF_VESICLES | Deprecated |
| BRENTANI_CANCER_TESTIS | Deprecated |
| BRENTANI_DNA_METHYLATION_AND_MODIFICATION | Deprecated |
| BRENTANI_TRANSCRIPTION_FACTORS | Deprecated |
| BRENTANI_PROTEIN_MODIFICATION | Deprecated |
| BRENTANI_HORMONAL_FUNCTION | Deprecated |
| DORSAM_HOXA9_UP | DORSAM_HOXA9_TARGETS_UP |
| DORSAM_HOXA9_DN | DORSAM_HOXA9_TARGETS_DN |
| TSA_CD4_UP | MOREIRA_RESPONSE_TO_TSA_UP |
| TSA_CD4_DN | MOREIRA_RESPONSE_TO_TSA_DN |
| KUMAR_HOXA_DIFF | KUMAR_TARGETS_OF_MLL_AF9_FUSION |
| HEDVAT_ELF_UP | HEDVAT_ELF4_TARGETS_UP |
| HEDVAT_ELF_DN | HEDVAT_ELF4_TARGETS_DN |
| CANTHARIDIN_UP | ZHANG_RESPONSE_TO_CANTHARIDIN_UP |
| CANTHARIDIN_DN | ZHANG_RESPONSE_TO_CANTHARIDIN_DN |
| BRG1_ALAB_UP | HENDRICKS_SMARCA4_TARGETS_UP |
| BRG1_ALAB_DN | HENDRICKS_SMARCA4_TARGETS_DN |
| CROMER_HYPOPHARYNGEAL_MET_VS_NON_UP | CROMER_METASTASIS_UP |
| CROMER_HYPOPHARYNGEAL_MET_VS_NON_DN | CROMER_METASTASIS_DN |
| — | CROMER_TUMORIGENESIS_UP |
| — | CROMER_TUMORIGENESIS_DN |
| CHIARETTI_T_ALL | Deprecated |
| CHIARETTI_T_ALL_DIFF | Deprecated |
| — | CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY |
| — | CHIARETTI_T_ALL_RELAPSE_PROGNOSIS |
| BRUNO_IL3_DN | BRUNO_HEMATOPOIESIS |
| BASSO_HCL_DIFF | Deprecated |
| — | BASSO_HAIRY_CELL_LEUKEMIA_UP |
| — | BASSO_HAIRY_CELL_LEUKEMIA_DN |
| CIS_RESIST_GASTRIC_UP | Deprecated |
| 5FU_RESIST_GASTRIC_DN | KANG_FLUOROURACIL_RESISTANCE_DN |
| 5FU_RESIST_GASTRIC_UP | KANG_FLUOROURACIL_RESISTANCE_UP |
| DOX_RESIST_GASTRIC_UP | KANG_DOXORUBICIN_RESISTANCE_UP |
| DOX_RESIST_GASTRIC_DN | KANG_DOXORUBICIN_RESISTANCE_DN |
| — | KANG_CISPLATIN_RESISTANCE_UP |
| — | KANG_CISPLATIN_RESISTANCE_DN |
| CIS_RESIST_LUNG_UP | WHITESIDE_CISPLATIN_RESISTANCE_UP |
| CIS_RESIST_LUNG_DN | WHITESIDE_CISPLATIN_RESISTANCE_DN |
| CHANG_SERUM_RESPONSE_UP | Deprecated |
| CHANG_SERUM_RESPONSE_DN | Deprecated |
| SERUM_FIBROBLAST_CORE_DN | Deprecated |
| SERUM_FIBROBLAST_CELLCYCLE | Deprecated |
| SERUM_FIBROBLAST_CORE_UP | Deprecated |
| — | CHANG_CORE_SERUM_RESPONSE_UP |
| — | CHANG_CORE_SERUM_RESPONSE_DN |
| — | CHANG_CYCLING_GENES |
| ALZHEIMERS_INCIPIENT_UP | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP |
| ALZHEIMERS_DISEASE_DN | BLALOCK_ALZHEIMERS_DISEASE_DN |
| ALZHEIMERS_DISEASE_UP | BLALOCK_ALZHEIMERS_DISEASE_UP |
| ALZHEIMERS_INCIPIENT_DN | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN |
| RORIE_ES_PNET_UP | RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP |
| RORIE_ES_PNET_DN | RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN |
| FRASOR_ER_UP | FRASOR_RESPONSE_TO_ESTRADIOL_UP |
| FRASOR_ER_DN | FRASOR_RESPONSE_TO_ESTRADIOL_DN |
| — | FRASOR_RESPONSE_TO_SERM_OR_ICI_UP |
| — | FRASOR_RESPONSE_TO_SERM_OR_ICI_DN |
| PDGF_ES_UP | CHEN_PDGF_TARGETS |
| PASSERINI_APOPTOSIS | Deprecated |
| PASSERINI_TRANSCRIPTION | Deprecated |
| PASSERINI_EM | Deprecated |
| PASSERINI_ADHESION | Deprecated |
| PASSERINI_INFLAMMATION | Deprecated |
| PASSERINI_SIGNAL | Deprecated |
| PASSERINI_OXIDATION | Deprecated |
| PASSERINI_IMMUNE | Deprecated |
| PASSERINI_PROLIFERATION | Deprecated |
| PASSERINI_GROWTH | Deprecated |
| PASSERINI_COMPLEMENT | Deprecated |
| STEFFEN_AML_PML_PLZF_TRGT | Deprecated |
| — | MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP |
| — | MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN |
| LH_GRANULOSA_DN | Deprecated |
| FSH_GRANULOSA_UP | Deprecated |
| GN_CAMP_GRANULOSA_DN | Deprecated |
| GN_CAMP_GRANULOSA_UP | Deprecated |
| FSH_GRANULOSA_DN | Deprecated |
| LH_GRANULOSA_UP | Deprecated |
| — | SASSON_RESPONSE_TO_GONADOTROPHINS_UP |
| — | SASSON_RESPONSE_TO_GONADOTROPHINS_DN |
| — | SASSON_RESPONSE_TO_FORSKOLIN_UP |
| — | SASSON_RESPONSE_TO_FORSKOLIN_DN |
| JISON_SICKLE_CELL | Deprecated |
| JISON_SICKLECELL_DIFF | Deprecated |
| — | JISON_SICKLE_CELL_DISEASE_UP |
| — | JISON_SICKLE_CELL_DISEASE_DN |
| REFRACTORY_GASTRIC_UP | KIM_GASTRIC_CANCER_CHEMOSENSITIVITY |
| IDX_TSA_DN_CLUSTER4 | BURTON_ADIPOGENESIS_10 |
| IDX_TSA_DN_CLUSTER6 | BURTON_ADIPOGENESIS_12 |
| IDX_TSA_UP_CLUSTER5 | BURTON_ADIPOGENESIS_5 |
| IDX_TSA_UP_CLUSTER3 | BURTON_ADIPOGENESIS_3 |
| IDX_TSA_DN_CLUSTER2 | BURTON_ADIPOGENESIS_8 |
| IDX_TSA_UP_CLUSTER2 | BURTON_ADIPOGENESIS_2 |
| IDX_TSA_UP_CLUSTER4 | BURTON_ADIPOGENESIS_4 |
| IDX_TSA_UP_CLUSTER1 | BURTON_ADIPOGENESIS_1 |
| IDX_TSA_DN_CLUSTER1 | BURTON_ADIPOGENESIS_7 |
| IDX_TSA_DN_CLUSTER5 | BURTON_ADIPOGENESIS_11 |
| IDX_TSA_DN_CLUSTER3 | BURTON_ADIPOGENESIS_9 |
| IDX_TSA_UP_CLUSTER6 | BURTON_ADIPOGENESIS_6 |
| STOSSI_ER_UP | STOSSI_ESTRADIOL_SIGNALING_VIA_ESTROGEN_RECEPTORS |
| DIAB_NEPH_UP | BAELDE_DIABETIC_NEPHROPATHY_UP |
| DIAB_NEPH_DN | BAELDE_DIABETIC_NEPHROPATHY_DN |
| ADIP_HUMAN_UP | URS_ADIPOCYTE_DIFFERENTIATION_UP |
| ADIP_HUMAN_DN | URS_ADIPOCYTE_DIFFERENTIATION_DN |
| ROS_MOUSE_AORTA_UP | KEEN_RESPONSE_TO_ROSIGLITAZONE_UP |
| ROS_MOUSE_AORTA_DN | KEEN_RESPONSE_TO_ROSIGLITAZONE_DN |
| BHATTACHARYA_ESC_UP | BHATTACHARYA_EMBRYONIC_STEM_CELL |
| — | VALK_AML_CLUSTER_1 |
| — | VALK_AML_CLUSTER_2 |
| — | VALK_AML_CLUSTER_3 |
| — | VALK_AML_CLUSTER_4 |
| — | VALK_AML_CLUSTER_5 |
| — | VALK_AML_CLUSTER_6 |
| — | VALK_AML_CLUSTER_7 |
| — | VALK_AML_CLUSTER_8 |
| — | VALK_AML_CLUSTER_9 |
| — | VALK_AML_CLUSTER_10 |
| — | VALK_AML_CLUSTER_11 |
| — | VALK_AML_CLUSTER_12 |
| — | VALK_AML_CLUSTER_13 |
| — | VALK_AML_CLUSTER_15 |
| — | VALK_AML_CLUSTER_16 |
| — | VALK_AML_WITH_T_8_21_TRANSLOCATION |
| — | VALK_AML_WITH_11Q23_REARRANGED |
| — | VALK_AML_WITH_EVI1 |
| — | VALK_AML_WITH_CEBPA |
| — | VALK_AML_WITH_FLT3_ITD |
| IL6_FIBRO_UP | Deprecated |
| IL6_SCAR_FIBRO_UP | DASU_IL6_SIGNALING_SCAR_UP |
| IL6_SCAR_FIBRO_DN | DASU_IL6_SIGNALING_SCAR_DN |
| — | DASU_IL6_SIGNALING_UP |
| — | DASU_IL6_SIGNALING_DN |
| WIELAND_HEPATITIS_B_INDUCED | WIELAND_UP_BY_HBV_INFECTION |
| HEARTFAILURE_ATRIA_DN | KAAB_FAILED_HEART_ATRIUM_DN |
| ATRIA_UP | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP |
| HEARTFAILURE_ATRIA_UP | KAAB_FAILED_HEART_ATRIUM_UP |
| VENTRICLES_UP | KAAB_HEART_ATRIUM_VS_VENTRICLE_DN |
| HEARTFAILURE_VENTRICLE_DN | KAAB_FAILED_HEART_VENTRICLE_DN |
| — | KAAB_FAILED_HEART_VENTRICLE_UP |
| LEI_MYB_REGULATED_GENES | LEI_MYB_TARGETS |
| CIS_XPC_DN | WANG_CISPLATIN_RESPONSE_AND_XPC_DN |
| CIS_XPC_UP | WANG_CISPLATIN_RESPONSE_AND_XPC_UP |
| CHAUVIN_ANDROGEN_REGULATED_GENES | On Hold |
| GENOTOXINS_4HRS_DISCR | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR |
| GENOTOXINS_ALL_24HRS_REG | HU_GENOTOXIC_DAMAGE_24HR |
| GENOTOXINS_24HRS_DISCR | HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR |
| GENOTOXINS_ALL_4HRS_REG | HU_GENOTOXIC_DAMAGE_4HR |
| IGLESIAS_E2FMINUS_DN | IGLESIAS_E2F_TARGETS_DN |
| IGLESIAS_E2FMINUS_UP | IGLESIAS_E2F_TARGETS_UP |
| RAY_P210_DIFF | Deprecated |
| BCRABL_HL60_CDNA_UP | Deprecated |
| BCRABL_HL60_AFFY_UP | Deprecated |
| BCRABL_HL60_AFFY_DN | Deprecated |
| BCRABL_HL60_CDNA_DN | Deprecated |
| — | RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP |
| — | RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN |
| CANCER_NEOPLASTIC_META_UP | RHODES_CANCER_META_SIGNATURE |
| CANCER_UNDIFFERENTIATED_META_UP | RHODES_UNDIFFERENTIATED_CANCER |
| KNUDSEN_PMNS_UP | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP |
| KNUDSEN_PMNS_DN | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN |
| WALLACE_JAK2_DIFF | Deprecated |
| — | WALLACE_JAK2_TARGETS_UP |
| — | WALLACE_JAK2_TARGETS_DN |
| AGEING_BRAIN_DN | LU_AGING_BRAIN_DN |
| AGEING_BRAIN_UP | LU_AGING_BRAIN_UP |
| SANSOM_APC_LOSS4_UP | SANSOM_APC_TARGETS_UP |
| SANSOM_APC_5_DN | SANSOM_APC_TARGETS_DN |
| SANSOM_APC_4_DN | Deprecated |
| SANSOM_APC_LOSS5_UP | Deprecated |
| AGUIRRE_PANCREAS_CHR12 | Deprecated |
| AGUIRRE_PANCREAS_CHR9 | Deprecated |
| AGUIRRE_PANCREAS_CHR1 | Deprecated |
| AGUIRRE_PANCREAS_CHR19 | Deprecated |
| AGUIRRE_PANCREAS_CHR18 | Deprecated |
| AGUIRRE_PANCREAS_CHR7 | Deprecated |
| AGUIRRE_PANCREAS_CHR8 | Deprecated |
| AGUIRRE_PANCREAS_CHR17 | Deprecated |
| AGUIRRE_PANCREAS_CHR22 | Deprecated |
| AGUIRRE_PANCREAS_CHR6 | Deprecated |
| — | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP |
| — | AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN |
| HALMOS_CEBP_DN | HALMOS_CEBPA_TARGETS_DN |
| HALMOS_CEBP_UP | HALMOS_CEBPA_TARGETS_UP |
| LEE_TCELLS10_UP | Deprecated |
| LEE_TCELLS8_UP | Deprecated |
| LEE_TCELLS9_UP | Deprecated |
| LEE_TCELLS3_UP | Deprecated |
| LEE_TCELLS4_UP | Deprecated |
| LEE_TCELLS5_UP | Deprecated |
| LEE_TCELLS1_UP | Deprecated |
| LEE_TCELLS6_UP | Deprecated |
| LEE_TCELLS7_UP | Deprecated |
| LEE_TCELLS2_UP | Deprecated |
| — | LEE_EARLY_T_LYMPHOCYTE_UP |
| — | LEE_EARLY_T_LYMPHOCYTE_DN |
| — | LEE_INTRATHYMIC_T_PROGENITOR |
| — | LEE_DOUBLE_POLAR_THYMOCYTE |
| — | LEE_SP4_THYMOCYTE |
| — | LEE_RECENT_THYMIC_EMIGRANT |
| — | LEE_NAIVE_T_LYMPHOCYTE |
| — | LEE_DIFFERENTIATING_T_LYMPHOCYTE |
| KIM_TH_CELLS_UP | KIM_GERMINAL_CENTER_T_HELPER_UP |
| KIM_TH_CELLS_DN | KIM_GERMINAL_CENTER_T_HELPER_DN |
| ROSS_CBF | ROSS_AML_OF_CBF_TYPE |
| ROSS_PML_RAR | ROSS_AML_WITH_PML_RARA_FUSION |
| ROSS_CBF_MYH | ROSS_AML_WITH_CBFB_MYH11_FUSION |
| ROSS_MLL_FUSION | ROSS_AML_WITH_MLL_FUSIONS |
| ROSS_CBF_LEUKEMIA | Deprecated |
| ROSS_FAB_M7 | ROSS_AML_OF_FAB_M7_TYPE |
| ROSS_AML1_ETO | ROSS_AML_WITH_AML1_ETO_FUSION |
| — | ROSS_LEUKEMIA_WITH_MLL_FUSIONS |
| HEMATOP_STEM_ALL_UP | GEORGANTAS_HSC_MARKERS |
| ADDYA_K562_HEMIN_TREATMENT | ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN |
| TENEDINI_MEGAKARYOCYTIC_GENES | TENEDINI_MEGAKARYOCYTE_MARKERS |
| UEDA_MOUSE_SCN | UEDA_CENTRAL_CLOCK |
| UEDA_MOUSE_LIVER | UEDA_PERIFERAL_CLOCK |
| — | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP |
| — | KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN |
| WELCH_GATA1 | On Hold |
| MARTINELLI_IFNS_DIFF | Deprecated |
| — | MARTINELLI_IMMATURE_NEUTROPHIL_UP |
| — | MARTINELLI_IMMATURE_NEUTROPHIL_DN |
| NOUZOVA_CPG_METHLTD | NOUZOVA_METHYLATED_IN_APL |
| NOUZOVA_CPG_H4_UP | NOUZOVA_TRETINOIN_AND_H4_ACETYLATION |
| ASTON_DEPRESSION_DN | ASTON_MAJOR_DEPRESSIVE_DISORDER_DN |
| ASTON_OLIGODENDROGLIA_MYELINATION_SUBSET | Deprecated |
| ASTON_DEPRESSION_UP | ASTON_MAJOR_DEPRESSIVE_DISORDER_UP |
| FLECHNER_KIDNEY_TRANSPLANT_WELL_PBL_DN | FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN |
| FLECHNER_KIDNEY_TRANSPLANT_REJECTION_UP | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP |
| FLECHNER_KIDNEY_TRANSPLANT_WELL_PBL_UP | FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP |
| FLECHNER_KIDNEY_TRANSPLANT_REJECTION_PBL_DN | FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN |
| FLECHNER_KIDNEY_TRANSPLANT_REJECTION_DN | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN |
| FLECHNER_KIDNEY_TRANSPLANT_WELL_DN | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN |
| FLECHNER_KIDNEY_TRANSPLANT_REJECTION_PBL_UP | FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP |
| FLECHNER_KIDNEY_TRANSPLANT_WELL_UP | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP |
| GREENBAUM_E2A_DN | GREENBAUM_E2A_TARGETS_DN |
| GREENBAUM_E2A_UP | GREENBAUM_E2A_TARGETS_UP |
| NAB_LUNG_DN | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN |
| NAB_LUNG_UP | JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP |
| HADDAD_HSC_CD7_DN | Deprecated |
| HADDAD_HSC_CD10_UP | Deprecated |
| HADDAD_HSC_CD7_UP | Deprecated |
| HADDAD_CD45CD7_PLUS_VS_MINUS_UP | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP |
| HADDAD_HPCLYMPHO_ENRICHED | HADDAD_B_LYMPHOCYTE_PROGENITOR |
| HADDAD_CD45CD7_PLUS_VS_MINUS_DN | HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN |
| BASSO_GERMINAL_CENTER_CD40_DN | BASSO_CD40_SIGNALING_DN |
| BASSO_GERMINAL_CENTER_CD40_UP | BASSO_CD40_SIGNALING_UP |
| TSA_HEPATOMA_UP | CHIBA_RESPONSE_TO_TSA |
| NICK_RHAPC_UP | Deprecated |
| — | NICK_RESPONSE_TO_PROC_TREATMENT_UP |
| — | NICK_RESPONSE_TO_PROC_TREATMENT_DN |
| — | LEE_LIVER_CANCER_SURVIVAL_DN |
| — | LEE_LIVER_CANCER_SURVIVAL_UP |
| SCHURINGA_STAT5A_UP | SCHURINGA_STAT5A_TARGETS_UP |
| SCHURINGA_STAT5A_DN | SCHURINGA_STAT5A_TARGETS_DN |
| MANALO_HYPOXIA_DN | MANALO_HYPOXIA_DN |
| MANALO_HYPOXIA_UP | MANALO_HYPOXIA_UP |
| FSH_OVARY_MCV152_DN | JI_RESPONSE_TO_FSH_DN |
| FSH_OVARY_MCV152_UP | JI_RESPONSE_TO_FSH_UP |
| ABRAHAM_MM_VS_AL_UP | Deprecated |
| ABRAHAM_MM_VS_AL_DN | Deprecated |
| ABRAHAM_AL_VS_MM_UP | ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP |
| ABRAHAM_AL_VS_MM_DN | ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN |
| KUROKAWA_5FU_IFN_SENSITIVE_VS_RESISTANT_DN | KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN |
| KUROKAWA_5FU_IFN_SENSITIVE_VS_RESISTANT_UP | KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_UP |
| TSA_HEPATOMA_CANCER_UP | CHIBA_RESPONSE_TO_TSA_UP |
| TSA_HEPATOMA_CANCER_DN | CHIBA_RESPONSE_TO_TSA_DN |
| HASLINGER_B_CLL_17P13 | HASLINGER_B_CLL_WITH_17P13_DELETION |
| HASLINGER_B_CLL_MUTATED | HASLINGER_B_CLL_WITH_MUTATED_VH_GENES |
| HASLINGER_B_CLL_13Q14 | HASLINGER_B_CLL_WITH_13Q14_DELETION |
| HASLINGER_B_CLL_11Q23 | HASLINGER_B_CLL_WITH_11Q23_DELETION |
| HASLINGER_B_CLL_12 | HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY |
| HASLINGER_B_CLL_6Q21 | HASLINGER_B_CLL_WITH_6Q21_DELETION |
| NING_COPD_DN | NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN |
| NING_COPD_UP | NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP |
| SASAKI_TCELL_LYMPHOMA_VS_CD4_UP | SASAKI_ADULT_T_CELL_LEUKEMIA |
| SASAKI_ATL_UP | Deprecated |
| IGF_VS_PDGF_DN | KUNINGER_IGF1_VS_PDGFB_TARGETS_DN |
| IGF_VS_PDGF_UP | KUNINGER_IGF1_VS_PDGFB_TARGETS_UP |
| PRMT5_KD_UP | PAL_PRMT5_TARGETS_UP |
| PRMT5_KD_DN | PAL_PRMT5_TARGETS_DN |
| HANSON_NFKAPPB_IND | HANSON_HRAS_SIGNALING_VIA_NFKB |
| RUIZ_TENASCIN_TARGETS | Deprecated |
| — | RUIZ_TNC_TARGETS_UP |
| — | RUIZ_TNC_TARGETS_DN |
| LOTEM_LEUKEMIA_UP | Deprecated |
| MMS_HUMAN_LYMPH_LOW_4HRS_DN | Deprecated |
| BLEO_HUMAN_LYMPH_HIGH_24HRS_UP | Deprecated |
| MMS_HUMAN_LYMPH_HIGH_24HRS_DN | Deprecated |
| BLEO_MOUSE_LYMPH_HIGH_24HRS_DN | Deprecated |
| BLEO_HUMAN_LYMPH_HIGH_4HRS_UP | Deprecated |
| MMS_MOUSE_LYMPH_HIGH_24HRS_UP | Deprecated |
| MMS_MOUSE_LYMPH_HIGH_4HRS_UP | Deprecated |
| BLEO_MOUSE_LYMPH_LOW_24HRS_DN | Deprecated |
| MMS_HUMAN_LYMPH_HIGH_24HRS_UP | Deprecated |
| BLEO_MOUSE_LYMPH_HIGH_4HRS_UP | Deprecated |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_1 |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_2 |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_3 |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_4 |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_5 |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_6 |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_7 |
| — | TERAMOTO_OPN_TARGETS_CLUSTER_8 |
| — | TERAMOTO_FIG_7C_UP |
| — | TERAMOTO_FIG_7C_DN |
| — | SCHLOSSER_SERUM_RESPONSE_UP |
| — | SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC |
| — | SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY |
| — | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM |
| — | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN |
| — | SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP |
| — | SCHLOSSER_SERUM_RESPONSE_DN |
| BRCA1_OVEREXP_PROSTATE_UP | Deprecated |
| BRCA1KO_MEF_DN | Deprecated |
| BRCA1_OVEREXP_PROSTATE_DN | Deprecated |
| — | BAE_BRCA1_TARGETS_UP |
| — | BAE_BRCA1_TARGETS_DN |
| — | VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP |
| — | VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN |
| — | LI_TABLE_1_UP |
| — | LI_TABLE_1_DN |
| — | LI_WILMS_TUMOR_ANAPLASTIC_UP |
| — | LI_WILMS_TUMOR_ANAPLASTIC_DN |
| — | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP |
| — | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN |
| GOLDRATH_HP | GOLDRATH_HOMEOSTATIC_PROLIFERATION |
| GOLDRATH_CYTOLYTIC | Deprecated |
| GOLDRATH_CELLCYCLE | Deprecated |
| GOLDRATH_MEMORY | GOLDRATH_IMMUNE_MEMORY |
| — | GOLDRATH_ANTIGEN_RESPONSE |
| STAEGE_EFTS_UP | STAEGE_EWING_FAMILY_TUMOR |
| — | MEINHOLD_FIG_3S |
| — | MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP |
| — | MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN |
| — | ODONNELL_METASTASIS_UP |
| — | ODONNELL_METASTASIS_DN |
| VANASSE_BCL2_TARGETS | VANASSE_BCL2_TARGETS |
| — | VANASSE_BCL2_TARGETS_UP |
| — | VANASSE_BCL2_TARGETS_DN |
| AGEING_KIDNEY_SPECIFIC_DN | RODWELL_AGING_KIDNEY_NO_BLOOD_DN |
| AGEING_KIDNEY_DN | RODWELL_AGING_KIDNEY_DN |
| AGEING_KIDNEY_SPECIFIC_UP | RODWELL_AGING_KIDNEY_NO_BLOOD_UP |
| AGEING_KIDNEY_UP | RODWELL_AGING_KIDNEY_UP |
| LEE_ACOX1_DN | LEE_LIVER_CANCER_ACOX1_DN |
| LEE_ACOX1_UP | LEE_LIVER_CANCER_ACOX1_UP |
| LEE_CIP_DN | LEE_LIVER_CANCER_CIPROFIBRATE_DN |
| LEE_CIP_UP | LEE_LIVER_CANCER_CIPROFIBRATE_UP |
| LEE_DENA_DN | LEE_LIVER_CANCER_DENA_DN |
| LEE_DENA_UP | LEE_LIVER_CANCER_DENA_UP |
| LEE_E2F1_DN | LEE_LIVER_CANCER_E2F1_DN |
| LEE_E2F1_UP | LEE_LIVER_CANCER_E2F1_UP |
| LEE_MYC_DN | LEE_LIVER_CANCER_MYC_DN |
| LEE_MYC_E2F1_DN | LEE_LIVER_CANCER_MYC_E2F1_DN |
| LEE_MYC_E2F1_UP | LEE_LIVER_CANCER_MYC_E2F1_UP |
| LEE_MYC_TGFA_DN | LEE_LIVER_CANCER_MYC_TGFA_DN |
| LEE_MYC_TGFA_UP | LEE_LIVER_CANCER_MYC_TGFA_UP |
| LEE_MYC_UP | LEE_LIVER_CANCER_MYC_UP |
| JAIN_NEMO_DIFF | JAIN_NFKB_SIGNALING |
| KANG_TERT_UP | KANG_IMMORTALIZED_BY_TERT_UP |
| KANG_TERT_DN | KANG_IMMORTALIZED_BY_TERT_DN |
| — | SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP |
| — | SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN |
| — | ANDRECHEK_ERBB2_TARGETS_UP |
| — | ANDRECHEK_ERBB2_TARGETS_DN |
| — | SCHRAMM_INHBA_TARGETS_UP |
| — | SCHRAMM_INHBA_TARGETS_DN |
| LU_IL4BCELL | LU_IL4_SIGNALING |
| — | KRASNOSELSKY_TABLE_3 |
| — | COLLIS_PRKDC_SUBSTRATES |
| — | COLLIS_PRKDC_REGULATORS |
| — | AGARWAL_AKT_PATHWAY_TARGETS |
| — | YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN |
| — | YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP |
| — | HU_TABLE_1_UP |
| — | HU_TABLE_1_DN |
| — | HU_ANGIOGENESIS_UP |
| — | HU_ANGIOGENESIS_DN |
| — | JAZAG_TGFB1_SIGNALING_UP |
| — | JAZAG_TGFB1_SIGNALING_DN |
| — | JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP |
| — | JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN |
| — | KAN_RESPONSE_TO_ARSENIC_TRIOXIDE |
| MARCINIAK_CHOP_DIFF | MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP |
| ZUCCHI_EPITHELIAL_DN | ZUCCHI_METASTASIS_DN |
| ZUCCHI_EPITHELIAL_UP | ZUCCHI_METASTASIS_UP |
| CORDERO_KRAS_KD_VS_CONTROL_DN | SWEET_KRAS_TARGETS_DN |
| CORDERO_KRAS_KD_VS_CONTROL_UP | SWEET_KRAS_TARGETS_UP |
| — | SWEET_LUNG_CANCER_KRAS_UP |
| — | SWEET_LUNG_CANCER_KRAS_DN |
| — | SWEET_KRAS_ONCOGENIC_SIGNATURE |
| — | TSUNODA_CISPLATIN_RESISTANCE_UP |
| — | TSUNODA_CISPLATIN_RESISTANCE_DN |
| — | TSUNODA_TABLE_2_UP |
| — | TSUNODA_TABLE_2_DN |
| — | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP |
| — | WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN |
| — | LANG_MYB_FAMILY_TARGETS |
| — | DACOSTA_TABLE_1S_XPCS_4_UP |
| — | DACOSTA_TABLE_1S_XPCS_4_DN |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN |
| — | DACOSTA_TABLE_1S_TTD_8_UP |
| — | DACOSTA_TABLE_1S_TTD_8_DN |
| — | DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP |
| — | DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN |
| — | DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP |
| — | DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_UP |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN |
| — | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP |
| — | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP |
| — | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN |
| — | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP |
| — | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN |
| — | LUI_TABLE_1_UP |
| — | LUI_TABLE_1_DN |
| — | LUI_THYROID_CANCER_PAX8_PPARG_UP |
| — | LUI_THYROID_CANCER_PAX8_PPARG_DN |
| — | LUI_THYROID_CANCER_CLUSTER_1 |
| — | LUI_THYROID_CANCER_CLUSTER_2 |
| — | LUI_THYROID_CANCER_CLUSTER_3 |
| — | LUI_THYROID_CANCER_CLUSTER_4 |
| — | LUI_THYROID_CANCER_CLUSTER_5 |
| — | LUI_TARGETS_OF_PAX8_PPARG_FUSION |
| — | ZHANG_INTERFERON_RESPONSE |
| BOQUEST_CD31PLUS_VS_CD31MINUS_DN | Deprecated |
| BOQUEST_CD31PLUS_VS_CD31MINUS_UP | Deprecated |
| — | BOQUEST_STEM_CELL_UP |
| — | BOQUEST_STEM_CELL_DN |
| — | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP |
| — | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN |
| WANG_MLL_CBP_VS_GMP_UP | WANG_TARGETS_OF_MLL_CBP_FUSION_UP |
| WANG_MLL_CBP_VS_GMP_DN | WANG_TARGETS_OF_MLL_CBP_FUSION_DN |
| — | WAESCH_ANAPHASE_PROMOTING_COMPLEX |
| — | WAESCH_APC_YEAST |
| — | SCHULTE_TRKB_0.5H VS TRKB |
| — | SCHULTE_TRKB_1H VS TRKB |
| — | SCHULTE_TRKB_6H VS TRKB |
| — | SCHULTE_TRKB_24H VS TRKB |
| — | SCHULTE_TRKA_0.5H VS TRKA |
| — | SCHULTE_TRKA_1H VS TRKA |
| — | SCHULTE_TRKA_6H VS TRKA |
| — | SCHULTE_TRKA_24H VS TRKA |
| — | SCHULTE_VEC_0.5H VS VEC |
| — | SCHULTE_VEC_1H VS VEC |
| — | SCHULTE_VEC_6H VS VEC |
| — | SCHULTE_VEC_24H VS VEC |
| — | MISSIAGLIA_REGULATED_BY_METHYLATION_UP |
| — | MISSIAGLIA_REGULATED_BY_METHYLATION_DN |
| KENNY_WNT_UP | KENNY_CTNNB1_TARGETS_UP |
| KENNY_WNT_DN | KENNY_CTNNB1_TARGETS_DN |
| — | LI_PROSTATE_CANCER_EPIGENETIC |
| BECKER_ESTROGEN_RESPONSIVE_SUBSET_2 | Deprecated |
| BECKER_TAMOXIFEN_RESISTANT_UP | BECKER_TAMOXIFEN_RESISTANCE_UP |
| BECKER_IFN_INDUCIBLE_SUBSET_1 | Deprecated |
| BECKER_CANCER_ASSOCIATED_SUBSET_1 | Deprecated |
| BECKER_CANCER_ASSOCIATED_SUBSET_2 | Deprecated |
| BECKER_TAMOXIFEN_RESISTANT_DN | BECKER_TAMOXIFEN_RESISTANCE_DN |
| ET743_RESIST_UP | MARCHINI_TRABECTEDIN_RESISTANCE_UP |
| ET743_RESIST_DN | MARCHINI_TRABECTEDIN_RESISTANCE_DN |
| NUMATA_G_CSF_DIFF | NUMATA_CSF3_SIGNALING_VIA_STAT3 |
| — | URBICH_MRNA_EXPRESSION_IN_EPC_UP |
| — | URBICH_MRNA_EXPRESSION_IN_EPC_DN |
| — | URBICH_MRNA_EXPRESSION_IN_HUVEC_UP |
| — | URBICH_MRNA_EXPRESSION_IN_HUVEC_DN |
| — | URBICH_RNA_EXPRESSION_IN_CD14+_MONOCYTES_UP |
| — | URBICH_RNA_EXPRESSION_IN_CD14+_MONOCYTES_DN |
| — | DIRMEIER_LMP1_RESPONSE_EARLY |
| — | DIRMEIER_CLUSTER_2 |
| — | DIRMEIER_LMP1_RESPONSE_LATE_UP |
| — | DIRMEIER_LMP1_RESPONSE_LATE_DN |
| — | NEBEN_FIG_3 |
| — | NEBEN_FIG_1 |
| — | NEBEN_AML_WITH_MUTATED_FLT3_OR_NRAS_UP |
| — | NEBEN_AML_WITH_MUTATED_FLT3_OR_NRAS_DN |
| — | NEBEN_TABLE_2_FLT3-TKD_UP |
| — | NEBEN_TABLE_2_FLT3-TKD_DN |
| — | NEBEN_TABLE_2_NRAS_UP |
| — | NEBEN_TABLE_2_NRAS_DN |
| — | BORLAK_LIVER_CANCER_EGF_UP |
| — | BORLAK_LIVER_CANCER_EGF_DN |
| — | CASTRO_APC IN YEAST |
| — | CASTRO_S_POMBE |
| — | CASTRO_ANAPHASE_PROMOTING_COMPLEX |
| AD12_ANY_DN | Deprecated |
| AD12_24HRS_DN | Deprecated |
| AD12_32HRS_DN | Deprecated |
| AD12_48HRS_DN | Deprecated |
| — | DORN_ADENOVIRUS_INFECTION_12HR_UP |
| — | DORN_ADENOVIRUS_INFECTION_12HR_DN |
| — | DORN_ADENOVIRUS_INFECTION_24HR_UP |
| — | DORN_ADENOVIRUS_INFECTION_24HR_DN |
| — | DORN_ADENOVIRUS_INFECTION_32HR_UP |
| — | DORN_ADENOVIRUS_INFECTION_32HR_DN |
| — | DORN_ADENOVIRUS_INFECTION_48HR_UP |
| — | DORN_ADENOVIRUS_INFECTION_48HR_DN |
| — | HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER |
| — | HEIDENBLAD_TABLE_1S |
| — | HEIDENBLAD_AMPLICON_8Q24_UP |
| — | HEIDENBLAD_AMPLICON_8Q24_DN |
| — | HEIDENBLAD_AMPLICON_12P11_12_UP |
| — | HEIDENBLAD_AMPLICON_12P11_12_DN |
| — | BEGUM_FIG_5_UP |
| — | BEGUM_FIG_5_DN |
| — | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP |
| — | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN |
| — | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3 |
| — | KANG_GIST_WITH_PDGFRA_UP |
| — | KANG_GIST_WITH_PDGFRA_DN |
| LE_MYELIN_DN | LE_EGR2_TARGETS_DN |
| LE_MYELIN_UP | LE_EGR2_TARGETS_UP |
| LEI_HOXC8_DN | LEI_HOXC8_TARGETS_UP |
| LEI_HOXC8_UP | LEI_HOXC8_TARGETS_DN |
| WONG_IFNA_HCC_RESISTANT_VS_SENSITIVE_UP | WONG_IFNA2_RESISTANCE_UP |
| WONG_IFNA_HCC_RESISTANT_VS_SENSITIVE_DN | WONG_IFNA2_RESISTANCE_DN |
| LIZUKA_G1_SM_G2 | IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN |
| LIZUKA_G1_GR_G2 | IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP |
| LIZUKA_G2_SM_G3 | IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN |
| LIZUKA_G2_GR_G3 | IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP |
| LIZUKA_L0_SM_L1 | IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN |
| LIZUKA_L0_GR_L1 | IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP |
| LIZUKA_L1_SM_G1 | IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN |
| LIZUKA_L1_GR_G1 | IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP |
| CHESLER_D6MIT150_TRANSCRIPTION_FACTORS_GLOCUS | Deprecated |
| CHESLER_D6MIT150_CIS_GLOCUS | CHESLER_BRAIN_D6MIT150_QTL_CIS |
| CHESLER_BRAIN_CIS_GENES | CHESLER_BRAIN_QTL_CIS |
| CHESLER_BRAIN_ONLY_SUBSET | Deprecated |
| CHESLER_BRAIN_TRANS_GENES | CHESLER_BRAIN_QTL_TRANS |
| CHESLER_BRAIN_HIGHEST_VARIANCE_GENES | CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE |
| CHESLER_HIGHEST_FOLD_RANGE_GENES | CHESLER_BRAIN_HIGHEST_EXPRESSION |
| CHESLER_D6MIT150_NEURAL_TARGETS_GLOCUS | CHESLER_BRAIN_D6MIT150_QTL_TRANS |
| CHESLER_BRAIN_NEURAL_HIGH_GENES | Deprecated |
| BYSTRYKH_SCP2_QTL | BYSTRYKH_SCP2_QTL |
| BYSTRYKH_FGF3_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 |
| BYSTRYKH_HSC_CIS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS |
| BYSTRYKH_HSC_AND_BRAIN_TRANS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS |
| BYSTRYKH_HSC_AND_BRAIN_CIS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS |
| BYSTRYKH_RUNX1_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1 |
| BYSTRYKH_HSC_TRANS_REGULATED_QTL | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS |
| BYSTRYKH_FLI1_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1 |
| BYSTRYKH_IL3RA_TARGETS | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA |
| BYSTRYKH_HSC_TRANS_REGULATED_BY_QTL_SCP2 | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS |
| TNFA_NFKB_DEP_UP | Deprecated |
| — | TIAN_TNF_SIGNALING_VIA_NFKB |
| — | TIAN_TNF_SIGNALING_NOT_VIA_NFKB |
| BRG1_H1299_UP | MEDINA_SMARCA4_TARGETS |
| — | NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF |
| — | FUNG_IL2_SIGNALING_2 |
| — | FUNG_IL2_SIGNALING_1 |
| — | FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1 |
| — | FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES |
| — | PATIL_TABLE_2 |
| — | PATIL_LIVER_CANCER |
| — | DAUER_STAT3_TARGETS_UP |
| — | DAUER_STAT3_TARGETS_DN |
| — | WANG_METHYLATED_IN_BREAST_CANCER |
| — | WOERNER_TABLE_3 |
| — | SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP |
| — | SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN |
| — | SILIGAN_BOUND_BY_EWS_FLT1_FUSION |
| — | MATTIOLI_MGUS_VS_PCL |
| — | MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA |
| — | MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS |
| — | MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS |
| — | CAIRO_PML_TARGETS_BOUND_BY_MYC_UP |
| — | CAIRO_PML_TARGETS_BOUND_BY_MYC_DN |
| PEART_HISTONE_UP | PEART_HDAC_PROLIFERATION_CLUSTER_UP |
| PEART_HISTONE_DN | PEART_HDAC_PROLIFERATION_CLUSTER_DN |
| ROTH_HTERT_DIFF | Deprecated |
| ROTH_HTERT_DN | ROETH_TERT_TARGETS_DN |
| ROTH_HTERT_UP | ROETH_TERT_TARGETS_UP |
| SANA_TNFA_ENDOTHELIAL_DN | SANA_RESPONSE_TO_TNF_DN |
| SANA_IFNG_ENDOTHELIAL_UP | SANA_RESPONSE_TO_IFNG_UP |
| SANA_TNFA_ENDOTHELIAL_UP | SANA_RESPONSE_TO_TNF_UP |
| SANA_IFNG_ENDOTHELIAL_DN | SANA_RESPONSE_TO_IFNG_DN |
| — | MANN_RESPONSE_TO_AMIFOSTINE_UP |
| — | MANN_RESPONSE_TO_AMIFOSTINE_DN |
| — | JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP |
| — | JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN |
| — | JOHANSSON_TABLE_2_PDGFRX |
| — | JOHANSSON_TABLE_2_TUMOR |
| — | JOHANSSON_TABLE_2_BTL |
| — | JOHANSSON_TABLE_2_OTHER |
| — | JOHANSSON_TABLE_2_DIFF |
| — | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP |
| — | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN |
| WANG_HOXA9_VS_MEIS1_DN | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN |
| WANG_HOXA9_VS_MEIS1_UP | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP |
| APPEL_IMATINIB_UP | APPEL_IMATINIB_RESPONSE |
| CHEN_HOXA5_TARGETS_UP | Deprecated |
| CHEN_HOXA5_TARGETS_DN | Deprecated |
| — | CHEN_HOXA5_TARGETS_6HR_UP |
| — | CHEN_HOXA5_TARGETS_6HR_DN |
| — | CHEN_HOXA5_TARGETS_9HR_UP |
| — | CHEN_HOXA5_TARGETS_9HR_DN |
| — | KARLSSON_TABLE_2 |
| BASSO_REGULATORY_HUBS | BASSO_B_LYMPHOCYTE_NETWORK |
| — | BARIS_THYROID_CANCER_UP |
| — | BARIS_THYROID_CANCER_DN |
| FALT_BCLL_IG_MUTATED_VS_WT_UP | FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP |
| FALT_BCLL_IG_MUTATED_VS_WT_DN | FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN |
| FALT_BCLL_DN | FAELT_B_CLL_WITH_VH3_21_DN |
| FALT_BCLL_UP | FAELT_B_CLL_WITH_VH3_21_UP |
| — | AMUNDSON_DNA_DAMAGE_RESPONSE_TP53 |
| — | AMUNDSON_SUPPL_DATA_SET_3 |
| — | AMUNDSON_GENOTOXIC_SIGNATURE |
| — | AMUNDSON_RESPONSE_TO_ARSENITE |
| — | MAINA_HYPOXIA_VHL_TARGETS_UP |
| — | MAINA_HYPOXIA_VHL_TARGETS_DN |
| — | MAINA_VHL_TARGETS_UP |
| — | MAINA_VHL_TARGETS_DN |
| — | SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS |
| — | SNIJDERS_TABLE_1S |
| MOREAUX_TACI_XG_13_UP | Deprecated |
| MOREAUX_TACI_HI_IN_PPC_UP | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN |
| MOREAUX_TACI_BAFF_DN | Deprecated |
| MOREAUX_TACI_XG_13_DN | Deprecated |
| MOREAUX_TACI_BAFF_UP | Deprecated |
| MOREAUX_TACI_HI_VS_LOW_UP | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP |
| MOREAUX_TACI_HI_VS_LOW_DN | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN |
| MOREAUX_TACI_HI_IN_BMPC | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP |
| — | WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION |
| MARSHALL_SPLEEN_BAL | Deprecated |
| — | MARSHALL_VIRAL_INFECTION_RESPONSE_UP |
| — | MARSHALL_VIRAL_INFECTION_RESPONSE_DN |
| ALCALAY_AML_NPMC_UP | ALCALAY_AML_BY_NPM1_LOCALIZATION_UP |
| ALCALAY_AML_NPMC_DN | ALCALAY_AML_BY_NPM1_LOCALIZATION_DN |
| TCELL_ANERGIC_UP | SAFFORD_T_LYMPHOCYTE_ANERGY |
| — | VAN_VUGT_MITOTIC_EXIT_GENES |
| GH_EXOGENOUS_EARLY_UP | Deprecated |
| GH_EXOGENOUS_LATE_UP | Deprecated |
| GH_EXOGENOUS_ANY_UP | XU_GH1_EXOGENOUS_TARGETS_UP |
| GH_EXOGENOUS_EARLY_DN | Deprecated |
| GH_AUTOCRINE_UP | XU_GH1_AUTOCRINE_TARGETS_UP |
| GH_EXOGENOUS_ANY_DN | XU_GH1_EXOGENOUS_TARGETS_DN |
| GH_AUTOCRINE_DN | XU_GH1_AUTOCRINE_TARGETS_DN |
| GH_EXOGENOUS_ALL_UP | Deprecated |
| GH_EXOGENOUS_MIDDLE_UP | Deprecated |
| GH_EXOGENOUS_LATE_DN | Deprecated |
| — | SASAKI_TARGETS_OF_TP73_AND_TP63 |
| — | RUGO_TABLE_1S |
| — | RUGO_ENVIRONMENTAL_STRESS_RESPONSE_UP |
| — | RUGO_ENVIRONMENTAL_STRESS_RESPONSE_DN |
| — | RUGO_RESPONSE_TO_4NQO |
| — | RUGO_RESPONSE_TO_GAMMA_RADIATION |
| — | RUGO_UV_RESPONSE |
| — | RUGO_STRESS_RESPONSE_SUBSET_F |
| — | RUGO_STRESS_RESPONSE_SUBSET_H |
| — | RUGO_STRESS_RESPONSE_SUBSET_G |
| — | RUGO_TABLE_2S_UP |
| — | RUGO_TABLE_2S_DN |
| — | YANAGIDA_CIS_AT_26 |
| — | YANAGIDA_RIS_AT_20 |
| — | YANAGIDA_RIS_AT_5 |
| — | CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP |
| — | CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN |
| — | POOLA_INVASIVE_BREAST_CANCER_UP |
| — | POOLA_INVASIVE_BREAST_CANCER_DN |
| CARIES_PULP_HIGH_UP | Deprecated |
| CARIES_PULP_DN | MCLACHLAN_DENTAL_CARIES_DN |
| CARIES_PULP_UP | MCLACHLAN_DENTAL_CARIES_UP |
| MYOD_NIH3T3_DN | DELASERNA_MYOD_TARGETS_DN |
| MYOD_NIH3T3_UP | DELASERNA_MYOD_TARGETS_UP |
| MYOD_BRG1_UP | DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4 |
| — | KORKOLA_TABLE_1S |
| — | KORKOLA_EMBRYONAL_CARCINOMA |
| — | KORKOLA_TERATOMA |
| — | KORKOLA_YOLK_SAC_TUMOR |
| — | KORKOLA_CHORIOCARCINOMA |
| PITUITARY_FETAL_DN | MA_PITUITARY_FETAL_VS_ADULT_DN |
| PITUITARY_FETAL_UP | MA_PITUITARY_FETAL_VS_ADULT_UP |
| IRS1_KO_ADIP_DN | TSENG_IRS1_TARGETS_DN |
| IRS1_KO_ADIP_UP | TSENG_IRS1_TARGETS_UP |
| IRS_KO_ADIP_DN | TSENG_ADIPOGENIC_POTENTIAL_DN |
| IRS_KO_ADIP_UP | TSENG_ADIPOGENIC_POTENTIAL_UP |
| ET743_SARCOMA_24HRS_UP | Deprecated |
| ET743_SARCOMA_UP | MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP |
| ET743_SARCOMA_72HRS_DN | Deprecated |
| ET743_SARCOMA_72HRS_UP | Deprecated |
| ET743_SARCOMA_24HRS_DN | Deprecated |
| ET743_SARCOMA_6HRS_UP | Deprecated |
| ET743_SARCOMA_DN | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN |
| ET743_SARCOMA_48HRS_DN | Deprecated |
| — | WEINMANN_ADAPTATION_TO_HYPOXIA_UP |
| — | WEINMANN_ADAPTATION_TO_HYPOXIA_DN |
| — | YANAGIHARA_ESX1_TARGETS |
| — | ZIRN_TRETINOIN_RESPONSE_WT1_UP |
| — | ZIRN_TRETINOIN_RESPONSE_WT1_DN |
| — | ZIRN_TRETINOIN_RESPONSE_UP |
| — | ZIRN_TRETINOIN_RESPONSE_DN |
| — | LANDIS_ERBB2_BREAST_TUMORS_65_UP |
| — | LANDIS_ERBB2_BREAST_TUMORS_65_DN |
| — | LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP |
| — | LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN |
| — | LANDIS_TABLE_1S_UP |
| — | LANDIS_TABLE_1S_DN |
| — | LANDIS_ERBB2_BREAST_TUMORS_324_UP |
| — | LANDIS_ERBB2_BREAST_TUMORS_324_DN |
| — | GRUETZMANN_PANCREATIC_CANCER_UP |
| — | GRUETZMANN_PANCREATIC_CANCER_DN |
| GAMMA_UNIQUE_FIBRO_DN | Deprecated |
| UV_ESR_OLD_UNREG | Deprecated |
| UV_ESR_WS_UNREG | Deprecated |
| GAMMA-UV_FIBRO_DN | Deprecated |
| 4NQO_UNIQUE_FIBRO_DN | Deprecated |
| 4NQO_UNIQUE_FIBRO_UP | Deprecated |
| UV-4NQO_FIBRO_UP | Deprecated |
| ESR_FIBROBLAST_DN | Deprecated |
| UV_UNIQUE_FIBRO_DN | Deprecated |
| 4NQO_ESR_OLD_UNREG | Deprecated |
| UV_UNIQUE_FIBRO_UP | Deprecated |
| GAMMA_ESR_WS_UNREG | Deprecated |
| GAMMA-UV_FIBRO_UP | Deprecated |
| UV-4NQO_FIBRO_DN | Deprecated |
| 4NQO_ESR_WS_UNREG | Deprecated |
| GAMMA_ESR_OLD_UNREG | Deprecated |
| GAMMA_UNIQUE_FIBRO_UP | Deprecated |
| ESR_FIBROBLAST_UP | Deprecated |
| — | KYNG_DNA_DAMAGE_BY_4NQO |
| — | KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION |
| — | KYNG_DNA_DAMAGE_BY_UV |
| — | KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION |
| — | KYNG_DNA_DAMAGE_BY_4NQO_OR_UV |
| — | KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS |
| — | KYNG_DNA_DAMAGE_UP |
| — | KYNG_DNA_DAMAGE_DN |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP |
| — | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN |
| — | FARMER_BREAST_CANCER_APOCRINE VS LUMINAL |
| — | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL |
| — | FARMER_BREAST_CANCER_BASAL_VS_LULMINAL |
| — | FARMER_BREAST_CANCER_CLUSTER_1 |
| — | FARMER_BREAST_CANCER_CLUSTER_8 |
| — | FARMER_BREAST_CANCER_CLUSTER_7 |
| — | FARMER_BREAST_CANCER_CLUSTER_6 |
| — | FARMER_BREAST_CANCER_CLUSTER_5 |
| — | FARMER_BREAST_CANCER_CLUSTER_4 |
| — | FARMER_BREAST_CANCER_CLUSTER_2 |
| — | FARMER_BREAST_CANCER_CLUSTER_3 |
| ZHANG_EFT_EWSFLI1_UP | ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION |
| — | GLINSKY_CANCER_DEATH_UP |
| — | GLINSKY_CANCER_DEATH_DN |
| — | VANHARANTA_UTERINE_FIBROID_UP |
| — | VANHARANTA_UTERINE_FIBROID_DN |
| — | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP |
| — | VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN |
| — | VANHARANTA_TABLE_1 |
| — | KERLEY_RESPONSE_TO_CISPLATIN_UP |
| — | KERLEY_RESPONSE_TO_CISPLATIN_DN |
| — | OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
| — | OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN |
| — | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
| — | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN |
| — | OUELLET_TABLE_11S_UP |
| — | OUELLET_TABLE_11S_DN |
| — | OUELLET_TABLE_12S_UP |
| — | OUELLET_TABLE_12S_DN |
| — | OUELLET_TABLE_3_UP |
| — | OUELLET_TABLE_3_DN |
| — | OUELLET_TABLE_2_UP |
| — | OUELLET_TABLE_2_DN |
| FERRARI_4HPR_UP | FERRARI_4HPR_UP |
| — | FERRARI_RESPONSE_TO_FENRETINIDE_UP |
| — | FERRARI_RESPONSE_TO_FENRETINIDE_DN |
| AGED_MOUSE_HIPPOCAMPUS_MULTI_UP | Deprecated |
| AGED_MOUSE_HIPPOCAMPUS_ANY_DN | Deprecated |
| AGED_MOUSE_RETINA_ANY_UP | Deprecated |
| AGED_MOUSE_HIPPOCAMPUS_ANY_UP | Deprecated |
| AGED_MOUSE_RETINA_ANY_DN | Deprecated |
| BCNU_GLIOMA_NOMGMT_24HRS_UP | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP |
| BCNU_GLIOMA_MGMT_24HRS_DN | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN |
| BCNU_GLIOMA_NOMGMT_48HRS_UP | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP |
| BCNU_GLIOMA_NOMGMT_48HRS_DN | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN |
| BCNU_GLIOMA_MGMT_48HRS_DN | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN |
| BCNU_GLIOMA_MGMT_48HRS_UP | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP |
| — | BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN |
| — | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP |
| GERY_CEBP_TARGETS | GERY_CEBP_TARGETS |
| CPR_LOW_LIVER_UP | WENG_POR_TARGETS_GLOBAL_UP |
| CPR_LOW_LIVER_DN | WENG_POR_TARGETS_GLOBAL_DN |
| CPR_NULL-LOW_LIVER_UP | WENG_POR_DOSAGE |
| CPR_NULL_LIVER_UP | WENG_POR_TARGETS_LIVER_UP |
| CPR_NULL_LIVER_DN | WENG_POR_TARGETS_LIVER_DN |
| HYPERME_COLONCA_SW48 | WEBER_METHYLATED_IN_COLON_CANCER |
| — | INAMURA_LUNG_CANCER_SCC_UP |
| — | INAMURA_LUNG_CANCER_SCC_DN |
| — | INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP |
| — | INAMURA_LUNG_CANCER_SCC_SUBTYPES_DN |
| — | ROSTY_TABLE_4S_UP |
| — | ROSTY_TABLE_4S_DN |
| — | ROSTY_TABLE_5S_UP |
| — | ROSTY_TABLE_5S_DN |
| — | ROSTY_TABLE_1S |
| — | ROSTY_TABLE_2S |
| — | ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER |
| — | ROSTY_TABLE_6S |
| — | YAN_ESCAPE_FROM_ANOIKIS |
| — | EINAV_INTERFERON_SIGNATURE_IN_CANCER |
| — | LUCAS_TABLE_2_UP |
| — | LUCAS_TABLE_2_DN |
| — | LUCAS_HNF4A_TARGETS_UP |
| — | LUCAS_HNF4A_TARGETS_DN |
| — | GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION |
| — | SIMBULAN_UV_RESPONSE_NORMAL_UP |
| — | SIMBULAN_UV_RESPONSE_NORMAL_DN |
| — | SIMBULAN_UV_RESPONSE_IMMORTALIZED_UP |
| — | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN |
| — | WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP |
| — | WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN |
| — | WATTEL_FIG_1_DN |
| — | WATTEL_FIG_1_UP |
| NOVA2_KO_SPLICING | ULE_SPLICING_VIA_NOVA2 |
| — | GYORFFY_TABLE_2_UP |
| — | GYORFFY_TABLE_2_DN |
| — | GYORFFY_TABLE_2_AGAIN_UP |
| — | GYORFFY_TABLE_2_AGAIN_DN |
| — | GYORFFY_FIG_2A_UP |
| — | GYORFFY_FIG_2A_DN |
| — | GYORFFY_FIG_2B_UP |
| — | GYORFFY_FIG_2B_DN |
| — | GYORFFY_DOXORUBICIN_RESISTANCE |
| — | GYORFFY_MITOXANTRONE_RESISTANCE |
| — | UROSEVIC_RESPONSE_TO_IMIQUIMOD |
| ZMPSTE24_KO_DN | VARELA_ZMPSTE24_TARGETS_DN |
| ZMPSTE24_KO_UP | VARELA_ZMPSTE24_TARGETS_UP |
| — | BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP |
| — | BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN |
| — | BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP |
| — | BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN |
| — | TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP |
| — | TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN |
| — | GALE_APL_WITH_FLT3_MUTATED_DN |
| — | GALE_APL_WITH_FLT3_MUTATED_UP |
| ERM_KO_SERTOLI_DN | CHEN_ETV5_TARGETS_SERTOLI |
| ERM_KO_TESTES_DN | CHEN_ETV5_TARGETS_TESTIS |
| VERHAAK_AML_NPM1_MUT_VS_WT_UP | VERHAAK_AML_WITH_NPM1_MUTATED_UP |
| VERHAAK_AML_NPM1_MUT_VS_WT_DN | VERHAAK_AML_WITH_NPM1_MUTATED_DN |
| — | WU_ALZHEIMER_DISEASE_UP |
| — | WU_ALZHEIMER_DISEASE_DN |
| — | CHOW_RASSF1_TARGETS_UP |
| — | CHOW_RASSF1_TARGETS_DN |
| — | KIM_MYC_AMPLIFICATION_TARGETS_UP |
| — | KIM_MYC_AMPLIFICATION_TARGETS_DN |
| — | KIM_MYCN_AMPLIFICATION_TARGETS_UP |
| — | KIM_MYCN_AMPLIFICATION_TARGETS_DN |
| — | KIM_MYCL1_AMPLIFICATION_TARGETS_UP |
| — | KIM_MYCL1_AMPLIFICATION_TARGETS_DN |
| — | SYED_TABLE_1_UP |
| — | SYED_TABLE_1_DN |
| — | SYED_ESTRADIOL_RESPONSE |
| TFF2_KO_UP | Deprecated |
| — | BAUS_TFF2_TARGETS_UP |
| — | BAUS_TFF2_TARGETS_DN |
| LAL_KO_6MO_UP | LIAN_LIPA_TARGETS_6M |
| LAL_KO_3MO_UP | LIAN_LIPA_TARGETS_3M |
| — | MIZUKAMI_HYPOXIA_UP |
| — | MIZUKAMI_HYPOXIA_DN |
| BAF57_BT549_DN | WANG_SMARCE1_TARGETS_DN |
| BAF57_BT549_UP | WANG_SMARCE1_TARGETS_UP |
| IFN_BETA_GLIOMA_UP | NATSUME_RESPONSE_TO_INTERFERON_BETA_UP |
| IFN_BETA_GLIOMA_DN | NATSUME_RESPONSE_TO_INTERFERON_BETA_DN |
| XU_ATRA_PLUSNSC_UP | XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP |
| XU_ATRA_UP | XU_RESPONSE_TO_TRETINOIN_UP |
| XU_ATRA_DN | XU_RESPONSE_TO_TRETINOIN_DN |
| XU_ATRA_PLUSNSC_DN | XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN |
| SHEPARD_CRASH_AND_BURN_MUT_VS_WT_UP | SHEPARD_CRUSH_AND_BURN_MUTANT_UP |
| SHEPARD_BMYB_MORPHOLINO_DN | SHEPARD_BMYB_MORPHOLINO_DN |
| SHEPARD_GENES_COMMON_BW_CB_MO | SHEPARD_BMYB_TARGETS |
| SHEPARD_CRASH_AND_BURN_MUT_VS_WT_DN | SHEPARD_CRUSH_AND_BURN_MUTANT_DN |
| SHEPARD_BMYB_MORPHOLINO_UP | SHEPARD_BMYB_MORPHOLINO_UP |
| SHEPARD_NEG_REG_OF_CELL_PROLIFERATION | Deprecated |
| SHEPARD_CELL_PROLIFERATION | Deprecated |
| SHEPARD_POS_REG_OF_CELL_PROLIFERATION | Deprecated |
| — | LIU_TABLE_1 |
| — | SEIDEN_MET_SIGNALING |
| — | SEIDEN_ONCOGENESIS_BY_MET |
| — | SEIDEN-LONG_TABLE_3 |
| CHIARETTI_ZAP70_DIFF | CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70 |
| — | OSWALD_HEMATOPOIETIC_STEM_CELLS_IN_COLLAGEN_GEL_UP |
| — | OSWALD_HEMATOPOIETIC_STEM_CELLS_IN_COLLAGEN_GEL_DN |
| — | KOBAYASHI_RESPONSE_TO_ROMIDEPSIN |
| — | KLEIN_TARGETS_OF_BCR_ABL1_FUSION |
| — | LIU_CMYB_TARGETS_UP |
| — | LIU_CMYB_TARGETS_DN |
| — | LIU_VMYB_TARGETS_UP |
| — | LIU_VMYB_TARGETS_DN |
| — | LIU_TABLE_1S_CMYB_UP |
| — | LIU_TABLE_1S_CMYB_DN |
| — | LIU_TABLE_4S_UP |
| — | LIU_TABLE_4S_DN |
| — | LIU_TARGETS_OF_VMYB_VS_CMYB_UP |
| — | LIU_TARGETS_OF_VMYB_VS_CMYB_DN |
| — | HASINA_NOL7_TARGETS_UP |
| — | HASINA_NOL7_TARGETS_DN |
| POD1_KO_DN | CUI_TCF21_TARGETS_UP |
| POD1_KO_MOST_DN | Deprecated |
| POD1_KO_MOST_UP | CUI_TCF21_TARGETS_DN |
| POD1_KO_UP | Deprecated |
| — | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP |
| — | JAATINEN_HEMATOPOIETIC_STEM_CELL_DN |
| — | WANG_RESPONSE_TO_BEXAROTENE_UP |
| — | WANG_RESPONSE_TO_BEXAROTENE_DN |
| — | ROVERSI_GLIOMA_COPY_NUMBER_DN |
| — | ROVERSI_GLIOMA_LOH_REGIONS |
| — | ROVERSI_GLIOMA_COPY_NUMBER_UP |
| — | KONDO_HYPOXIA |
| — | TSAI_RESPONSE_TO_IONIZING_RADIATION |
| — | HUMMERICH_CO. VS TPA_UP |
| — | HUMMERICH_CO. VS TPA_DN |
| — | HUMMERICH_BENIGN_SKIN_TUMOR_UP |
| — | HUMMERICH_BENIGN_SKIN_TUMOR_DN |
| — | HUMMERICH_CO. VS SCC_UP |
| — | HUMMERICH_CO. VS SCC_DN |
| — | HUMMERICH_MALIGNANT_SKIN_TUMOR_UP |
| — | HUMMERICH_MALIGNANT_SKIN_TUMOR_DN |
| — | HUMMERICH_CO. VS PAP_MALIGNANT TUMOURS_UP |
| — | HUMMERICH_CO. VS PAP_MALIGNANT TUMOURS_DN |
| — | HUMMERICH_CO. VS TPA_MALIGNANT TUMOURS_UP |
| — | HUMMERICH_CO. VS TPA_MALIGNANT TUMOURS_DN |
| — | HUMMERICH_SKIN_CANCER_PROGRESSION_UP |
| — | HUMMERICH_SKIN_CANCER_PROGRESSION_DN |
| — | KOINUMA_COLON_CANCER_MSI_UP |
| — | KOINUMA_COLON_CANCER_MSI_DN |
| — | YANG_BREAST_CANCER_ESR1_UP |
| — | YANG_BREAST_CANCER_ESR1_DN |
| — | YANG_BREAST_CANCER_ESR1_LASER_UP |
| — | YANG_BREAST_CANCER_ESR1_LASER_DN |
| — | YANG_BREAST_CANCER_ESR1_BULK_UP |
| — | YANG_BREAST_CANCER_ESR1_BULK_DN |
| MYC_ONCOGENIC_SIGNATURE | BILD_MYC_ONCOGENIC_SIGNATURE |
| E2F3_ONCOGENIC_SIGNATURE | BILD_E2F3_ONCOGENIC_SIGNATURE |
| RAS_ONCOGENIC_SIGNATURE | BILD_HRAS_ONCOGENIC_SIGNATURE |
| SRC_ONCOGENIC_SIGNATURE | BILD_SRC_ONCOGENIC_SIGNATURE |
| CTNNB1_oncogenic_signature | BILD_CTNNB1_ONCOGENIC_SIGNATURE |
| — | STANHILL_HRAS_TRANSFROMATION_UP |
| — | STANHILL_HRAS_TRANSFROMATION_DN |
| — | HOWLIN_MAMMARY_GLAND_UP |
| — | HOWLIN_MAMMARY_GLAND_DN |
| — | HOWLIN_PUBERTAL_MAMMARY_GLAND |
| — | HOWLIN_CITED1_TARGETS_1_UP |
| — | HOWLIN_CITED1_TARGETS_1_DN |
| — | HOWLIN_CITED1_TARGETS_2_UP |
| — | HOWLIN_CITED1_TARGETS_2_DN |
| — | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP |
| — | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN |
| — | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP |
| — | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN |
| — | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP |
| — | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN |
| — | IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM |
| — | IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM |
| — | GREER_TABLE_1 |
| KAMMINGA_EZH2_TARGETS | KAMMINGA_EZH2_TARGETS |
| — | KAMMINGA_SENESCENCE |
| — | UREN_TABLE_1 |
| YANG_OSTECLASTS_SIG | Deprecated |
| — | YOSHIMURA_MAPK8_TARGETS_UP |
| — | YOSHIMURA_MAPK8_TARGETS_DN |
| — | COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP |
| — | COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN |
| — | KREPPEL_CD99_TARGETS_UP |
| — | KREPPEL_CD99_TARGETS_DN |
| — | RASHI_RESPONSE_TO_IONIZING_RADIATION_1 |
| — | RASHI_RESPONSE_TO_IONIZING_RADIATION_2 |
| — | RASHI_RESPONSE_TO_IONIZING_RADIATION_3 |
| — | RASHI_RESPONSE_TO_IONIZING_RADIATION_4 |
| — | RASHI_RESPONSE_TO_IONIZING_RADIATION_5 |
| — | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 |
| — | RASHI_NFKB1_TARGETS |
| — | CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN |
| — | BALDWIN_PRKCI_TARGETS_UP |
| — | BALDWIN_PRKCI_TARGETS_DN |
| — | SANCHEZ_MDM2_TARGETS |
| — | AUNG_GASTRIC_CANCER |
| — | BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP |
| — | BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN |
| MATSUDA_VALPHAINKT_DIFF | MATSUDA_NATURAL_KILLER_DIFFERENTIATION |
| — | LI_TABLE_1S |
| — | LI_LUNG_CANCER |
| — | LI_AMPLIFIED_IN_LUNG_CANCER |
| — | LI_TABLE_3S |
| YU_CMYC_UP | YU_MYC_TARGETS_UP |
| YU_CMYC_DN | YU_MYC_TARGETS_DN |
| — | TIEN_INTESTINE_PROBIOTICS_2HR_UP |
| — | TIEN_INTESTINE_PROBIOTICS_2HR_DN |
| — | TIEN_INTESTINE_PROBIOTICS_6HR_UP |
| — | TIEN_INTESTINE_PROBIOTICS_6HR_DN |
| — | TIEN_INTESTINE_PROBIOTICS_24HR_UP |
| — | TIEN_INTESTINE_PROBIOTICS_24HR_DN |
| — | BIDUS_METASTASIS_UP |
| — | BIDUS_METASTASIS_DN |
| — | HATADA_METHYLATED_IN_LUNG_CANCER_UP |
| — | HATADA_METHYLATED_IN_LUNG_CANCER_DN |
| — | SHANK_TAL1_TARGETS_UP |
| — | SHANK_TAL1_TARGETS_DN |
| — | SEMBA_FHIT_TARGETS_UP |
| — | SEMBA_FHIT_TARGETS_DN |
| — | KORKOLA_EMBRYONAL_CARCINOMA_UP |
| — | KORKOLA_EMBRYONAL_CARCINOMA_DN |
| — | KORKOLA_TERATOMA_UP |
| — | KORKOLA_TERATOMA_DN |
| — | KORKOLA_YOLK_SAC_TUMOR_UP |
| — | KORKOLA_YOLK_SAC_TUMOR_DN |
| — | KORKOLA_CHORIOCARCINOMA_UP |
| — | KORKOLA_CHORIOCARCINOMA_DN |
| — | KORKOLA_SEMINOMA_UP |
| — | KORKOLA_SEMINOMA_DN |
| — | KORKOLA_CORRELATED_WITH_POU5F1 |
| — | KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP |
| — | KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN |
| — | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP |
| — | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN |
| XU_CBP_UP | XU_CREBBP_TARGETS_UP |
| XU_CBP_DN | XU_CREBBP_TARGETS_DN |
| — | LANDIS_TABLE_1_UP |
| — | LANDIS_TABLE_1_DN |
| — | LANDIS_BREAST_CANCER_PROGRESSION_UP |
| — | LANDIS_BREAST_CANCER_PROGRESSION_DN |
| — | ENK_UV_RESPONSE_EPIDERMIS_UP |
| — | ENK_UV_RESPONSE_EPIDERMIS_DN |
| — | ENK_UV_RESPONSE_KERATINOCYTE_UP |
| — | ENK_UV_RESPONSE_KERATINOCYTE_DN |
| — | CHAN_INTERFERON_PRODUCING_DENDRITIC_CELL |
| — | LA_MEN1_TARGETS |
| — | REN_MIF_TARGETS_UP |
| — | REN_MIF_TARGETS_DN |
| — | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP |
| — | WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN |
| — | WANG_TABLE_1_BE_VS_NE_UP |
| — | WANG_TABLE_1_BE_VS_NE_DN |
| — | WANG_BARRETTS_ESOPHAGUS_UP |
| — | WANG_BARRETTS_ESOPHAGUS_DN |
| — | WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP |
| — | WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN |
| — | WANG_ESOPHAGUS_CANCER_PROGRESSION_UP |
| — | WANG_ESOPHAGUS_CANCER_PROGRESSION_DN |
| — | KOMMAGANI_TP63_GAMMA_TARGETS |
| GH_GHRHR_KO_24HRS_UP | GOVONI_GH1_TARGETS_24HR_UP |
| GH_GHRHR_KO_6HRS_UP | GOVONI_GH1_TARGETS_6HR_UP |
| GH_GHRHR_KO_24HRS_DN | GOVONI_GH1_TARGETS_24HR_DN |
| GH_GHRHR_KO_6HRS_DN | GOVONI_GH1_TARGETS_6HR_DN |
| — | WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP |
| — | WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN |
| — | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP |
| — | WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN |
| — | SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP |
| — | SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_DN |
| — | HOOI_ST7_TARGETS_UP |
| — | HOOI_ST7_TARGETS_DN |
| — | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP |
| — | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN |
| — | SOTIRIOU_TABLE_1S_UP |
| — | SOTIRIOU_TABLE_1S_DN |
| — | NAKAMURA_LUNG_CANCER |
| — | NAKAMURA_LUNG_CANCER_MARKERS |
| — | NAKAMURA_ALVEOLAR_EPITHELIUM |
| — | NAKAMURA_ALVEOLAR_AND_BRONCHIOLAR_EPITHELIA |
| — | NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA |
| — | NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS |
| — | DOANE_BREAST_CANCER_CLASSES_UP |
| — | DOANE_BREAST_CANCER_CLASSES_DN |
| — | DOANE_RESPONSE_TO_ANDROGEN_UP |
| — | DOANE_RESPONSE_TO_ANDROGEN_DN |
| — | DOANE_BREAST_CANCER_ESR1_UP |
| — | DOANE_BREAST_CANCER_ESR1_DN |
| — | GESERICK_TERT_TARGETS_UP |
| — | GESERICK_TERT_TARGETS_DN |
| — | GESERICK_TABLE_1S_UP |
| — | GESERICK_TABLE_1S_DN |
| — | CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP |
| — | CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_DN |
| — | CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP |
| — | CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN |
| HESS_HOXAANMEIS1_DN | HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN |
| HESS_HOXAANMEIS1_UP | HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP |
| MENSE_HYPOXIA_DN | MENSE_HYPOXIA_DN |
| MENSE_HYPOXIA_UP | MENSE_HYPOXIA_UP |
| MENSE_HYPOXIA_TRANSPORTER_GENES | Deprecated |
| MENSE_HYPOXIA_APOPTOSIS_GENES | Deprecated |
| — | ODONNELL_TFRC_TARGETS_UP |
| — | ODONNELL_TFRC_TARGETS_DN |
| — | ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP |
| — | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN |
| RUTELLA_HEMATOGFSNDCS_DIFF | Deprecated |
| RUTELLA_HEPATGFSNDCS_UP | Deprecated |
| — | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP |
| — | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN |
| — | RUTELLA_RESPONSE_TO_HGF_UP |
| — | RUTELLA_RESPONSE_TO_HGF_DN |
| — | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP |
| — | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN |
| — | PROVENZANI_METASTASIS_UP |
| — | PROVENZANI_METASTASIS_DN |
| — | LEE_LIVER_CANCER_HEPATOBLAST |
| — | FURUKAWA_DUSP6_TARGETS_PCI35_UP |
| — | FURUKAWA_DUSP6_TARGETS_PCI35_DN |
| — | FURUKAWA_DUSP6_TARGETS_PK8 |
| — | LINDGREN_BLADDER_CANCER_CLUSTER_1_UP |
| — | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN |
| — | LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP |
| — | LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN |
| — | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP |
| — | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN |
| — | LINDGREN_BLADDER_CANCER_CLUSTER_2B |
| — | LINDGREN_TABLE_4AS |
| — | LINDGREN_TABLE_4BS |
| — | LINDGREN_TABLE_4CS |
| — | LINDGREN_TABLE_4DS |
| — | LINDGREN_TABLE_4ES |
| — | LINDGREN_TABLE_4FS |
| — | LINDGREN_TABLE_4GS |
| — | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE |
| — | LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q |
| — | EHRLICH_TABLE_1_DN |
| — | EHRLICH_TABLE_1_UP |
| — | PIEPOLI_LGI1_TARGETS_UP |
| — | PIEPOLI_LGI1_TARGETS_DN |
| — | SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP |
| — | SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN |
| — | LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP |
| — | LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN |
| — | LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP |
| — | LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN |
| — | LOPEZ_EPITHELIOID_MESOTHELIOMA |
| — | LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP |
| — | LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN |
| — | LOPEZ_MESOTHELIOMA_SURVIVAL_UP |
| — | LOPEZ_MESOTHELIOMA_SURVIVAL_DN |
| — | WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP |
| — | WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_DN |
| — | HAEGERSTRAND_RESPONSE_TO_IMATINIB |
| — | DITTMER_PTHLH_TARGETS_UP |
| — | DITTMER_PTHLH_TARGETS_DN |
| — | MAYBURD_RESPONSE_TO_L663536_UP |
| — | MAYBURD_RESPONSE_TO_L663536_DN |
| — | ELVIDGE_TABLE_3_UP |
| — | ELVIDGE_TABLE_3_DN |
| — | ELVIDGE_TABLE_1_UP |
| — | ELVIDGE_TABLE_1_DN |
| — | ELVIDGE_HYPOXIA_UP |
| — | ELVIDGE_HYPOXIA_DN |
| — | ELVIDGE_HYPOXIA_BY_DMOG_UP |
| — | ELVIDGE_HYPOXIA_BY_DMOG_DN |
| — | ELVIDGE_HIF1A_TARGETS_UP |
| — | ELVIDGE_HIF1A_TARGETS_DN |
| — | ELVIDGE_HIF2A_TARGETS_UP |
| — | ELVIDGE_HIF2A_TARGETS_DN |
| — | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP |
| — | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN |
| — | LUND_TABLE_1 |
| — | LUND_SILENCED_BY_METHYLATION |
| — | UDAYAKUMAR_MED1_TARGETS_UP |
| — | UDAYAKUMAR_MED1_TARGETS_DN |
| — | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP |
| — | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN |
| — | HOLLMAN_APOPTOSIS_VIA_CD40_UP |
| — | HOLLMAN_APOPTOSIS_VIA_CD40_DN |
| — | WINNEPENNINCKX_MELANOMA_METASTASIS_DN |
| — | WINNEPENNINCKX_MELANOMA_METASTASIS_UP |
| — | UZONYI_TABLE_5S_6S_UP |
| — | UZONYI_TABLE_5S_6S_DN |
| — | UZONYI_TABLE_7S_8S_UP |
| — | UZONYI_TABLE_7S_8S_DN |
| — | UZONYI_TABLE_9S_10S_UP |
| — | UZONYI_TABLE_9S_10S_DN |
| — | UZONYI_TABLE_11S_12S_UP |
| — | UZONYI_TABLE_11S_12S_DN |
| — | UZONYI_TABLE_13S_14S_UP |
| — | UZONYI_TABLE_13S_14S_DN |
| — | UZONYI_TABLE_15S_16S_UP |
| — | UZONYI_TABLE_15S_16S_DN |
| — | UZONYI_TABLE_3S_4S_UP |
| — | UZONYI_TABLE_3S_4S_DN |
| — | UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN |
| — | CHIARADONNA_TARGETS_OF_KRAS_AND_CDC25_UP |
| — | CHIARADONNA_TARGETS_OF_KRAS_AND_CDC25_DN |
| — | CHIARADONNA_KRAS_TARGETS_UP |
| — | CHIARADONNA_KRAS_TARGETS_DN |
| — | CHIARADONNA_CDC25_TARGETS_UP |
| — | CHIARADONNA_CDC25_TARGETS_DN |
| — | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1 |
| — | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 |
| — | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 |
| — | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 |
| — | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 |
| — | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6 |
| — | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP |
| — | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN |
| — | AFFAR_YY1_TARGETS_UP |
| — | AFFAR_YY1_TARGETS_DN |
| HOUSTIS_ROS | HOUSTIS_ROS |
| — | VIEMANN_TNF_SIGNATURE |
| — | BILBAN_B_CLL_LPL_UP |
| — | BILBAN_B_CLL_LPL_DN |
| — | BILBAN_TABLE_2S_UP |
| — | BILBAN_TABLE_2S_DN |
| — | LIU_PROSTATE_CANCER_UP |
| — | LIU_PROSTATE_CANCER_DN |
| — | LIU_SOX4_TARGETS_UP |
| — | LIU_SOX4_TARGETS_DN |
| NGUYEN_KERATO_UP | NGUYEN_NOTCH1_TARGETS_UP |
| NGUYEN_KERATO_DN | NGUYEN_NOTCH1_TARGETS_DN |
| — | KARAKAS_TGFB1_SIGNALING |
| — | KARAKAS_TGFB1_SIGNALING_2_UP |
| — | KARAKAS_TGFB1_SIGNALING_2_DN |
| FLOTHO_CASP8AP2_MRD_DIFF | Deprecated |
| — | FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP |
| — | FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN |
| — | PRAMOONJAGO_SOX4_TARGETS_UP |
| — | PRAMOONJAGO_SOX4_TARGETS_DN |
| — | PRAMOONJAGO_TABLE_1_UP |
| — | PRAMOONJAGO_TABLE_1_DN |
| — | PRAMOONJAGO_TABLE_4_UP |
| — | PRAMOONJAGO_TABLE_4_DN |
| — | ONKEN_UVEAL_MELANOMA_UP |
| — | ONKEN_UVEAL_MELANOMA_DN |
| — | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP |
| — | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN |
| — | NEIMAN_TABLE_1S_UP |
| — | NEIMAN_TABLE_1S_DN |
| — | NEIMAN_TABLE_1S_TF_UP |
| — | NEIMAN_TABLE_1S_TF_DN |
| — | NEIMAN_TABLE_1S_END_STAGE_UP |
| — | NEIMAN_TABLE_1S_END_STAGE_DN |
| — | DUNNE_TABLE_1_UP |
| — | DUNNE_TABLE_1_DN |
| — | DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP |
| — | DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN |
| — | DUNNE_TABLE_5_UP |
| — | DUNNE_TABLE_5_DN |
| — | DUNNE_TABLE_2_UP |
| — | DUNNE_TABLE_2_DN |
| — | DUNNE_TABLE_3 |
| — | DUNNE_TABLE_5_ONE_MORE |
| — | PATTERSON_DOCETAXEL_RESISTANCE |
| — | YAMANAKA_GLIOMA_SURVIVAL_PROGNOSIS_POOR_VS_GOOD |
| — | YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP |
| — | YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN |
| RADMACHER_AMLNORMALKARYTYPE_SIG | RADMACHER_AML_PROGNOSIS |
| — | ROYLANCE_BREAST_CANCER_CHR16Q_COPY_NUMBER_UP |
| — | ROYLANCE_BREAST_CANCER_CHR16Q_COPY_NUMBER_DN |
| — | RIBAS_KINASE_PROQINASE_SELECTIVITY_PANEL |
| WALKER_MM_SNP_DIFF | Deprecated |
| — | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP |
| — | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN |
| — | KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP |
| — | KAPOSI_LIVER_CANCER_POOR_SURVIVAL_DN |
| — | JAERVINEN_TABLES_2S_AND_4S_UP |
| — | JAERVINEN_TABLES_2S_AND_4S_DN |
| — | JAERVINEN_TABLE_3S_AND_5S_UP |
| — | JAERVINEN_TABLE_3S_AND_5S_DN |
| — | JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER |
| ZHAN_MM_CD138_CD1_VS_REST | ZHAN_MULTIPLE_MYELOMA_CD1_UP |
| ZHAN_MM_CD1_VS_CD2_DN | ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN |
| ZHAN_MM_MOLECULAR_CLASSI_UP | ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP |
| ZHAN_MM_CD138_LB_VS_REST | ZHAN_MULTIPLE_MYELOMA_LB_UP |
| ZHAN_MM_CD1_VS_CD2_UP | ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP |
| ZHAN_MM_CD138_PR_VS_REST | ZHAN_MULTIPLE_MYELOMA_PR_UP |
| ZHAN_MM_CD138_CD2_VS_REST | ZHAN_MULTIPLE_MYELOMA_CD2_UP |
| ZHAN_MM_CD138_MF_VS_REST | ZHAN_MULTIPLE_MYELOMA_MF_UP |
| ZHAN_MM_CD138_MS_VS_REST | ZHAN_MULTIPLE_MYELOMA_MS_UP |
| ZHAN_MM_CD138_HP_VS_REST | ZHAN_MULTIPLE_MYELOMA_HP_UP |
| ZHAN_MM_MOLECULAR_CLASSI_DN | ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN |
| — | ZHAN_MULTIPLE_MYELOMA_CD1_DN |
| — | ZHAN_MULTIPLE_MYELOMA_CD2_DN |
| — | ZHAN_MULTIPLE_MYELOMA_LB_DN |
| — | ZHAN_MULTIPLE_MYELOMA_HP_DN |
| — | ZHAN_MULTIPLE_MYELOMA_MF_DN |
| — | ZHAN_MULTIPLE_MYELOMA_MS_DN |
| — | ZHAN_MULTIPLE_MYELOMA_PR_DN |
| — | HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER |
| — | HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER |
| — | ESTECIO_METHYLATED_IN_HEAD_AND_NECK_CANCER_UP |
| — | ESTECIO_METHYLATED_IN_HEAD_AND_NECK_CANCER_DN |
| — | OSMAN_BLADDER_CANCER_UP |
| — | OSMAN_BLADDER_CANCER_DN |
| — | PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP |
| — | PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN |
| — | GAZDA_TABLE_1S_UP |
| — | GAZDA_TABLE_1S_DN |
| — | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP |
| — | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN |
| — | GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP |
| — | GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN |
| — | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP |
| — | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_4 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_10 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_20 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_14 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_11 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_3 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_28 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_19 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 |
| — | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_13 |
| — | WANG_RESPONSE_TO_ANDROGEN_UP |
| — | WANG_RESPONSE_TO_ANDROGEN_DN |
| — | WANG_RESPONSE_TO_FORSKOLIN_UP |
| — | WANG_RESPONSE_TO_FORSKOLIN_DN |
| — | HUMMEL_BURKITTS_LYMPHOMA_UP |
| — | HUMMEL_BURKITTS_LYMPHOMA_DN |
| BROWN_GRAN_MONO_DIFFERENTIATION | BROWN_MYELOID_CELL_DEVELOPMENT_UP |
| BROWN_MYELOID_PROLIF_AND_SELF_RENEWAL | BROWN_MYELOID_CELL_DEVELOPMENT_DN |
| — | BROWN_CD131_MUTATED |
| — | NEWMAN_ERCC6_TARGETS_UP |
| — | NEWMAN_ERCC6_TARGETS_DN |
| — | NEWMAN_TABLE_1S_UP |
| — | NEWMAN_TABLE_1S_DN |
| — | PACHER_TARGETS_OF_IGF1_AND_IGF2_UP |
| — | PACHER_TARGETS_OF_IGF1_AND_IGF2_DN |
| — | PACHER_TABLES_2_5_UP |
| — | PACHER_TABLES_2_5_DN |
| — | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP |
| — | FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN |
| — | OHASHI_AURKA_TARGETS |
| — | OHASHI_AURKB_TARGETS |
| — | MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER |
| — | TSAI_DNAJB4_TARGETS_UP |
| — | TSAI_DNAJB4_TARGETS_DN |
| — | OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP |
| — | OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_DN |
| — | BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER |
| — | OZANNE_AP1_TARGETS_UP |
| — | OZANNE_AP1_TARGETS_DN |
| — | HWANG_PROSTATE_CANCER_MARKERS |
| — | TIMOFEEVA_TABLE_1S_UP |
| — | TIMOFEEVA_TABLE_1S_DN |
| — | TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_UP |
| — | TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN |
| — | TAKEDA_TABLE_1S_UP |
| — | TAKEDA_TABLE_1S_DN |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP |
| — | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN |
| — | LAIHO_COLORECTAL_CANCER_SERRATED_UP |
| — | LAIHO_COLORECTAL_CANCER_SERRATED_DN |
| — | LAIHO_TABLE_3S_UP |
| — | LAIHO_TABLE_3S_DN |
| — | ROESCH_HEAD_NECK_CANCER_UP |
| — | ROESCH_HEAD_NECK_CANCER_DN |
| — | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION |
| — | MOTAMED_RESPONSE_TO_ANDROGEN_UP |
| — | MOTAMED_RESPONSE_TO_ANDROGEN_DN |
| — | LOTEM_TABLE_2 |
| — | DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP |
| — | DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN |
| — | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP |
| — | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN |
| — | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP |
| — | DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN |
| — | DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP |
| — | DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN |
| — | FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP |
| — | FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN |
| — | FOURNIER_ACINAR_DEVELOPMENT_LATE_UP |
| — | FOURNIER_ACINAR_DEVELOPMENT_LATE_DN |
| — | FOURNIER_TABLES_4S_AND_5S_UP |
| — | FOURNIER_TABLES_4S_AND_5S_DN |
| — | FOURNIER_TABLES_2S_AND_3S_UP |
| — | FOURNIER_TABLES_2S_AND_3S_DN |
| — | FOURNIER_ACINAR_DEVELOPMENT_LATE_2 |
| — | NAM_FXYD5_TARGETS_UP |
| — | NAM_FXYD5_TARGETS_DN |
| — | FRASOR_TAMOXIFEN_RESPONSE_UP |
| — | FRASOR_TAMOXIFEN_RESPONSE_DN |
| — | EGUCHI_CELL_CYCLE_RB1_TARGETS |
| — | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
| — | BORCZUK_MALIGNANT_MESOTHELIOMA_DN |
| — | SHIRAISHI_PLZF_TARGETS_UP |
| — | SHIRAISHI_PLZF_TARGETS_DN |
| — | COLDREN_GEFITINIB_RESISTANCE_UP |
| — | COLDREN_GEFITINIB_RESISTANCE_DN |
| — | KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP |
| — | KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN |
| — | HANNA_CHEMOKINE_AND_ANGIOGENIC_FACTOR_EXPRESSION_IN_DNK_CELLS |
| — | GALLUZZI_PERMEABILIZE_MITOCHONDRIA |
| — | GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION |
| — | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP |
| — | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN |
| — | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP |
| — | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN |
| — | BUDHU_LIVER_CANCER_METASTASIS_UP |
| — | BUDHU_LIVER_CANCER_METASTASIS_DN |
| — | KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP |
| — | KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN |
| — | KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP |
| — | KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN |
| — | KOKKINAKIS_TABLE_1S_48HR_UP |
| — | KOKKINAKIS_TABLE_1S_48HR_DN |
| — | KOKKINAKIS_TABLE_1S_96H_UP |
| — | KOKKINAKIS_TABLE_1S_96H_DN |
| — | CHOI_ATL_CHRONIC_VS_ACUTE_UP |
| — | CHOI_ATL_CHRONIC_VS_ACUTE_DN |
| — | CHOI_ATL_ACUTE_STAGE |
| — | CHOI_ATL_STAGE_PREDICTOR |
| — | OLSSON_E2F3_TARGETS_UP |
| — | OLSSON_E2F3_TARGETS_DN |
| — | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP |
| — | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN |
| — | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP |
| — | RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN |
| — | CASTELLANO_HRAS_TARGETS_UP |
| — | CASTELLANO_HRAS_TARGETS_DN |
| — | CASTELLANO_HRAS_AND_NRAS_TARGETS_UP |
| — | CASTELLANO_HRAS_AND_NRAS_TARGETS_DN |
| — | CASTELLANO_NRAS_TARGETS_UP |
| — | CASTELLANO_NRAS_TARGETS_DN |
| — | CODY_NON_TUMORIGENIC_HYBRIDS_UP |
| — | CODY_NON_TUMORIGENIC_HYBRIDS_DN |
| — | CODY_MULTIPLE_CHROMOSOME_3P_TUMOR_SUPPRESSOR_GENES_UP |
| — | CODY_MULTIPLE_CHROMOSOME_3P_TUMOR_SUPPRESSOR_GENES_DN |
| — | KONG_RNA_KNOCKDOWN_OF_E2F1_AND_E2F3 |
| — | KONG_E2F1_TARGETS |
| — | KONG_E2F3_TARGETS |
| — | MUELLER_TABLE_1 |
| — | MUELLER_METHYLATED_IN_GLIOBLASTOMA |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP |
| — | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN |
| — | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP |
| — | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN |
| — | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP |
| — | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN |
| — | SENGUPTA_EBNA1_ANTICORRELATED |
| — | HAHTOLA_SEZARY_SYNDROM_UP |
| — | HAHTOLA_SEZARY_SYNDROM_DN |
| — | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP |
| — | HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN |
| — | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP |
| — | HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN |
| — | HAHTOLA_MYCOSIS_FUNGOIDES_UP |
| — | HAHTOLA_MYCOSIS_FUNGOIDES_DN |
| — | HAHTOLA_CTCL_CUTANEOUS |
| — | HAHTOLA_CTCL_PATHOGENESIS |
| — | HUTTMANN_B_CLL_POOR_SURVIVAL_UP |
| — | HUTTMANN_B_CLL_POOR_SURVIVAL_DN |
| — | NADERI_BREAST_CANCER_PROGNOSIS_UP |
| — | NADERI_BREAST_CANCER_PROGNOSIS_DN |
| — | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP |
| — | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN |
| — | PASTURAL_RIZ1_TARGETS_UP |
| — | PASTURAL_RIZ1_TARGETS_DN |
| — | ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_UP |
| — | ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN |
| — | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP |
| — | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN |
| — | HAMAI_APOPTOSIS_VIA_TRAIL_UP |
| — | HAMAI_APOPTOSIS_VIA_TRAIL_DN |
| — | LIU_CDX2_TARGETS_UP |
| — | LIU_CDX2_TARGETS_DN |
| — | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP |
| — | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN |
| — | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP |
| — | CASORELLI_APL_SECONDARY_VS_DE_NOVO_DN |
| — | CASORELLI_TABLE_3_UP |
| — | CASORELLI_TABLE_3_DN |
| — | HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2 |
| — | MATHEW_FANCONI_ANEMIA_GENES |
| — | STREICHER_FIG_8B_UP |
| — | STREICHER_FIG_8B_DN |
| — | STREICHER_LSM1_TARGETS_UP |
| — | STREICHER_LSM1_TARGETS_DN |
| — | CHIN_BREAST_CANCER_COPY_NUMBER_UP |
| — | CHIN_BREAST_CANCER_COPY_NUMBER_DN |
| — | ABDULRAHMAN_KIDNEY_CANCER_VHL_UP |
| — | ABDULRAHMAN_KIDNEY_CANCER_VHL_DN |
| — | HO_LIVER_CANCER_VASCULAR_INVASION |
| — | TURNER_TABLE_2_UP |
| — | TURNER_TABLE_2_DN |
| — | BOWIE_ECM_HMEC_LX |
| — | BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX |
| — | BOWIE_TAM_HMEC_LX |
| — | BOWIE_RESPONSE_TO_TAMOXIFEN |
| — | YEMELYANOV_GR_TARGETS_UP |
| — | YEMELYANOV_GR_TARGETS_DN |
| — | GAL_LEUKEMIC_STEM_CELL_UP |
| — | GAL_LEUKEMIC_STEM_CELL_DN |
| — | CORRADETTI_MTOR_PATHWAY_REGULATORS_UP |
| — | CORRADETTI_MTOR_PATHWAY_REGULATORS_DN |
| — | BARRIER_COLON_CANCER_RECURRENCE_UP |
| — | BARRIER_COLON_CANCER_RECURRENCE_DN |
| — | AIYAR_COBRA1_TARGETS_UP |
| — | AIYAR_COBRA1_TARGETS_DN |
| — | ZHONG_EPIGENETIC_SILENCING_IN_LUNG_CANCER_UP |
| — | ZHONG_EPIGENETIC_SILENCING_IN_LUNG_CANCER_DN |
| — | CROSBY_E2F4_TARGETS |
| — | WONG_ENDMETRIUM_CANCER_UP |
| — | WONG_ENDMETRIUM_CANCER_DN |
| — | WONG_ENDOMETRIAL_CANCER_LATE |
| — | WATANABE_COLON_CANCER_MSI_VS_MSS_UP |
| — | WATANABE_COLON_CANCER_MSI_VS_MSS_DN |
| — | POTTI_5FU_SENSITIVITY |
| — | POTTI_ADRIAMYCIN_SENSITIVITY |
| — | POTTI_CYTOXAN_SENSITIVITY |
| — | POTTI_DOCETAXEL_SENSITIVITY |
| — | POTTI_ETOPOSIDE_SENSITIVITY |
| — | POTTI_PACLITAXEL_SENSITIVITY |
| — | POTTI_TOPOTECAN_SENSITIVITY |
| — | GILMORE_DROSOPHILA_NFKAPPAB_CORE_SIGNALING |
| — | GILMORE_CORE_NFKB_PATHWAY |
| — | SCHEIDEREIT_IKK_TARGETS |
| — | SCHEIDEREIT_IKK_INTERACTING_PROTEINS |
| — | DUTTA_APOPTOSIS_VIA_NFKB |
| — | DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS |
| — | LI_CISPLATIN_RESISTANCE_DN |
| — | LI_CISPLATIN_RESISTANCE_UP |
| — | BASAKI_YBX1_TARGETS_UP |
| — | BASAKI_YBX1_TARGETS_DN |
| — | IVANOV_MUTATED_IN_COLON_CANCER |
| — | IVANOV_TABLE_1A |
| — | HORIUCHI_WTAP_TARGETS_UP |
| — | HORIUCHI_WTAP_TARGETS_DN |
| — | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP |
| — | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN |
| — | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP |
| — | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN |
| — | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP |
| — | HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN |
| — | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP |
| — | HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN |
| — | XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR |
| — | XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR |
| — | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP |
| — | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN |
| — | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP |
| — | XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN |
| — | XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP |
| — | XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN |
| — | XU_AKT1_TARGETS_6HR |
| — | XU_AKT1_TARGETS_48HR |
| — | XU_TABLE_8S |
| — | XU_TABLE_9S_UP |
| — | XU_TABLE_9S_DN |
| — | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP |
| — | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN |
| — | MAVILIO_TABLE_1S_1M |
| — | MAVILIO_TABLE_1S_4M |
| — | DODD_NASOPHARYNGEAL_CARCINOMA_UP |
| — | DODD_NASOPHARYNGEAL_CARCINOMA_DN |
| — | GAUSSMAN_MLL_AF4_FUSION_VS_CONTROL_UP |
| — | GAUSSMAN_MLL_AF4_FUSION_VS_CONTROL_DN |
| — | GAUSSMANN_AF4_MLL_FUSION_VS_CONTROL_UP |
| — | GAUSSMANN_AF4_MLL_FUSION_VS_CONTROL_DN |
| — | GAUSSMANN_MLL_AF4_AND_AF4_MLL_FUSIONS_VS_CONTROL_DN_UP |
| — | GAUSSMANN_MLL_AF4_AND_AF4_MLL_FUSIONS_VS_CONTROL_DN_DN |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP |
| — | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN |
| — | NAGASHIMA_NRG1_SIGNALING_UP |
| — | NAGASHIMA_NRG1_SIGNALING_DN |
| — | NAGASHIMA_EGF_SIGNALING_UP |
| — | NAGASHIMA_EGF_SIGNALING_DN |
| — | SCHMAHL_PDGF_SIGNALING |
| — | KOBAYASHI_EGFR_SIGNALING_6HR_UP |
| — | KOBAYASHI_EGFR_SIGNALING_6HR_DN |
| — | KOBAYASHI_EGFR_SIGNALING_24HR_UP |
| — | KOBAYASHI_EGFR_SIGNALING_24HR_DN |
| — | SAIGUSA_TABLE_1 |
| — | CHEBOTAEV_GR_TARGETS_UP |
| — | CHEBOTAEV_GR_TARGETS_DN |
| — | LEIN_NEURON_MARKERS |
| — | LEIN_ASTROCYTE_MARKERS |
| — | LEIN_OLIGODENDROCYTE_MARKERS |
| — | LEIN_CHOROID_PLEXUS_MARKERS |
| — | LEIN_MIDBRAIN_MARKERS |
| — | LEIN_PONS_MARKERS |
| — | LEIN_MEDULLA_MARKERS |
| — | LEIN_CEREBELLUM_MARKERS |
| — | LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES |
| — | LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES |
| — | LEIN_MRNA_TARGETING_ASTROCYTES |
| — | GRAESSMANN_SUPPLEMENT_2_APOPTOSIS_UP |
| — | GRAESSMANN_SUPPLEMENT_2_APOPTOSIS_DN |
| — | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP |
| — | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN |
| — | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP |
| — | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN |
| — | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP |
| — | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN |
| — | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP |
| — | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN |
| — | HOEBEKE_ACUTE_MYELOID_LEUKEMIA_UP |
| — | HOEBEKE_ACUTE_MYELOID_LEUKEMIA_DN |
| — | HOEBEKE_LYMPHOID_STEM_CELL_UP |
| — | HOEBEKE_LYMPHOID_STEM_CELL_DN |
| — | TOMLINS_PROSTATE_CANCER_UP |
| — | TOMLINS_PROSTATE_CANCER_DN |
| — | TOMLINS_METASTASIS_UP |
| — | TOMLINS_METASTASIS_DN |
| — | VILIMAS_NOTCH1_TARGETS_UP |
| — | VILIMAS_NOTCH1_TARGETS_DN |
| — | VILIMAS_FIG_1A |
| — | GRABARCZYK_BCL11B_TARGETS_UP |
| — | GRABARCZYK_BCL11B_TARGETS_DN |
| — | ZERBINI_RESPONSE_TO_SULINDAC_UP |
| — | ZERBINI_RESPONSE_TO_SULINDAC_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G2 |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G5_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP |
| — | BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN |
| — | BERTRAM_ALZGENE |
| — | BERTRAM_ALLELE VS. GENOTYPE CONTRASTS FOR POLYMORPHISMS |
| — | BERTRAM_ALLELIC CONTRASTS |
| — | BERTRAM_ALZGENE_UP |
| — | BERTRAM_ALZGENE_DN |
| — | BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP |
| — | BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN |
| — | HAMPE_CROHN_DISEASE_ASSOCIATED_SNPS |
| — | SCHLESINGER_METHYLATED_IN_COLON_CANCER |
| — | SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER |
| — | SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER |
| — | WIDSCHWENDTER_NORMAL_OVARIES_VS_OVARIAN CANCERS |
| — | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP |
| — | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN |
| — | SPIELMAN_SNP GENOTYPES |
| — | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP |
| — | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN |
| — | WHITEFORD_PEDIATRIC_CANCER_MARKERS |
| — | GRADE_METASTASIS_UP |
| — | GRADE_METASTASIS_DN |
| — | GRADE_COLON_CANCER_UP |
| — | GRADE_COLON_CANCER_DN |
| — | GRADE_COLON_AND_RECTAL_CANCER_UP |
| — | GRADE_COLON_AND_RECTAL_CANCER_DN |
| — | GRADE_COLON_VS_RECTAL_CANCER_UP |
| — | GRADE_COLON_VS_RECTAL_CANCER_DN |
| — | LABBE_WNT3A_TARGETS_UP |
| — | LABBE_WNT3A_TARGETS_DN |
| — | LABBE_TGFB1_TARGETS_UP |
| — | LABBE_TGFB1_TARGETS_DN |
| — | LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP |
| — | LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN |
| — | NAKAMURA_CANCER_MICROENVIRONMENT_UP |
| — | NAKAMURA_CANCER_MICROENVIRONMENT_DN |
| — | NAKAMURA_TABLE_1_2_UP |
| — | NAKAMURA_TABLE_1_2_DN |
| — | NAKAMURA_METASTASIS |
| — | NAKAMURA_METASTASIS_MODEL_UP |
| — | NAKAMURA_METASTASIS_MODEL_DN |
| — | GRATIAS_RETINOBLASTOMA_16Q24 |
| — | OHM_METHYLATED_IN_ADULT_CANCERS |
| — | OHM_EMBRYONIC_CARCINOMA_UP |
| — | OHM_EMBRYONIC_CARCINOMA_DN |
| — | CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP |
| — | CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN |
| — | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP |
| — | BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN |
| — | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP |
| — | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN |
| — | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP |
| — | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN |
| — | BERENJENO_TRANSFORMED_BY_RHOA_UP |
| — | BERENJENO_TRANSFORMED_BY_RHOA_DN |
| — | RIZ_ERYTHROID_DIFFERENTIATION |
| — | RIZ_ERYTHROID_DIFFERENTIATION_CCNE1 |
| — | RIZ_ERYTHROID_DIFFERENTIATION_HBZ |
| — | RIZ_ERYTHROID_DIFFERENTIATION_HEMGN |
| — | RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2 |
| — | RIZ_ERYTHROID_DIFFERENTIATION_6HR |
| — | RIZ_ERYTHROID_DIFFERENTIATION_12HR |
| — | SHI_SPARC_TARGETS_UP |
| — | SHI_SPARC_TARGETS_DN |
| — | MOHANKUMAR_TLX1_TARGETS_UP |
| — | MOHANKUMAR_TLX1_TARGETS_DN |
| — | NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP |
| — | NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN |
| — | APPIERTO_RESPONSE_TO_FENRETINIDE_UP |
| — | APPIERTO_RESPONSE_TO_FENRETINIDE_DN |
| — | GAVIN_TR_CELL_EFFECTOR_GENES |
| — | GAVIN_FOXP3_TARGETS_CLUSTER_T4 |
| — | GAVIN_FOXP3_TARGETS_CLUSTER_T7 |
| — | GAVIN_FOXP3_TARGETS_CLUSTER_P2 |
| — | GAVIN_FOXP3_TARGETS_CLUSTER_P3 |
| — | GAVIN_FOXP3_TARGETS_CLUSTER_P4 |
| — | GAVIN_FOXP3_TARGETS_CLUSTER_P6 |
| — | GAVIN_FOXP3_TARGETS_CLUSTER_P7 |
| — | GAVIN_PDE3B_TARGETS |
| — | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP |
| — | GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN |
| — | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP |
| — | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN |
| — | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP |
| — | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN |
| — | LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL |
| — | WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP |
| — | WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN |
| — | WEST_ADRENOCORTICAL_TUMOR_UP |
| — | WEST_ADRENOCORTICAL_TUMOR_DN |
| — | WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP |
| — | WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN |
| — | DONATO_CELL_CYCLE_TRETINOIN |
| — | CHO_NR4A1_TARGETS |
| — | BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP |
| — | BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN |
| — | BHATI_TABLE_1S_UP |
| — | BHATI_TABLE_1S_DN |
| — | CLIMENT_BREAST_CANCER_COPY_NUMBER_UP |
| — | CLIMENT_BREAST_CANCER_COPY_NUMBER_DN |
| — | ZHENG_BOUND_BY_FOXP3 |
| — | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP |
| — | ZHENG_FOXP3_TARGETS_IN_THYMUS_DN |
| — | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP |
| — | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN |
| — | ZHENG_FOXP3_TARGETS_UP |
| — | ZHENG_FOXP3_TARGETS_DN |
| — | MARSON_BOUND_BY_FOXP3_STIMULATED |
| — | MARSON_BOUND_BY_FOXP3_UNSTIMULATED |
| — | MARSON_BOUND_BY_E2F4_UNSTIMULATED |
| — | MARSON_FOXP3_TARGETS_STIMULATED_UP |
| — | MARSON_FOXP3_TARGETS_STIMULATED_DN |
| — | MARSON_FOXP3_CORE_DIRECT_TARGETS |
| — | MARSON_TCELL_BIOLOGY_FOXP3_TARGET_GENES |
| — | MARSON_SUPPLEMENTARY_TABLE_7B |
| — | MARSON_SUPPLEMENTARY_TABLE_8B |
| — | MARSON_SUPPLEMENTARY_TABLE_10 |
| — | MARSON_FOXP3_TARGETS_UP |
| — | MARSON_FOXP3_TARGETS_DN |
| — | HE_PTEN_TARGETS_UP |
| — | HE_PTEN_TARGETS_DN |
| — | MURATA_VIRULENCE_OF_H_PILORI |
| — | BUSA_SAM68_TARGETS_UP |
| — | BUSA_SAM68_TARGETS_DN |
| — | TANAKA_TABLE_1S_UP |
| — | TANAKA_TABLE_1S_DN |
| — | DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP |
| — | DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN |
| — | GUTIERREZ_TABLE_1_UP |
| — | GUTIERREZ_TABLE_1_DN |
| — | GUTIERREZ_TABLE_2_UP |
| — | GUTIERREZ_TABLE_2_DN |
| — | GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP |
| — | GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN |
| — | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP |
| — | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN |
| — | GUTIERREZ_MULTIPLE_MYELOMA_UP |
| — | GUTIERREZ_MULTIPLE_MYELOMA_DN |
| — | GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2 |
| — | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP |
| — | WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN |
| — | TOMIDA_METASTASIS_UP |
| — | TOMIDA_METASTASIS_DN |
| — | TOMIDA_LUNG_CANCER_POOR_SURVIVAL |
| — | DAWSON_METHYLATED_IN_LYMPHOMA_TCL1 |
| — | HEINTZMAN_TSS CLASSES_UP |
| — | HEINTZMAN_TSS CLASSES_DN |
| — | SHARMA_TABLE_1_UP |
| — | SHARMA_TABLE_1_DN |
| — | SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM |
| — | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP |
| — | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN |
| — | TSUDA_ALVEOLAR_SOFT_PART_SARCOMA |
| — | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP |
| — | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN |
| — | YAGUE_PRETUMOR_DRUG_RESISTANCE_UP |
| — | YAGUE_PRETUMOR_DRUG_RESISTANCE_DN |
| — | NAKAYAMA_FGF2_TARGETS |
| — | PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP |
| — | PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN |
| — | AKL_HTLV1_INFECTION_UP |
| — | AKL_HTLV1_INFECTION_DN |
| — | JAEGER_METASTASIS_UP |
| — | JAEGER_METASTASIS_DN |
| — | ERCAN_DCC_TARGETS |
| — | LUDWICZEK_TREATING_IRON_OVERLOAD |
| — | WAKASUGI_HAVE_ZNF143_BINDING_SITES |
| — | IGARASHI_ATF4_TARGETS_UP |
| — | IGARASHI_ATF4_TARGETS_DN |
| — | WIKMAN_ASBESTOS_LUNG_CANCER_UP |
| — | WIKMAN_ASBESTOS_LUNG_CANCER_DN |
| — | NOJIMA_SFRP2_TARGETS_UP |
| — | NOJIMA_SFRP2_TARGETS_DN |
| — | TAKAYAMA_BOUND_BY_AR |
| — | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP |
| — | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN |
| — | VECCHI_GASTRIC_CANCER_EARLY_UP |
| — | VECCHI_GASTRIC_CANCER_EARLY_DN |
| — | BRUECKNER_TARGETS_OF_LET7_MICRORNA_UP |
| — | BRUECKNER_TARGETS_OF_LET7_MICRORNA_DN |
| — | PODAR_RESPONSE_TO_ADAPHOSTIN_UP |
| — | PODAR_RESPONSE_TO_ADAPHOSTIN_DN |
| — | LU_TUMOR_VASCULATURE_UP |
| — | LU_TUMOR_VASCULATURE_DN |
| — | LU_TABLE_2 |
| — | LU_TUMOR_ENDOTHELIAL_MARKERS_UP |
| — | LU_TUMOR_ENDOTHELIAL_MARKERS_DN |
| — | LU_TUMOR_ANGIOGENESIS_UP |
| — | LU_TUMOR_ANGIOGENESIS_DN |
| — | LU_TABLE_1S_UP |
| — | LU_TABLE_1S_DN |
| — | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK |
| — | AKDEMIR_LOW_STRINGENCY_RADIATION_RESPONSE_NORMAL_VS_P53_LOF_UP |
| — | AKDEMIR_LOW_STRINGENCY_RADIATION_RESPONSE_NORMAL_VS_P53_LOF_DN |
| — | AKDEMIR_DROSOPHILA_P53_LOF_VS_NORMAL_UP |
| — | AKDEMIR_DROSOPHILA_P53_LOF_VS_NORMAL_DN |
| — | AKDEMIR_RIPD GENES |
| — | AKDEMIR_P53 |
| — | AKDEMIR_RIPD_GENES |
| — | AMIT_FIG_4GS |
| — | AMIT_DELAYED_EARLY_GENES |
| — | AMIT_EGF_RESPONSE_20_HELA |
| — | AMIT_EGF_RESPONSE_40_HELA |
| — | AMIT_EGF_RESPONSE_60_HELA |
| — | AMIT_EGF_RESPONSE_120_HELA |
| — | AMIT_EGF_RESPONSE_240_HELA |
| — | AMIT_EGF_RESPONSE_480_HELA |
| — | AMIT_EGF_RESPONSE_20_MCF10A |
| — | AMIT_EGF_RESPONSE_40_MCF10A |
| — | AMIT_EGF_RESPONSE_60_MCF10A |
| — | AMIT_EGF_RESPONSE_120_MCF10A |
| — | AMIT_EGF_RESPONSE_240_MCF10A |
| — | AMIT_EGF_RESPONSE_480_MCF10A |
| — | AMIT_EGF_PEAK 240 MIN |
| — | AMIT_SERUM_RESPONSE_20_MCF10A |
| — | AMIT_SERUM_RESPONSE_40_MCF10A |
| — | AMIT_SERUM_RESPONSE_60_MCF10A |
| — | AMIT_SERUM_RESPONSE_120_MCF10A |
| — | AMIT_SERUM_RESPONSE_240_MCF10A |
| — | AMIT_SERUM_RESPONSE_480_MCF10A |
| — | MARKS_HDAC_TARGETS_UP |
| — | MARKS_HDAC_TARGETS_DN |
| — | MARKS_ACETYLATED_NON_HISTONE_PROTEINS |
| — | MAHADEVAN_IMATINIB_RESISTANCE_UP |
| — | MAHADEVAN_IMATINIB_RESISTANCE_DN |
| — | MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH |
| — | MAHADEVAN_RESPONSE_TO_MP470_DN |
| — | MAHADEVAN_RESPONSE_TO_MP470_UP |
| — | RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP |
| — | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN |
| — | KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION |
| — | HUANG_DASATINIB_RESISTANCE_UP |
| — | HUANG_DASATINIB_RESISTANCE_DN |
| — | HUANG_TABLE_2_UP |
| — | HUANG_TABLE_2_DN |
| — | WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP |
| — | WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN |
| — | WEBER_METHYLATED_HCP_IN_SPERM_DN |
| — | WEBER_METHYLATED_HCP_IN_SPERM_UP |
| — | WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP |
| — | WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN |
| — | WEBER_METHYLATED_ICP_IN_FIBROBLAST |
| — | WEBER_METHYLATED_ICP_IN_SPERM_UP |
| — | WEBER_METHYLATED_ICP_IN_SPERM_DN |
| — | WEBER_METHYLATED_LCP_IN_SPERM_UP |
| — | WEBER_METHYLATED_LCP_IN_SPERM_DN |
| — | SPIRA_SMOKERS_LUNG_CANCER_UP |
| — | SPIRA_SMOKERS_LUNG_CANCER_DN |
| — | SPIRA_TABLE_3S_UP |
| — | SPIRA_TABLE_3S_DN |
| — | RODRIGUES_DCC_TARGETS_UP |
| — | RODRIGUES_DCC_TARGETS_DN |
| — | RODRIGUES_NTN1_TARGETS_UP |
| — | RODRIGUES_NTN1_TARGETS_DN |
| — | RODRIGUES_NTN1_AND_DCC_TARGETS |
| — | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_UP |
| — | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN |
| — | GREENMAN_KINASES_WITH_DRIVER_MUTATIONS |
| — | CORRE_MULTIPLE_MYELOMA_UP |
| — | CORRE_MULTIPLE_MYELOMA_DN |
| — | MOOK_TABLE_1_UP |
| — | MOOK_TABLE_1_DN |
| — | MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN |
| — | MATTHEWS_TABLE_1BS |
| — | MATTHEWS_AP1_TARGETS |
| — | QI_TABLE_1 |
| — | QI_PLASMACYTOMA_UP |
| — | QI_PLASMACYTOMA_DN |
| — | WANG_GENES_IN_PAR1_CANDIDATE_REGION |
| — | TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA |
| — | ZINDY_FIG_3CB |
| — | LAU_APOPTOSIS_CDKN2A_UP |
| — | LAU_APOPTOSIS_CDKN2A_DN |
| — | SANSOM_APC_TARGETS |
| — | SANSOM_APC_MYC_TARGETS |
| — | SANSOM_APC_TARGETS_REQUIRE_MYC |
| — | SANSOM_SUPPLEMENTAL_TABLE_3A |
| — | SANSOM_SUPPLEMENTAL_TABLE_3B |
| — | SANSOM_WNT_PATHWAY_REQUIRE_MYC |
| — | ONO_CD4+_T_CELLS_AML1>2.0_FOXP3>2.0 |
| — | ONO_CD4+_T_CELLS_AML1>2.0_FOXP3<0.5 |
| — | ONO_CD4+_T_CELLS_AML1<0.5_FOXP3>2.0 |
| — | ONO_CD4+_T_CELLS_AML1<0.5_FOXP3<0.5 |
| — | ONO_CD4+_T_CELLS_0.5<AML1<2.0_FOXP3>2.0 |
| — | ONO_CD4+_T_CELLS_0.5<AML1<2.0_FOXP3<0.5 |
| — | ONO_CD4+_T_CELLS_AML1>2.0_0.5<FOXP3<2.0 |
| — | ONO_CD4+_T_CELLS_AML1<0.5_0.5<FOXP3<2.0 |
| — | ONO_AML1_TARGETS_UP |
| — | ONO_AML1_TARGETS_DN |
| — | ONO_FOXP3_TARGETS_UP |
| — | ONO_FOXP3_TARGETS_DN |
| — | TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP |
| — | TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN |
| — | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP |
| — | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN |
| — | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP |
| — | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN |
| — | TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP |
| — | TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN |
| — | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP |
| — | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN |
| — | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP |
| — | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN |
| — | WANG_LSD1_TARGETS_UP |
| — | WANG_LSD1_TARGETS_DN |
| — | SCHAVOLT_TARGETS_OF_TP53_AND_TP63 |
| — | CHASSOT_SKIN_WOUND |
| — | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP |
| — | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN |
| — | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP |
| — | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN |
| — | RODRIGUES_THYROID_CARCINOMA_UP |
| — | RODRIGUES_THYROID_CARCINOMA_DN |
| — | KROEGER_TABLE_1S_2_UP |
| — | KROEGER_TABLE_1S_2_DN |
| — | KROEGER_TABLE_1S_3_UP |
| — | KROEGER_TABLE_1S_3_DN |
| — | KROEGER_TABLE_1S_1_UP |
| — | KROEGER_TABLE_1S_1_DN |
| — | CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP |
| — | CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN |
| — | HUPER_BREAST_BASAL_VS_LUMINAL_UP |
| — | HUPER_BREAST_BASAL_VS_LUMINAL_DN |
| — | MALONEY_RESPONSE_TO_17AAG_UP |
| — | MALONEY_RESPONSE_TO_17AAG_DN |
| — | BLUM_RESPONSE_TO_SALIRASIB_UP |
| — | BLUM_RESPONSE_TO_SALIRASIB_DN |
| — | CUI_GLUCOSE_DEPRIVATION |
| — | WINTER_HYPOXIA_UP |
| — | WINTER_HYPOXIA_DN |
| — | WINTER_HYPOXIA_METAGENE |
| — | WINTER_TABLE_2S_UP |
| — | WINTER_TABLE_2S_DN |
| — | ALONSO_METASTASIS_EMT_UP |
| — | ALONSO_METASTASIS_EMT_DN |
| — | ALONSO_METASTASIS_NEURAL_UP |
| — | ALONSO_METASTASIS_NEURAL_DN |
| — | ALONSO_METASTASIS_UP |
| — | ALONSO_METASTASIS_DN |
| — | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP |
| — | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN |
| — | HU_HSF1_TRANSCRIPTION_FACTOR_TARGETS |
| — | WHITEHURST_PACLITAXEL_SENSITIVITY |
| — | CHANDRAN_METASTASIS_TOP50_UP |
| — | CHANDRAN_METASTASIS_TOP50_DN |
| — | CHANDRAN_METASTASIS_UP |
| — | CHANDRAN_METASTASIS_DN |
| — | KIM_TABLE_1S_UP |
| — | KIM_TABLE_1S_DN |
| — | KIM_WT1_TARGETS_UP |
| — | KIM_WT1_TARGETS_DN |
| — | KIM_WT1_TARGETS_8HR_UP |
| — | KIM_WT1_TARGETS_8HR_DN |
| — | KIM_WT1_TARGETS_12HR_UP |
| — | KIM_WT1_TARGETS_12HR_DN |
| — | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA |
| — | TANAKA_BAC |
| — | WANG_TUMOR_INVASIVENESS_UP |
| — | WANG_TUMOR_INVASIVENESS_DN |
| — | JIANG_TIP30_TARGETS_UP |
| — | JIANG_TIP30_TARGETS_DN |
| — | GRESHOCK_CANCER_COPY_NUMBER_UP |
| — | GRESHOCK_CANCER_COPY_NUMBER_DN |
| — | WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC |
| — | TSAI_RESPONSE_TO_RADIATION_THERAPY |
| — | MIKI_COEXPRESSED_WITH_CYP19A1 |
| — | NGO_MALIGNANT_GLIOMA_1P_LOH |
| — | STEGMEIER_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS |
| — | STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS |
| — | WELCH_TABLE_1S_UP |
| — | WELCH_TABLE_1S_DN |
| — | DIERICK_DROSOPHILA_SEROTONIN_FUNCTION_GENES |
| — | DIERICK_SEROTONIN_FUNCTION_GENES |
| — | LEE_TARGETS_OF_PTCH1_AND_SUFU_UP |
| — | LEE_TARGETS_OF_PTCH1_AND_SUFU_DN |
| — | WANG_LMO4_TARGETS_UP |
| — | WANG_LMO4_TARGETS_DN |
| — | WANG_CLIM2_TARGETS_UP |
| — | WANG_CLIM2_TARGETS_DN |
| — | MARKEY_RB1_CHRONIC_LOF_UP |
| — | MARKEY_RB1_CHRONIC_LOF_DN |
| — | MARKEY_RB1_ACUTE_LOF_UP |
| — | MARKEY_RB1_ACUTE_LOF_DN |
| — | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER |
| — | VARKI_SIALIC_ACID_BIOLOGY_HUMANS_VERSUS_OTHER_HOMINIDS |
| — | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP |
| — | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN |
| — | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP |
| — | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN |
| — | THEODOROU_MAMMARY_TUMORIGENESIS |
| — | HUI_MAPK14_TARGETS_UP |
| — | HUI_MAPK14_TARGETS_DN |
| — | SENESE_HDAC1_TARGETS_UP |
| — | SENESE_HDAC1_TARGETS_DN |
| — | SENESE_HDAC1_AND_HDAC2_TARGETS_UP |
| — | SENESE_HDAC1_AND_HDAC2_TARGETS_DN |
| — | SENESE_HDAC2_TARGETS_UP |
| — | SENESE_HDAC2_TARGETS_DN |
| — | SENESE_HDAC3_TARGETS_UP |
| — | SENESE_HDAC3_TARGETS_DN |
| — | DAIRKEE_TERT_TARGETS_UP |
| — | DAIRKEE_TERT_TARGETS_DN |
| — | BEIER_TABLE_1_UP |
| — | BEIER_TABLE_1_DN |
| — | BEIER_GLIOMA_STEM_CELL_UP |
| — | BEIER_GLIOMA_STEM_CELL_DN |
| — | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP |
| — | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN |
| — | STEMMER_TABLE_1_UP |
| — | STEMMER_TABLE_1_DN |
| — | STEMMER_TABLE_2_UP |
| — | STEMMER_TABLE_2_DN |
| — | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP |
| — | BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN |
| — | BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP |
| — | BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN |
| — | BOYLAN_MULTIPLE_MYELOMA_D_UP |
| — | BOYLAN_MULTIPLE_MYELOMA_D_DN |
| — | BOYLAN_MULTIPLE_MYELOMA_C_D_UP |
| — | BOYLAN_MULTIPLE_MYELOMA_C_D_DN |
| — | BOYLAN_MULTIPLE_MYELOMA_C_UP |
| — | BOYLAN_MULTIPLE_MYELOMA_C_DN |
| — | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP |
| — | BOYLAN_MULTIPLE_MYELOMA_PCA1_DN |
| — | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP |
| — | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN |
| — | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS |
| — | HELLEBREKERS_TABLE_5S |
| — | REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS |
| — | GU_PDEF_TARGETS_UP |
| — | GU_PDEF_TARGETS_DN |
| — | PARENT_MTOR_SIGNALING_UP |
| — | PARENT_MTOR_SIGNALING_DN |
| — | TOOKER_TABLE_1S_UP |
| — | TOOKER_TABLE_1S_DN |
| — | TOOKER_GEMCITABINE_RESISTANCE_UP |
| — | TOOKER_GEMCITABINE_RESISTANCE_DN |
| — | TOOKER_RESPONSE_TO_BEXAROTENE_UP |
| — | TOOKER_RESPONSE_TO_BEXAROTENE_DN |
| — | AIGNER_ZEB1_TARGETS |
| — | WOOD_EBV_EBNA1_TARGETS_UP |
| — | WOOD_EBV_EBNA1_TARGETS_DN |
| — | WANG_HCP_PROSTATE_CANCER |
| — | MCBRYAN_FIG_1D_UP |
| — | MCBRYAN_FIG_1D_DN |
| — | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP |
| — | MCBRYAN_PUBERTAL_BREAST_3_4WK_DN |
| — | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP |
| — | MCBRYAN_PUBERTAL_BREAST_4_5WK_DN |
| — | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP |
| — | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN |
| — | MCBRYAN_PUBERTAL_BREAST_6_7WK_UP |
| — | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN |
| — | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP |
| — | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN |
| — | MCBRYAN_TERMINAL_END_BUD_UP |
| — | MCBRYAN_TERMINAL_END_BUD_DN |
| — | MCBRYAN_FIG_1C |
| — | MCBRYAN_FIG_5B |
| — | MCBRYAN_TABLE_2S |
| — | JU_AGING_TERC_TARGETS_UP |
| — | JU_AGING_TERC_TARGETS_DN |
| — | TURJANSKI_MAPK1_AND_MAPK2_TARGETS |
| — | TURJANSKI_MAPK8_AND_MAPK9_TARGETS |
| — | TURJANSKI_MAPK7_TARGETS |
| — | TURJANSKI_MAPK11_TARGETS |
| — | TURJANSKI_MAPK14_TARGETS |
| — | TURJANSKI_MAPK12_TARGETS |
| — | TURJANSKI_MAPK13_TARGETS |
| — | OXFORD_RALA_TARGETS_UP |
| — | OXFORD_RALA_TARGETS_DN |
| — | OXFORD_RALB_TARGETS_DN |
| — | OXFORD_RALB_TARGETS_UP |
| — | OXFORD_RALA_AND_RALB_TARGETS_UP |
| — | OXFORD_RALA_AND_RALB_TARGETS_DN |
| — | OXFORD_RALA_OR_RALB_TARGETS_UP |
| — | OXFORD_RALA_OR_RALB_TARGETS_DN |
| — | SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP |
| — | SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN |
| — | PYEON_HPV_POSITIVE_TUMORS_UP |
| — | PYEON_HPV_POSITIVE_TUMORS_DN |
| — | PYEON_TABLE_4_UP |
| — | PYEON_TABLE_4_DN |
| — | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP |
| — | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN |
| — | MASER_ONCOGENE_TABLE_6S |
| — | MASER_TUMOR_SUPPRESSOR_TABLE_6S |
| — | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP |
| — | EBAUER_TABLE_1S |
| — | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN |
| — | EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION |
| — | DARWICHE_SKIN_TUMOR_PROMOTER_UP |
| — | DARWICHE_SKIN_TUMOR_PROMOTER_DN |
| — | DARWICHE_PAPILLOMA_RISK_LOW_UP |
| — | DARWICHE_PAPILLOMA_RISK_LOW_DN |
| — | DARWICHE_PAPILLOMA_RISK_HIGH_UP |
| — | DARWICHE_PAPILLOMA_RISK_HIGH_DN |
| — | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP |
| — | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN |
| — | DARWICHE_PAPILLOMA_PROGRESSION_RISK |
| — | DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_UP |
| — | DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN |
| — | EASTON_SNPS_ASSOCIATED_WITH_BREAST_CANCER |
| — | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP |
| — | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN |
| — | LASTOWSKA_COAMPLIFIED_WITH_MYCN |
| — | LASTOWSKA_TABLE_3 |
| — | HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3 |
| — | TANG_SENESCENCE_TP53_TARGETS_UP |
| — | TANG_SENESCENCE_TP53_TARGETS_DN |
| — | CHINTAPALLI_DROSOPHILA TISSUES |
| — | CHINTAPALLI_DROSOPHILA MELANOGASTER |
| — | FOSTER_INFLAMMATORY_RESPONSE_LPS_UP |
| — | FOSTER_INFLAMMATORY_RESPONSE_LPS_DN |
| — | DEN_INTERACT_WITH_LCA5 |
| — | YANAGISAWA_LUNG_CANCER_RECURRENCE |
| — | PEREZ_TP53_TARGETS |
| — | PEREZ_TP63_TARGETS |
| — | PEREZ_TP53_AND_TP63_TARGETS |
| — | TESAR_ALK_TARGETS_HUMAN_ES_4D_UP |
| — | TESAR_ALK_TARGETS_HUMAN_ES_4D_DN |
| — | TESAR_ALK_TARGETS_HUMAN_ES_5D_UP |
| — | TESAR_ALK_TARGETS_HUMAN_ES_5D_DN |
| — | TESAR_ALK_TARGETS_EPISC_3D_UP |
| — | TESAR_ALK_TARGETS_EPISC_3D_DN |
| — | TESAR_ALK_TARGETS_EPISC_4D_UP |
| — | TESAR_ALK_TARGETS_EPISC_4D_DN |
| — | TESAR_ALK_TARGETS_MOUSE_ES_3D_UP |
| — | TESAR_ALK_TARGETS_MOUSE_ES_3D_DN |
| — | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP |
| — | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN |
| — | TESAR_ALK_TARGETS_MOUSE_ES_D4_UP |
| — | TESAR_ALK_TARGETS_MOUSE_ES_D4_DN |
| — | TESAR_JAK_TARGETS_MOUSE_ES_D3_UP |
| — | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN |
| — | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP |
| — | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN |
| — | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP |
| — | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN |
| — | MULLIGHAN_MLL_SIGNATURE_1_UP |
| — | MULLIGHAN_MLL_SIGNATURE_1_DN |
| — | MULLIGHAN_MLL_SIGNATURE_2_UP |
| — | MULLIGHAN_MLL_SIGNATURE_2_DN |
| — | MULLIGHAN_NPM1_SIGNATURE_3_UP |
| — | MULLIGHAN_NPM1_SIGNATURE_3_DN |
| — | SUZUKI_AMPLIFIED_IN_ORAL_CANCER |
| — | MIKKELSEN_TABLE_4S_NPC_UP |
| — | MIKKELSEN_TABLE_4S_NPC_DN |
| — | MIKKELSEN_TABLE_4S_MEF_UP |
| — | MIKKELSEN_TABLE_4S_MEF_DN |
| — | MIKKELSEN_ES_HCP_WITH_H3K27ME3 |
| — | MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED |
| — | MIKKELSEN_ES_ICP_WITH_H3K27ME3 |
| — | MIKKELSEN_ES_ICP_WITH_H3K4ME3 |
| — | MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MIKKELSEN_ES_LCP_WITH_H3K27ME3 |
| — | MIKKELSEN_ES_LCP_WITH_H3K4ME3 |
| — | MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 |
| — | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 |
| — | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 |
| — | MIKKELSEN_NPC_WITH_LCP_H3K27ME3 |
| — | MIKKELSEN_NPC_LCP_WITH_H3K4ME3 |
| — | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 |
| — | MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED |
| — | MIKKELSEN_TABLE_4S_MEF_ICP_K27 |
| — | SANDHU_SNP |
| — | SANDHU_SNPS |
| — | LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP |
| — | LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN |
| — | LIEN_BREAST_CARCINOMA_METAPLASTIC |
| — | THUM_SYSTOLIC_HEART_FAILURE_UP |
| — | THUM_SYSTOLIC_HEART_FAILURE_DN |
| — | ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS |
| — | ALCALA_APOPTOSIS |
| — | DELYS_THYROID_CANCER_UP |
| — | DELYS_THYROID_CANCER_DN |
| — | DELYS_TABLE_4S |
| — | DELYS_TABLE_2S_UP |
| — | DELYS_TABLE_2S_DN |
| — | DELYS_TABLE_3S_UP |
| — | DELYS_TABLE_3S_DN |
| — | DELYS_TABLE_5S |
| — | KESHELAVA_MULTIPLE_DRUG_RESISTANCE |
| — | MIGNOT_RLS |
| — | OKAWA_NEUROBLASTOMA_1P36_31_DELETION |
| — | JI_METASTASIS_REPRESSED_BY_STK11 |
| — | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN |
| — | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP |
| — | JI_FIG_10S_UP |
| — | JI_FIG_10S_DN |
| — | JI_FIG_8S |
| — | SEIKE_LUNG_CANCER_POOR_SURVIVAL |
| — | BAKER_SAGA_COMPONENTS |
| — | NAGY_SAGA_COMPONENTS_YEAST |
| — | NAGY_ADA_COMPONENTS_YEAST |
| — | NAGY_TFTC_COMPONENTS_HUMAN |
| — | NAGY_STAGA_COMPONENTS_HUMAN |
| — | NAGY_ATAC_COMPONENTS_HUMAN |
| — | NAGY_SAGA_COMPONENTS_DROSOPHILA |
| — | NAGY_PCAF_COMPONENTS_HUMAN |
| — | NAGY_ATAC_COMPONENTS_DROSOPHILA |
| — | LAFON_NUA3_COMPONENTS |
| — | LAFON_SAS_COMPONENTS |
| — | LAFON_NUA4_COMPONENTS |
| — | MARTIN_INTERACT_WITH_HDAC |
| — | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP |
| — | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN |
| — | WILLIAMS_ESR1_TARGETS_UP |
| — | WILLIAMS_ESR1_TARGETS_DN |
| — | WILLIAMS_TABLE_2_UP |
| — | WILLIAMS_TABLE_2_DN |
| — | WILLIAMS_ESR2_TARGETS_UP |
| — | WILLIAMS_ESR2_TARGETS_DN |
| — | BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION |
| — | GROSS_HYPOXIA_VIA_HIF1A_ONLY |
| — | GROSS_ELK3_TARGETS_UP |
| — | GROSS_ELK3_TARGETS_DN |
| — | GROSS_HYPOXIA_VIA_ELK3_UP |
| — | GROSS_HYPOXIA_VIA_ELK3_DN |
| — | GROSS_HIF1A_TARGETS_UP |
| — | GROSS_HIF1A_TARGETS_DN |
| — | GROSS_HYPOXIA_VIA_HIF1A_UP |
| — | GROSS_HYPOXIA_VIA_HIF1A_DN |
| — | GROSS_HYPOXIA_VIA_ELK3_ONLY_UP |
| — | GROSS_HYPOXIA_VIA_ELK3_ONLY_DN |
| — | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP |
| — | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN |
| — | COWLING_MYCN_TARGETS |
| — | SCIBETTA_KDM5B_TARGETS_UP |
| — | SCIBETTA_KDM5B_TARGETS_DN |
| — | DURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP |
| — | DURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN |
| — | GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP |
| — | GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN |
| — | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP |
| — | GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN |
| — | GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP |
| — | GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN |
| — | GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP |
| — | GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN |
| — | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP |
| — | GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN |
| — | GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP |
| — | GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN |
| — | TANNO_HUMAN_ERYTHROBLAST_CULTURE_DAY_7_VS_DAY_14_UP |
| — | TANNO_HUMAN_ERYTHROBLAST_CULTURE_DAY_7_VS_DAY_14_DN |
| — | TANNO_TGFB_SUPERFAMILY |
| — | RUNNE_GENDER_EFFECT_UP |
| — | RUNNE_GENDER_EFFECT_DN |
| — | FALVELLA_SMOKERS_WITH_LUNG_CANCER |
| — | NUYTTEN_NIPP1_TARGETS_UP |
| — | NUYTTEN_NIPP1_TARGETS_DN |
| — | NUYTTEN_EZH2_TARGETS_UP |
| — | NUYTTEN_EZH2_TARGETS_DN |
| — | LIU_TABLE_3 |
| — | GOZGIT_ESR1_TARGETS_UP |
| — | GOZGIT_ESR1_TARGETS_DN |
| — | ROY_WOUND_BLOOD_VESSEL_UP |
| — | ROY_WOUND_BLOOD_VESSEL_DN |
| — | MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP |
| — | MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN |
| — | WAGNER_APO2_SENSITIVITY |
| — | GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS |
| — | GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS |
| — | DIXON_TABLE_1S |
| — | DIXON_TABLE_2S |
| — | DIXON_TABLE_3AS_NON_MHC |
| — | DIXON_TABLE_3AS_MHC |
| — | PALOMERO_GSI_SENSITIVITY_UP |
| — | PALOMERO_GSI_SENSITIVITY_DN |
| — | MONTERO_TABLE_3 |
| — | MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP |
| — | MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN |
| — | INGRAM_SHH_TARGETS_UP |
| — | INGRAM_SHH_TARGETS_DN |
| — | GARY_CD5_TARGETS_UP |
| — | GARY_CD5_TARGETS_DN |
| — | OZEN_MIR125B1_TARGETS |
| — | KAUFFMANN_MELANOMA_RELAPSE_UP |
| — | KAUFFMANN_MELANOMA_RELAPSE_DN |
| — | KAUFFMANN_DNA_REPAIR_GENES |
| — | KAUFFMANN_DNA_REPLICATION_GENES |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP |
| — | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_DN |
| — | SOUCEK_MYC_TARGETS |
| — | MANTOVANI_NFKB_TARGETS_UP |
| — | MANTOVANI_NFKB_TARGETS_DN |
| — | MANTOVANI_VIRAL_GPCR_SIGNALING_UP |
| — | MANTOVANI_VIRAL_GPCR_SIGNALING_DN |
| — | JIANG_CORE_DUPLICON_GENES |
| — | PUJANA_BREAST_CANCER_LIT_INT_NETWORK |
| — | PUJANA_XPRSS_INT_NETWORK |
| — | PUJANA_BRCA1_PCC_NETWORK |
| — | PUJANA_BRCA2_PCC_NETWORK |
| — | PUJANA_ATM_PCC_NETWORK |
| — | PUJANA_CHEK2_PCC_NETWORK |
| — | PUJANA_TABLE_4S |
| — | PUJANA_BCN_DIRECT_SUBNETWORK |
| — | PUJANA_BRCA_CENTERED_NETWORK |
| — | PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP |
| — | PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN |
| — | JEPSEN_SMRT_TARGETS |
| — | RAY_ALZHEIMERS_DISEASE |
| — | RICE_TABLE_1 |
| — | RICE_TABLE_2 |
| — | BAKER_TABLE_1 |
| — | BAKER_HEMATOPOESIS_STAT1_TARGETS |
| — | BAKER_HEMATOPOIESIS_STAT3_TARGETS |
| — | BAKER_HEMATOPOESIS_STAT5_TARGETS |
| — | SEKI_INFLAMMATORY_RESPONSE_LPS_UP |
| — | SEKI_INFLAMMATORY_RESPONSE_LPS_DN |
| — | YIN_ATF3_TARGETS |
| — | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP |
| — | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN |
| — | HARADA_UPD_REGIONS_IN_PANCREATIC_CANCER |
| — | HARADA_COPY_NUMBER_ANALYSIS_IN_PANCREATIC_CANCER_CELLS_UP |
| — | HARADA_COPY_NUMBER_ANALYSIS_IN_PANCREATIC_CANCER_CELLS_DN |
| — | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP |
| — | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN |
| — | GAZIN_EPIGENETIC_SILENCING_BY_KRAS |
| — | PIONTEK_PKD1_TARGETS_UP |
| — | PIONTEK_PKD1_TARGETS_DN |
| — | FONTAINE_GENES_SPECIFIC_TO_EXPRESSION_OF_T_UM |
| — | FONTAINE_TABLE_1S_FTA_UP |
| — | FONTAINE_TABLE_1S_FTA_DN |
| — | FONTAINE_TABLE_1S_FTA_ATY_UP |
| — | FONTAINE_TABLE_1S_FTA_ATY_DN |
| — | FONTAINE_TABLE_1S_FTA_ATY_FTA_UP |
| — | FONTAINE_TABLE_1S_FTA_ATY_FTA_DN |
| — | FONTAINE_TABLE_1S_FTA_ATY_PTC_UP |
| — | FONTAINE_TABLE_1S_FTA_ATY_PTC_DN |
| — | FONTAINE_TABLE_1S_PTC_UP |
| — | FONTAINE_TABLE_1S_PTC_DN |
| — | FONTAINE_TABLE_1S_FTA_PTC_UP |
| — | FONTAINE_TABLE_1S_FTA_PTC_DN |
| — | FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP |
| — | FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN |
| — | FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP |
| — | FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN |
| — | FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP |
| — | FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN |
| — | PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP |
| — | PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN |
| — | WANG_RECURRENT_LIVER_CANCER_UP |
| — | WANG_RECURRENT_LIVER_CANCER_DN |
| — | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP |
| — | SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN |
| — | SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP |
| — | SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN |
| — | ZEITLINGER_SIGNAL_TRANSDUCTION_GENES_STALLED_POL2 |
| — | ZEITLINGER_STALLED_POL2_AT_MUSCLE_GENES |
| — | MUSE_EXPRESSION_LEVELS_CHANGED_BY_NELF-RNAI_UP |
| — | MUSE_EXPRESSION_LEVELS_CHANGED_BY_NELF-RNAI_DN |
| — | GALIE_TUMOR_ANGIOGENESIS |
| — | GALIE_TUMOR_STEMNESS_GENES |
| — | MARTINEZ_PROBABLE_TARGETS_OF_MIR_145 |
| — | MARTINEZ_PROBABLE_TARGETS_OF_MIR_143 |
| — | MARTINEZ_PROBABLE_TARGETS_OF_MIR_368 |
| — | MARTINEZ_PROBABLE_TARGETS_OF_MIR_497 |
| — | MARTINEZ_PROBABLE_TARGETS_OF_MIR_218 |
| — | MARTINEZ_PROBABLE_TARGETS_OF_MIR_200C |
| — | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP |
| — | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN |
| — | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP |
| — | ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN |
| — | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP |
| — | ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN |
| — | ZHOU_INFLAMMATORY_RESPONSE_LPS_UP |
| — | ZHOU_INFLAMMATORY_RESPONSE_LPS_DN |
| — | KHETCHOUMIAN_TRIM24_TARGETS_UP |
| — | KHETCHOUMIAN_TRIM24_TARGETS_DN |
| — | SCHWAB_TARGETS_OF_BMYB_S427G_UP |
| — | SCHWAB_TARGETS_OF_BMYB_S427G_DN |
| — | SCHWAB_TARGETS_OF_BMYB_I624M_UP |
| — | SCHWAB_TARGETS_OF_BMYB_I624M_DN |
| — | LEE_NEURAL_CREST_STEM_CELL_UP |
| — | LEE_NEURAL_CREST_STEM_CELL_DN |
| — | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP |
| — | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN |
| — | KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS |
| — | KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD |
| — | KUIJL_KINASES_CONTROLLING_INTRACELLULAR_SALMONELA_GROWTH_UP |
| — | KUIJL_KINASES_CONTROLLING_INTRACELLULAR_SALMONELA_GROWTH_DN |
| — | HUNSBERGER_EXERCISE_REGULATED_GENES |
| — | PASQUALUCCI_TABLE_1S_UP |
| — | PASQUALUCCI_TABLE_1S_DN |
| — | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP |
| — | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN |
| — | PHILLIPS_TABLE_1 |
| — | WILCOX_PRESPONSE_TO_ROGESTERONE_UP |
| — | WILCOX_PRESPONSE_TO_ROGESTERONE_DN |
| — | NAKAYAMA_FRA2_TARGETS |
| — | GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11 |
| — | BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP |
| — | BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN |
| — | SABATES_COLORECTAL_ADENOMA_SIZE_UP |
| — | SABATES_COLORECTAL_ADENOMA_SIZE_DN |
| — | SABATES_COLORECTAL_ADENOMA_UP |
| — | SABATES_COLORECTAL_ADENOMA_DN |
| — | EHLERS_ANEUPLOIDY_UP |
| — | EHLERS_ANEUPLOIDY_DN |
| — | GUO_MIRNA_GENES_CORRELATED_WITH_ESOPHAGEAL_CANCER_SURVIVAL |
| — | STEARMAN_TUMOR_FIELD_EFFECT_UP |
| — | STEARMAN_TUMOR_FIELD_EFFECT_DN |
| — | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP |
| — | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN |
| — | HELLER_TABLE_1S |
| — | HELLER_TABLE_4S_AZA_DC |
| — | HELLER_TABLE_3S |
| — | HELLER_SILENCED_BY_METHYLATION_UP |
| — | HELLER_SILENCED_BY_METHYLATION_DN |
| — | HELLER_HDAC_TARGETS_UP |
| — | HELLER_HDAC_TARGETS_DN |
| — | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP |
| — | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN |
| — | CLAUS_PGR_POSITIVE_MENINGIOMA_UP |
| — | CLAUS_PGR_POSITIVE_MENINGIOMA_DN |
| — | TAVAZOIE_METASTASIS |
| — | WILLER_SNP_ASSOCIATION_WITH_HDL |
| — | WILLER_SNP_ASSOCIATION_WITH_LDL |
| — | WILLER_SNP_ASSOCIATION_WITH_TRIGLYCERIDES |
| — | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_LIPIDS_OR_LIPOPROTEINS |
| — | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_LDL |
| — | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_HDL |
| — | KATHIRESAN_LOCI_OF_SNPS_ASSOCIATED_WITH_BLOOD_TRIGLYCERIDES |
| — | KATHIRESAN_EFFECTS_OF_LOCI_ON_MULTIPLE_LIPOPROTEIN_OR_LIPID_TRAITS |
| — | KWAN_TRANSCRIPT_ISOFORM_CHANGES |
| — | COURTOIS_SENESCENCE_TRIGGERS |
| — | WONG_MITOCHONDRIA_GENE_MODULE |
| — | WONG_PROTEASOME_GENE_MODULE |
| — | AMUNDSON_TABLE_1S |
| — | AMUNDSON_GAMMA_RADIATION_RESISTANCE |
| — | AMUNDSON_GAMMA_RADIATION_RESPONSE |
| — | AMUNDSON_TABLE_4S_D0 |
| — | AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G |
| — | AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G |
| — | COATES_MACROPHAGE_M1_VS_M2_UP |
| — | COATES_MACROPHAGE_M1_VS_M2_DN |
| — | COATES_TABLE_3S_UP |
| — | COATES_TABLE_3S_DN |
| — | LOPEZ_MBD_TARGETS |
| — | LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED |
| — | LOPEZ_TABLE_3S |
| — | WENDT_COHESIN_TARGETS_UP |
| — | WENDT_COHESIN_TARGETS_DN |
| — | ZHANG_TLX_TARGETS_36HR_UP |
| — | ZHANG_TLX_TARGETS_36HR_DN |
| — | ZHANG_TLX_TARGETS_60HR_UP |
| — | ZHANG_TLX_TARGETS_60HR_DN |
| — | ZHANG_TLX_TARGETS_DN |
| — | ZHANG_TLX_TARGETS_UP |
| — | LEE_METASTASIS_AND_RNA_PROCESSING_UP |
| — | LEE_METASTASIS_AND_RNA_PROCESSING_DN |
| — | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP |
| — | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN |
| — | LIN_MELANOMA_COPY_NUMBER_UP |
| — | LIN_MELANOMA_COPY_NUMBER_DN |
| — | MARTINEZ_RB1_TARGETS_UP |
| — | MARTINEZ_RB1_TARGETS_DN |
| — | MARTINEZ_TP53_TARGETS_UP |
| — | MARTINEZ_TP53_TARGETS_DN |
| — | MARTINEZ_RB1_AND_TP53_TARGETS_UP |
| — | MARTINEZ_RB1_AND_TP53_TARGETS_DN |
| — | FINETTI_BREAST_CANCER_KINOME_RED |
| — | FINETTI_BREAST_CANCER_KINOME_GREEN |
| — | FINETTI_BREAST_CANCERS_KINOME_BLUE |
| — | FINETTI_BREAST_CANCERS_KINOME_GRAY |
| — | FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL |
| — | MASSARWEH_TAMOXIFEN_RESISTANCE_UP |
| — | MASSARWEH_TAMOXIFEN_RESISTANCE_DN |
| — | MASSARWEH_RESPONSE_TO_ESTRADIOL |
| — | LAGUINGE_TABLE_1 |
| — | WALLACE_TABLE_3_UP |
| — | WALLACE_TABLE_3_DN |
| — | WALLACE_PROSTATE_CANCER_UP |
| — | WALLACE_PROSTATE_CANCER_DN |
| — | WALLACE_PROSTATE_CANCER_RACE_UP |
| — | WALLACE_PROSTATE_CANCER_RACE_DN |
| — | BARREIRO_GENES_WITH_STRONGEST_SIGNATURES_FOR_POSITIVE_NATURAL_SELECTION |
| — | JONES_TCOF1_TARGETS |
| — | ZHENG_IL22_SIGNALING_UP |
| — | ZHENG_IL22_SIGNALING_DN |
| — | AUJLA_IL22_AND_IL17A_SIGNALING |
| — | ROPERO_HDAC2_TARGETS |
| — | COLINA_TARGETS_OF_4EBP1_AND_4EBP2 |
| — | HAN_PROTEINS_UNIQUE_TO_AP |
| — | HAN_PROTEINS_UNIQUE_TO_CAP |
| — | HAN_PROTEINS_UNIQUE_TO_CP |
| — | STROMNES_TABLE_2S_BRAIN_GROUP_1 |
| — | STROMNES_TABLE_2S_CORD_UP |
| — | STROMNES_TABLE_2S_CORD_DN |
| — | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP |
| — | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN |
| — | OUILLETTE_CLL_13Q14_DELETION_UP |
| — | OUILLETTE_CLL_13Q14_DELETION_DN |
| — | YOKOE_CANCER_TESTIS_ANTIGENS |
| — | MARZEC_IL2_SIGNALING_UP |
| — | MARZEC_IL2_SIGNALING_DN |
| — | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP |
| — | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN |
| — | IWANAGA_CARCINOGENESIS_BY_KRAS_UP |
| — | IWANAGA_CARCINOGENESIS_BY_KRAS_DN |
| — | BRUNEAU_SEPTATION_ATRIAL |
| — | BRUNEAU_SEPTATION_VENTRICULAR |
| — | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS |
| — | MELLMAN_TUT1_TARGETS_UP |
| — | MELLMAN_TUT1_TARGETS_DN |
| — | HUNT_ASSOCIATION_FOR_CELIAC_DISEASE |
| — | HUNT_CIS_EFFECTS_OF_CELIAC_ASSOCIATED_SNPS_ON_GENE_EXPRESSION_UP |
| — | HUNT_CIS_EFFECTS_OF_CELIAC_ASSOCIATED_SNPS_ON_GENE_EXPRESSION_DN |
| — | CAMPS_COLON_CANCER_COPY_NUMBER_UP |
| — | CAMPS_COLON_CANCER_COPY_NUMBER_DN |
| — | RIZKI_TUMOR_INVASIVENESS_3D_UP |
| — | RIZKI_TUMOR_INVASIVENESS_3D_DN |
| — | RIZKI_TUMOR_INVASIVENESS_2D_UP |
| — | RIZKI_TUMOR_INVASIVENESS_2D_DN |
| — | YAMASHITA_FIG_1C_UP |
| — | YAMASHITA_FIG_1C_DN |
| — | YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP |
| — | YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN |
| — | FUJII_YBX1_TARGETS_UP |
| — | FUJII_YBX1_TARGETS_DN |
| — | GOUYER_TUMOR_INVASIVENESS |
| — | GOUYER_TATI_TARGETS_UP |
| — | GOUYER_TATI_TARGETS_DN |
| — | LIU_LIVER_CANCER |
| — | LIU_BREAST_CANCER |
| — | LIU_NASOPHARYNGEAL_CARCINOMA |
| — | LIU_COMMON_CANCER_GENES |
| — | HAN_FIG_5A_UP |
| — | HAN_FIG_5A_DN |
| — | HAN_SATB1_TARGETS_UP |
| — | HAN_SATB1_TARGETS_DN |
| — | OSADA_ASCL1_TARGETS_UP |
| — | OSADA_ASCL1_TARGETS_DN |
| — | CHENG_IMPRINTED_BY_ESTRADIOL |
| — | DE_YY1_TARGETS_UP |
| — | DE_YY1_TARGETS_DN |
| — | BIERIE_INFLAMMATORY_RESPONSE_TGFB1 |
| — | MCCABE_BOUND_BY_HOXC6 |
| — | MCCABE_HOXC6_TARGETS_UP |
| — | MCCABE_HOXC6_TARGETS_DN |
| — | MCCABE_HOXC6_TARGETS_CANCER_UP |
| — | MCCABE_HOXC6_TARGETS_CANCER_DN |
| — | POS_RESPONSE_TO_HISTAMINE_UP |
| — | POS_RESPONSE_TO_HISTAMINE_DN |
| — | POS_HISTAMINE_RESPONSE_NETWORK |
| — | CHEN_METABOLIC_SYNDROM_NETWORK |
| — | CHEN_LIVER_METABOLISM_QTL_CIS |
| — | ZEGGINI_T2D_ASSOCIATED_SNPS |
| — | TOMLINSON_SNPS_ASSOCIATED_WITH_COLORECTAL_CANCER_SUSCEPTABILITY |
| — | LU_POSSIBLE_TARGET_GENES_OF_MIR_21 |
| — | DAIRKEE_CANCER_PRONE_RESPONSE_E2 |
| — | DAIRKEE_CANCER_PRONE_RESPONSE_BPA |
| — | DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 |
| — | YAMASHITA_SILENCED_BY_METHYLATION |
| — | YAMASHITA_METHYLATED_IN_PROSTATE_CANCER |
| — | OUYANG_PROSTATE_CANCER_PROGRESSION_UP |
| — | OUYANG_PROSTATE_CANCER_PROGRESSION_DN |
| — | OUYANG_PROSTATE_CANCER_MARKERS |
| — | RIGGI_EWING_SARCOMA_PROGENITOR_UP |
| — | RIGGI_EWING_SARCOMA_PROGENITOR_DN |
| — | RIGGI_SUPPL_DATA_1_DBDM_UP |
| — | RIGGI_SUPPL_DATA_1_DBDM_DN |
| — | RIGGI_SUPPL_DATA_2A |
| — | RIGGI_FIG_3C |
| — | GAUTSCHI_SRC_SIGNALING |
| — | VICENT_METASTASIS_UP |
| — | VICENT_METASTASIS_DN |
| — | AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 |
| — | HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP |
| — | HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN |
| — | ENGELMANN_CANCER_PROGENITORS_UP |
| — | ENGELMANN_CANCER_PROGENITORS_DN |
| — | WORSCHECH_TUMOR_REJECTION_UP |
| — | WORSCHECH_TUMOR_REJECTION_DN |
| — | WORSCHECH_TABLE_3 |
| — | WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP |
| — | WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN |
| — | WOO_LIVER_CANCER_RECURRENCE_UP |
| — | WOO_LIVER_CANCER_RECURRENCE_DN |
| — | LETTRE_HEIGHT_ASSOCIATED_VARIANTS |
| — | GUDBJARTSSON_SNPS_WITH_STRONGEST_HEIGHT_ASSOCIATION |
| — | GUDBJARTSSON_SNP_ASSOCIATION_WITH_HEIGHT_BETWEEN_10-5_AND_10-7 |
| — | GUDBJARTSSON_GENES_NEAR_LOCI_SHOWING_SUGGESTIVE_ASSOCIATION_WITH_HEIGHT |
| — | WEEDON_SNPS_ASSOCIATED_WITH_HEIGHT_VARIATION |
| — | LOCKWOOD_TABLE_2S |
| — | LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER |
| — | WONG_EMBRYONIC_STEM_CELL_CORE |
| — | WONG_ADULT_TISSUE_STEM_MODULE |
| — | UNGER_CHROMOSOMAL_CHANGES_IN_PAPILLARY_THYROID_CARCINOMAS |
| — | UNGER_ALTERATIONS_IN_RET_PTC_POSITIVE_AND_NEGATIVE_TUMORS_UP |
| — | UNGER_ALTERATIONS_IN_RET_PTC_POSITIVE_AND_NEGATIVE_TUMORS_DN |
| — | TING_SILENCED_BY_DICER |
| — | BOYERINAS_ONCOFETAL_TARGETS_OF_LET7 |
| — | MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP |
| — | MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN |
| — | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP |
| — | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN |
| — | ACEVEDO_LIVER_CANCER_UP |
| — | ACEVEDO_LIVER_CANCER_DN |
| — | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
| — | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN |
| — | ACEVEDO_TABLE_23S_UP |
| — | ACEVEDO_TABLE_23S_DN |
| — | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP |
| — | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN |
| — | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP |
| — | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN |
| — | ACEVEDO_METHYLATED_IN_LIVER_CANCER_UP |
| — | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN |
| — | HOQUE_METHYLATED_IN_CANCER |
| — | NADELLA_PRKAR1A_TARGETS_UP |
| — | NADELLA_PRKAR1A_TARGETS_DN |
| — | SAGIV_CD24_TARGETS_UP |
| — | SAGIV_CD24_TARGETS_DN |
| — | BLEWITT_GENES_IN_MOMMED1_LINKED_INTERVAL |
| — | FREDERICK_PRKCI_TARGETS |
| — | FRANKE_SNPS_ASSOCIATED_WITH_ULCERATIVE_COLITIS_OR_CROHN'S |
| — | FISHER_SNPS_ASSOCIATED_WITH_ULCERATIVE_COLITIS |
| — | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_3_UP |
| — | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_3_DN |
| — | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_2_UP |
| — | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_1_V_2_DN |
| — | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_2_V_3_UP |
| — | FINAK_BREAST_CANCER_TUMOR_STROMA_EXPRESSION_CLUSTER_2_V_3_DN |
| — | FINAK_BREAST_CANCER_SDPP_SIGNATURE |
| — | RAHMAN_TP53_TARGETS_PHOSPHORYLATED |
| — | BENPORATH_ES_1 |
| — | BENPORATH_ES_2 |
| — | BENPORATH_NANOG_TARGETS |
| — | BENPORATH_OCT4_TARGETS |
| — | BENPORATH_SOX2_TARGETS |
| — | BENPORATH_NOS_TARGETS |
| — | BENPORATH_NOS_TARGETS_TRANSCRIPTION_FACTORS |
| — | BENPORATH_SUZ12_TARGETS |
| — | BENPORATH_EED_TARGETS |
| — | BENPORATH_ES_WITH_H3K27ME3 |
| — | BENPORATH_PRC2_TARGETS |
| — | BENPORATH_MYC_TARGETS_WITH_EBOX |
| — | BENPORATH_MYC_MAX_TARGETS |
| — | BENPORATH_PROLIFERATION_BY_GO |
| — | BENPORATH_CYCLING_GENES |
| — | BENPORATH_PROLIFERATION |
| — | BENPORATH_ES_TRANSCRIPTION_REGULATORS |
| — | BENPORATH_ES_CORE_NINE |
| — | BENPORATH_ES_CORE_NINE_CORRELATED |
| — | PETRETTO_CARDIAC_HYPERTROPHY |
| — | PETRETTO_BLOOD_PRESSURE_UP |
| — | PETRETTO_BLOOD_PRESSURE_DN |
| — | PETRETTO_HEART_MASS_QTL_CIS_UP |
| — | PETRETTO_HEART_MASS_QTL_CIS_DN |
| — | PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP |
| — | PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN |
| — | BEHMOARAS_TABLE_1S_UP |
| — | BEHMOARAS_TABLE_1S_DN |
| — | SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP |
| — | SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN |
| — | SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP |
| — | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN |
| — | SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP |
| — | SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN |
| — | SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP |
| — | SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN |
| — | SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP |
| — | SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN |
| — | SMID_BREAST_CANCER_LUMINAL_B_UP |
| — | SMID_BREAST_CANCER_LUMINAL_B_DN |
| — | SMID_BREAST_CANCER_LUMINAL_A_UP |
| — | SMID_BREAST_CANCER_LUMINAL_A_DN |
| — | SMID_BREAST_CANCER_ERBB2_UP |
| — | SMID_BREAST_CANCER_ERBB2_DN |
| — | SMID_BREAST_CANCER_NORMAL_LIKE_UP |
| — | SMID_BREAST_CANCER_NORMAL_LIKE_DN |
| — | SMID_BREAST_CANCER_BASAL_UP |
| — | SMID_BREAST_CANCER_BASAL_DN |
| — | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP |
| — | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN |
| — | KUMAMOTO_TABLE_1S |
| — | ITO_PTTG1_TARGETS_UP |
| — | ITO_PTTG1_TARGETS_DN |
| — | LE_SKI_TARGETS_UP |
| — | LE_SKI_TARGETS_DN |
| — | MILI_PSEUDOPODIA |
| — | MILI_PSEUDOPODIA_CHEMOTAXIS_UP |
| — | MILI_PSEUDOPODIA_CHEMOTAXIS_DN |
| — | MILI_PSEUDOPODIA_HAPTOTAXIS_UP |
| — | MILI_PSEUDOPODIA_HAPTOTAXIS_DN |
| — | CHAMBERS_SNPS_ASSOCIATED_WITH_INSULIN_RESISTANCE |
| — | MUELLER_X_LINKED_COPY_NUMBER_UP |
| — | MUELLER_X_LINKED_COPY_NUMBER_DN |
| — | CAFFAREL_RESPONSE_TO_THC_UP |
| — | CAFFAREL_RESPONSE_TO_THC_DN |
| — | CAFFAREL_RESPONSE_TO_THC_8HR_5_UP |
| — | CAFFAREL_RESPONSE_TO_THC_8HR_5_DN |
| — | CAFFAREL_RESPONSE_TO_THC_8HR_3_UP |
| — | CAFFAREL_RESPONSE_TO_THC_8HR_3_DN |
| — | CAFFAREL_RESPONSE_TO_THC_24HR_3_UP |
| — | CAFFAREL_RESPONSE_TO_THC_24HR_3_DN |
| — | CAFFAREL_RESPONSE_TO_THC_24HR_5_UP |
| — | CAFFAREL_RESPONSE_TO_THC_24HR_5_DN |
| — | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP |
| — | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN |
| — | STARK_HYPPOCAMPUS_22Q11_DELETION_UP |
| — | STARK_HYPPOCAMPUS_22Q11_DELETION_DN |
| — | STARK_BRAIN_22Q11_DELETION |
| — | STARK_TABLE_3S |
| — | ZON_HSC_DEVELOPMENTAL_REGULATORS_AND_SELF-RENEWAL_FACTORS |
| — | MEHRA_FIG_1AS |
| — | KURLAND_TABLE_1 |
| — | ONDER_CDH1_TARGETS_2_UP |
| — | ONDER_CDH1_TARGETS_2_DN |
| — | ONDER_CDH1_TARGETS_1_UP |
| — | ONDER_CDH1_TARGETS_1_DN |
| — | ONDER_CDH1_TARGETS_3_UP |
| — | ONDER_CDH1_TARGETS_3_DN |
| — | ONDER_CDH1_SIGNALING_VIA_CTNNB1 |
| — | ZEILSTRA_CD44_TARGETS_UP |
| — | ZEILSTRA_CD44_TARGETS_DN |
| — | PUCA_TABLE_1S |
| — | LOEPER_IKZF1_TARGETS |
| — | CONNEROTTE_TABLE_2 |
| — | GUDBJARTSSON_PIGMENTATION_VARIANTS_ASSOCIATED_WITH_CM_OR_SKIN_CANCERS |
| — | SULEM_ASSOCIATION_WITH_PIGMENTATION_CHARACTERISTICS |
| — | SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_TO_EYE_COLOR |
| — | SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_TO_HAIR_COLOR |
| — | SULEM_ASSOCIATION_OF_GENETIC_VARIANTS_WITH_SKIN_SENSITIVITY_TO_SUN |
| — | KONDO_TABLE_1 |
| — | KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME1 |
| — | KONDO_TABLE_1S |
| — | KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3 |
| — | KONDO_PROSTATE_CANCER_WITH_H3K27ME3 |
| — | KONDO_COLON_CANCER_HCP_WITH_H3K27ME1 |
| — | KONDO_COLON_CANCER_HCP_WITH_H3K27ME3 |
| — | KONDO_EZH2_TARGETS |
| — | SAKAMOTO_SNPS_ASSOCIATED_WITH_GASTRIC_CANCER |
| — | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP |
| — | RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN |
| — | BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP |
| — | BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN |
| — | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP |
| — | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN |
| — | LIAO_HAVE_SOX4_BINDING_SITES |
| — | LIAO_METASTASIS |
| — | WEI_MIR34A_TARGETS |
| — | WEI_MYCN_TARGETS_WITH_E_BOX |
| — | SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP |
| — | SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN |
| — | COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP |
| — | COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN |
| — | DUBOIS_ULCERATIVE_COLITIS_ASSOCIATED_REGIONS |
| — | MIKKELSEN_PLURIPOTENT_STATE_UP |
| — | MIKKELSEN_PLURIPOTENT_STATE_DN |
| — | MIKKELSEN_DEDIFFERENTIATED_STATE_UP |
| — | MIKKELSEN_DEDIFFERENTIATED_STATE_DN |
| — | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY |
| — | MIKKELSEN_TABLE_2S_ES_ICP_BIV |
| — | MIKKELSEN_TABLE_2S_ES_LCP_BIV |
| — | MIKKELSEN_TABLE_2S_MCV81_HCP_K27 |
| — | MIKKELSEN_TABLE_2S_ES_ICP_K27 |
| — | MIKKELSEN_TABLE_2S_ES_LCP_K27 |
| — | MIKKELSEN_TABLE_2S_ES_ICP_K4 |
| — | MIKKELSEN_TABLE_2S_ES_LCP_K4 |
| — | MIKKELSEN_TABLE_2S_ES_HCP_NONE |
| — | MIKKELSEN_MCV6_HCP_WITH_H3K27ME3 |
| — | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 |
| — | MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 |
| — | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 |
| — | MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 |
| — | MIKKELSEN_MEF_LCP_WITH_H3K27ME3 |
| — | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 |
| — | MIKKELSEN_IPS_WITH_HCP_H3K27ME3 |
| — | MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED |
| — | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 |
| — | MIKKELSEN_IPS_ICP_WITH_H3K27ME3 |
| — | MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MIKKELSEN_IPS_LCP_WITH_H3K27ME3 |
| — | MIKKELSEN_IPS_LCP_WITH_H3K4ME3 |
| — | XU_TABLE_3_UP |
| — | XU_TABLE_3_DN |
| — | XU_TABLE_2S_UP |
| — | XU_TABLE_2S_DN |
| — | XU_TABLE_4S_UP |
| — | XU_TABLE_4S_DN |
| — | CERVERA_FIG_4C_UP |
| — | CERVERA_FIG_4C_DN |
| — | CERVERA_SDHB_TARGETS_2 |
| — | CERVERA_SDHB_TARGETS_1_UP |
| — | CERVERA_SDHB_TARGETS_1_DN |
| — | ROZANOV_MMP14_TARGETS_SUBSET |
| — | ROZANOV_MMP14_CORRELATED |
| — | ROZANOV_MMP14_TARGETS_UP |
| — | ROZANOV_MMP14_TARGETS_DN |
| — | KARP_FIG_2B |
| — | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C |
| — | LEE_LIVER_CANCER |
| — | LEE_LIVER_CANCER_TOP50 |
| — | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP |
| — | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN |
| — | MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP |
| — | MISHRA_UP_IN_NAIVE_MESENCHYMAL_STEM_CELLS |
| — | MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN |
| — | SANGIORGI_COPY_NUMBER_POLYMORPHISMS_UP |
| — | SANGIORGI_COPY_NUMBER_POLYMORPHISMS_DN |
| — | ZHANG_GATA6_TARGETS_UP |
| — | ZHANG_GATA6_TARGETS_DN |
| — | HASEGAWA_TUMORIGENESIS_BY_RET_C634R |
| — | SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP |
| — | SUH_COEXPRESSED_WITH_ID1_AND_ID2_DN |
| — | SCHOEN_NFKB_SIGNALING |
| — | ZHANG_BREAST_CANCER_PROGENITORS_UP |
| — | ZHANG_BREAST_CANCER_PROGENITORS_DN |
| — | MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP |
| — | MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN |
| — | WOTTON_RUNX_TARGETS_UP |
| — | WOTTON_RUNX_TARGETS_DN |
| — | KERKEL_SEQUENCE_DEPENDENCE_OF_ASM_AT_SNP_TAGGED_LOCI |
| — | SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM |
| — | SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE |
| — | SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE |
| — | SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE |
| — | SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL |
| — | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP |
| — | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN |
| — | FUJIWARA_PARK2_IN_LIVER_CANCER_UP |
| — | FUJIWARA_PARK2_IN_LIVER_CANCER_DN |
| — | PHAROAH_ASSOCIATIONS_WITH_PIGMENTATION_CM_AND_BCC |
| — | ALLEN_POLYMORPHISMS_SHOWING_SUMMARY_ORS |
| — | BARRETT_CD_RISK_LOCI |
| — | BARRETT_CROHN'S_RISK_LOCI_WITH_CORRELATED_NONSYNONYMOUS_SNP |
| — | BARRETT_CIS-EQTL_EFFECTS_FOR_CD_ASSOCIATED_SNPS |
| — | GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP |
| — | GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN |
| — | HUANG_FOXA2_TARGETS_UP |
| — | HUANG_FOXA2_TARGETS_DN |
| — | MITSIADES_RESPONSE_TO_APLIDIN_UP |
| — | MITSIADES_RESPONSE_TO_APLIDIN_DN |
| — | MAGDA_TABLE_2S_5002 |
| — | MAGDA_TABLE_2S_5002_ZN_UP |
| — | MAGDA_TABLE_2S_5002_ZN_DN |
| — | MAGDA_FC_5002_VS_CONTROL_UP |
| — | MAGDA_FC_5002_VS_CONTROL_DN |
| — | MAGDA_FC_5003_VS_CONTROL_UP |
| — | MAGDA_FC_5003_VS_CONTROL_DN |
| — | ZENG_RESPONSE_TO_ID8_SUPERNATENT_VERSUS_CONTROL_UP |
| — | ZENG_RESPONSE_TO_ID8_SUPERNATENT_VERSUS_CONTROL_DN |
| — | ZENG_RESPONSE_TO_ID8_TUMOR_VERSUS_CONTROL_UP |
| — | ZENG_RESPONSE_TO_ID8_TUMOR_VERSUS_CONTROL_DN |
| — | ZENG_RESPONSE_TO_ID8_IRRADIATED_TUMOR_VERSUS_CONTROL_UP |
| — | ZENG_RESPONSE_TO_ID8_IRRADIATED_TUMOR_VERSUS_CONTROL_DN |
| — | SCHMIDT_BASAL |
| — | SCHMIDT_CELLULAR_IMMUNSYSTEM |
| — | SCHMIDT_HUMORAL_IMMUNSYSTEM |
| — | SCHMIDT_INTERFERON |
| — | SCHMIDT_PROLIFERATION |
| — | SCHMIDT_ESTROGEN_RECEPTOR |
| — | SCHMIDT_CHR_17 |
| — | SCHMIDT_STROMAL |
| — | SCHMIDT_NORMAL_LIKE |
| — | SCHMIDT_JUN-FOS |
| — | SCHMIDT_TRANSCRIPTION |
| — | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP |
| — | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN |
| — | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING |
| — | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING |
| — | MEISSNER_ES_ICP_WITH_H3K4ME3 |
| — | MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MEISSNER_NPC_HCP_WITH_H3K27ME3 |
| — | MEISSNER_NPC_ICP_WITH_H3K4ME3 |
| — | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED |
| — | MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED |
| — | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 |
| — | MEISSNER_BRAIN_ICP_WITH_H3K4ME3 |
| — | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 |
| — | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED |
| — | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 |
| — | MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 |
| — | MEISSNER_NPC_HCP_WITH_H3K4ME2 |
| — | MEISSNER_BRAIN_HCP_WITH_H3K4ME2 |
| — | GALI_TABLE_1S |
| — | GALI_TP53_TARGETS_APOPTOTIC_UP |
| — | GALI_TP53_TARGETS_APOPTOTIC_DN |
| — | MOSERLE_IFNA_RESPONSE |
| — | MOSERLE_TABLE_4S |
| — | MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER |
| — | MCGARVEY_TABLE_2S |
| — | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP |
| — | WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN |
| — | GAURNIER_PSMD4_TARGETS |
| — | MCGOWAN_RSP6_TARGETS_UP |
| — | MCGOWAN_RSP6_TARGETS_DN |
| — | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD C |
| — | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD D |
| — | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD F |
| — | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD G |
| — | SHEDDEN_SUPP. DATA 2: GENES USED TO CLASSIFY: METHOD H |
| — | SHEDDEN_SUPPL. DATA 1: METHOD J |
| — | SHEDDEN_SUPPL. DATA 1: METHOD K |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 35 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 69 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 40 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 41 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 74 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 79 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 19 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 86 |
| — | SHEDDEN_SUPPL. DATA 1: METAGENE 31 |
| — | SHEDDEN_GENES_USED_TO_CLASSIFY_METHOD_B_RISK |
| — | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 |
| — | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4 |
| — | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5 |
| — | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 |
| — | BOCHKIS_MODEL_FOR_HEPATIC_BILE_ACID_HOMEOSTASIS_BY_FOXA2 |
| — | BOCHKIS_FOXA2_TARGETS |
| — | TONG_INTERACT_WITH_PTTG1 |
| — | BAEK_PROTEINS_DERIVED_FROM_MESSAGES_WITH_7-8MER_39-UTR_SITE_UP |
| — | BAEK_PROTEINS_DERIVED_FROM_MESSAGES_WITH_7-8MER_39-UTR_SITE_DN |
| — | LANDEMAINE_LUNG_METASTASIS |
| — | LANDEMAINE_TABLE_1S |
| — | AMBS_TABLE_1S |
| — | AMBS_TABLE_2S |
| — | CHANG_POU5F1_TARGETS_UP |
| — | CHANG_POU5F1_TARGETS_DN |
| — | LIU_PROSTATE_CANCER_RELATED_GENES_UP |
| — | LIU_PROSTATE_CANCER_RELATED_GENES_DN |
| — | LIU_INFLAMMATION_RELATED_GENES_IN_PROSTATE_CANCER_UP |
| — | LIU_INFLAMMATION_RELATED_GENES_IN_PROSTATE_CANCER_DN |
| — | LIU_GENES_IN_NETWORK_2_AND_3_UP |
| — | LIU_GENES_IN_NETWORK_2_AND_3_DN |
| — | LIU_VAV3_TARGETS_AND_NF-KAPPA-B_SIGNALING |
| — | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP |
| — | LIU_VAV3_PROSTATE_CARCINOGENESIS_DN |
| — | LIU_INFLAMMATION_RELATED_GENES_UP |
| — | LIU_INFLAMMATION_RELATED_GENES_DN |
| — | LIU_NETWORK_2_AND_3_UP |
| — | LIU_NETWORK_2_AND_3_DN |
| — | STONER_ESOPHAGEAL_CARCINOGENESIS_UP |
| — | STONER_ESOPHAGEAL_CARCINOGENESIS_DN |
| — | O'DONOVAN_SCHIZOPHRENIA_ASSOCIATION_LOCI |
| — | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP |
| — | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN |
| — | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP |
| — | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN |
| — | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP |
| — | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN |
| — | RICKMAN_METASTASIS_UP |
| — | RICKMAN_METASTASIS_DN |
| — | RICKMAN_TABLE_3S |
| — | RICKMAN_HEAD_AND_NECK_CANCER_A |
| — | RICKMAN_HEAD_AND_NECK_CANCER_B |
| — | RICKMAN_HEAD_AND_NECK_CANCER_C |
| — | RICKMAN_HEAD_AND_NECK_CANCER_D |
| — | RICKMAN_HEAD_AND_NECK_CANCER_E |
| — | RICKMAN_HEAD_AND_NECK_CANCER_F |
| — | RICKMAN_TABLE_9S |
| — | KRISHNAN_FURIN_TARGETS_UP |
| — | KRISHNAN_FURIN_TARGETS_DN |
| — | DOUGLAS_TABLE_1BS_UP |
| — | DOUGLAS_TABLE_1BS_DN |
| — | DOUGLAS_BMI1_TARGETS_UP |
| — | DOUGLAS_BMI1_TARGETS_DN |
| — | REN_ALVEOLAR_RHABDOMYOSARCOMA_UP |
| — | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN |
| — | KRIGE_AMINO_ACID_DEPRIVATION |
| — | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP |
| — | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN |
| — | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP |
| — | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN |
| — | GHO_ATF5_TARGETS_UP |
| — | GHO_ATF5_TARGETS_DN |
| — | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP |
| — | CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN |
| — | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP |
| — | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN |
| — | CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP |
| — | CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN |
| — | CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP |
| — | CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN |
| — | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP |
| — | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN |
| — | YASUDA_DIABETES_MELLITUS_ASSOCIATED_SNPS |
| — | FRIDMAN_SENESCENCE_UP |
| — | FRIDMAN_SENESCENCE_DN |
| — | FRIDMAN_IMMORTALIZATION_UP |
| — | FRIDMAN_IMMORTALIZATION_DN |
| — | ISHIKAWA_STING_SIGNALING |
| — | MUELLER_PLURINET |
| — | HONMA_DOCETAXEL_RESISTANCE |
| — | WU_CELL_MIGRATION |
| — | YAUCH_SUPPLEMENTARY_FILE_1_UP |
| — | YAUCH_SUPPLEMENTARY_FILE_1_DN |
| — | YAUCH_HEDGEHOG_PARACRINE_SIGNALING_UP |
| — | YAUCH_HEDGEHOG_PARACRINE_SIGNALING_DN |
| — | ZHOU_PANCREATIC_EXOCRINE_PROGENITOR |
| — | ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR |
| — | ZHOU_PANCREATIC_BETA_CELL |
| — | DURCHDEWALD_SKIN_CARCINOGENESIS_UP |
| — | DURCHDEWALD_SKIN_CARCINOGENESIS_DN |
| — | LI_CYTIDINE_ANALOGS_CYCTOTOXICITY |
| — | LI_CYTIDINE_ANALOG_PATHWAY |
| — | KIM_LRRC3B_TARGETS |
| — | BERNARD_PPAPDC1B_TARGETS_UP |
| — | BERNARD_PPAPDC1B_TARGETS_DN |
| — | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE |
| — | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM |
| — | ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST |
| — | KUGATHASAN_INFLAMMATORY_BOWEL_DISEASE_ASSOCIATION |
| — | TAGHAVI_NEOPLASTIC_TRANSFORMATION |
| — | TCGA_ALTERATIONS_IDENTIFIED_BY_RAE_UP |
| — | TCGA_ALTERATIONS_IDENTIFIED_BY_RAE_DN |
| — | TCGA_GLIOBLASTOMA_COPY_NUMBER_UP |
| — | TCGA_GLIOBLASTOMA_COPY_NUMBER_DN |
| — | TCGA_GTS_DEFINED_REGIONS_OF_INFORMATIVE_CNAS_UP |
| — | TCGA_GTS_DEFINED_REGIONS_OF_INFORMATIVE_CNAS_DN |
| — | TCGA_GLIOBLASTOMA_MUTATED |
| — | LOPES_METHYLATED_IN_COLON_CANCER_UP |
| — | LOPES_METHYLATED_IN_COLON_CANCER_DN |
| — | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP |
| — | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN |
| — | YANG_TABLE_3S_1 |
| — | YANG_MUC2_TARGETS_DUODENUM_3MO_UP |
| — | YANG_MUC2_TARGETS_DUODENUM_3MO_DN |
| — | YANG_MUC2_TARGETS_DUODENUM_6MO_UP |
| — | YANG_MUC2_TARGETS_DUODENUM_6MO_DN |
| — | YANG_MUC2_TARGETS_COLON_3MO_UP |
| — | YANG_MUC2_TARGETS_COLON_3MO_DN |
| — | YANG_TABLE_3S_2_UP |
| — | YANG_TABLE_3S_2_DN |
| — | YANG_TABLE_3S_3_UP |
| — | YANG_TABLE_3S_3_DN |
| — | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP |
| — | MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN |
| — | MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP |
| — | MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN |
| — | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 |
| — | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2 |
| — | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 |
| — | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4 |
| — | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5 |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN |
| — | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP |
| — | SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN |
| — | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3 |
| — | RAYCHAUDHURI_SNPS_ASSOCIATED_WITH_RHEUMATOID_ARTHRITIS |
| — | KOPP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_ASSOCIATED_VARIANTS |
| — | BARTON_RHEUMATOID_ARTHRITIS_ASSOCIATED_SNPS |
| — | FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION |
| — | FIRESTEIN_CTNNB1_PATHWAY |
| — | FIRESTEIN_PROLIFERATION |
| — | WILENSKY_RESPONSE_TO_DARAPLADIB |
| — | LIN_NPAS4_TARGETS_UP |
| — | LIN_NPAS4_TARGETS_DN |
| — | MAZAN-MAMCZARZ_QIN_TABLE_2S_HUR_UP |
| — | MAZAN-MAMCZARZ_QIN_TABLE_2S_HUR_DN |
| — | MAZAN-MAMCZARZ_TABLE_2S_AUF1 |
| — | MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP |
| — | MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN |
| — | JAKSCH_TABLE_1S_CACO2_UP |
| — | JAKSCH_TABLE_1S_CACO2_DN |
| — | JAKSCH_TABLE_1S_WM115_UP |
| — | JAKSCH_TABLE_1S_WM115_DN |
| — | SINGH_NFE2L2_TARGETS |
| — | PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP |
| — | PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN |
| — | LIU_FN1_TARGETS |
| — | CONRAD_STEM_CELL |
| — | CONRAD_GERMLINE_STEM_CELL |
| — | CADWELL_ATG16L1_TARGETS_UP |
| — | CADWELL_ATG16L1_TARGETS_DN |
| — | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP |
| — | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN |
| — | BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP |
| — | BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN |
| — | KATTAH_SURFACE_MARKERS_ASSOCIATED_WITH_ACTIVATED_OR_RESTING_T_CELLS |
| — | KATTAH_SAM-IDENTIFIED_MARKERS |
| — | CHIANG_COEXPRESSIONS_OF_UPSTREAM_EFFECTORS_AND_COX2 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTER_I-1 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTER_I-2 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_II_III_IV |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_I_II_III-1 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_I_II_III-2 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTERS_II_IV |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTER_III-1 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTER_III-2 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTER_IV-1 |
| — | MORI_EMU_MYC_LYMPHOMA_CLUSTER_IV_2 |
| — | MORI_PRE_BI_LYMPHOCYTE_UP |
| — | MORI_PRE_BI_LYMPHOCYTE_DN |
| — | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP |
| — | MORI_LARGE_PRE_BII_LYMPHOCYTE_DN |
| — | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP |
| — | MORI_SMALL_PRE_BII_LYMPHOCYTE_DN |
| — | MORI_IMMATURE_B_LYMPHOCYTE_UP |
| — | MORI_IMMATURE_B_LYMPHOCYTE_DN |
| — | MORI_MATURE_B_LYMPHOCYTE_UP |
| — | MORI_MATURE_B_LYMPHOCYTE_DN |
| — | MORI_PLASMA_CELL_UP |
| — | MORI_PLASMA_CELL_DN |
| — | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP |
| — | MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN |
| — | HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP |
| — | HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN |
| — | HOSHIDA_LIVER_CANCER_SURVIVAL_UP |
| — | HOSHIDA_LIVER_CANCER_SURVIVAL_DN |
| — | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS |
| — | BONCI_TARGETS_OF_MIR15A_AND_MIR16_1 |
| — | DING_HIGHLY_MUTATED_GENES_SHOW_COPY_NUMBER_VARIATIONS |
| — | DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY |
| — | DING_LUNG_CANCER_MUTATED_FREQUENTLY |
| — | DING_MUTATED_GENES_IN_LUNG_ADENOCARCINOMAS |
| — | DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER |
| — | DING_COPY_NUMBER_AND_EXPRESSION_CORRELATION_IN_HIGHLY_MUTATED_GENES |
| — | DING_MUTATION_AND_COPY_NUMBER_CHANGE_CORRELATION_IN_LUNG_ADENOCARCINOMAS_UP |
| — | DING_MUTATION_AND_COPY_NUMBER_CHANGE_CORRELATION_IN_LUNG_ADENOCARCINOMAS_DN |
| — | DING_MUTATION_AND_EXPRESSION_CORRELATION_IN_LUNG_ADENOCARCINOMAS_UP |
| — | DING_MUTATION_AND_EXPRESSION_CORRELATION_IN_LUNG_ADENOCARCINOMAS_DN |
| — | DING_LANG_CANCER_MUTATED |
| — | DING_LUNG_CANCER_MUTATED_RECURRENTLY |
| — | DING_LUNG_CANCER_BY_MUTATION_RATE |
| — | ZHENG_GLIOBLASTOMA_PLASTICITY_UP |
| — | ZHENG_GLIOBLASTOMA_PLASTICITY_DN |
| — | STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP |
| — | STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN |
| — | STEIN_ESRRA_TARGETS_UP |
| — | STEIN_ESRRA_TARGETS_DN |
| — | STEIN_TABLE_2S_UP |
| — | STEIN_TABLE_2S_DN |
| — | STEIN_ESR1_TARGETS |
| — | STEIN_ESRRA_TARGETS |
| — | STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA |
| — | RIGGINS_FIG_6A |
| — | RIGGINS_TAMOXIFEN_RESISTANCE_UP |
| — | RIGGINS_TAMOXIFEN_RESISTANCE_DN |
| — | YEGNASUBRAMANIAN_PROSTATE_CANCER |
| — | COOPER_TYPE_1_DIABETES_ASSOCIATED_SNPS |
| — | COOPER_TYPE_1_DIABETES_ASSOCIATED_SNPS_EXCLUDING_KNOWN_LOCI |
| — | KOYAMA_SEMA3B_TARGETS_UP |
| — | KOYAMA_SEMA3B_TARGETS_DN |
| — | MATZUK_OVULATION |
| — | MATZUK_CUMULUS_EXPANSION |
| — | MATZUK_FERTILIZATION |
| — | MATZUK_MATERNAL_EFFECT |
| — | MATZUK_IMPLANTATION_AND_UTERINE |
| — | MATZUK_POST-IMPLANTATION_AND_POST-PARTUM |
| — | MATZUK_STEROIDOGENESIS |
| — | MATZUK_MEIOTIC_AND_DNA_REPAIR |
| — | MATZUK_CENTRAL_FOR_FEMALE_FERTILITY |
| — | MATZUK_EMBRYONIC_GERM_CELL |
| — | MATZUK_EARLY_ANTRAL_FOLLICLE |
| — | MATZUK_SECONDARY_FOLLICLE |
| — | MATZUK_PRIMARY_FOLLICLE |
| — | MATZUK_PRIMORDIAL_FOLLICLE |
| — | MATZUK_LUTEAL_GENES |
| — | MATZUK_PREOVULATORY_FOLLICLE |
| — | MATZUK_MALE_REPRODUCTION_SERTOLI |
| — | MATZUK_SPERMATOGONIA |
| — | MATZUK_SPERMATOCYTE |
| — | MATZUK_SPERMATID_DIFFERENTIATION |
| — | MATZUK_SPERMATOZOA |
| — | MATZUK_GENETIC_MODEL_OF_MALE_REPRODUCTIVE_DEFECTS_IN_MICE_OTHER |
| — | MATZUK_MALE_REPRODUCTIVE_DISORDERS |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_1 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_2 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_3 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_4 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_6 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_8 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_9 |
| — | SHIN_B_CELL_LYMPHOMA_CLUSTER_10 |
| — | BAFNA_MUC4_TARGETS_UP |
| — | BAFNA_MUC4_TARGETS_DN |
| — | ABOLHASSANI_FIG_1C |
| — | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP |
| — | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN |
| — | NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_5P15_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_7P22_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_7P15_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_16P13_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_17P11_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_19P13_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_20P13_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_20P12_P11_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON |
| — | NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON |
| — | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER |
| — | NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER |
| — | HOULSTON_COLORECTAL_CANCER_ASSOCIATED_SNPS |
| — | KAO_ADAPTIVE_YEAST_CLONE_GENOTYPE |
| — | KAO_EXPRESSION_CHANGED_IN_ACTIVATED_GPA2_AND_RAS_UP |
| — | KAO_EXPRESSION_CHANGED_IN_ACTIVATED_GPA2_AND_RAS_DN |
| — | CHUNG_BLISTER_CYTOTOXICITY_UP |
| — | CHUNG_BLISTER_CYTOTOXICITY_DN |
| — | THUM_MIR-21_TARGETS_IN_HEART |
| — | THUM_MIR21_TARGETS_HEART_DISEASE_UP |
| — | THUM_MIR21_TARGETS_HEART_DISEASE_DN |
| — | JEON_SMAD6_TARGETS_UP |
| — | JEON_SMAD6_TARGETS_DN |
| — | HERRERO_EXPRESSION_EFFECTS_OF_PM02734_UP |
| — | HERRERO_EXPRESSION_EFFECTS_OF_PM02734_DN |
| — | WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT |
| — | SUNG_METASTASIS_STROMA_UP |
| — | SUNG_METASTASIS_STROMA_DN |
| — | CHEN_HYPOXIA_UP |
| — | CHEN_HYPOXIA_DN |
| — | CHEN_LACTIC_ACIDOSIS_RESPONSE_UP |
| — | CHEN_LACTIC_ACIDOSIS_RESPONSE_DN |
| — | CHEN_INVASIVENESS_GENE_SIGNATURE |
| — | CHEN_WOUND_HEALING_SIGNATURE_CORRELATING_WITH_TUMORS |
| — | CAIRO_LIVER_CANCER_HEPATOBLAST_C2_POOR_PROGNOSIS_UP |
| — | CAIRO_LIVER_CANCER_HEPATOBLAST_C2_POOR_PROGNOSIS_DN |
| — | CAIRO_HEPATOBLASTOMA_UP |
| — | CAIRO_HEPATOBLASTOMA_DN |
| — | CAIRO_HEPATOBLASTOMA_CLASSES_UP |
| — | CAIRO_HEPATOBLASTOMA_CLASSES_DN |
| — | CAIRO_LIVER_DEVELOPMENT_UP |
| — | CAIRO_LIVER_DEVELOPMENT_DN |
| — | CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL |
| — | POTTIER_CORTICOSTEROID_SENSITIVITY |
| — | HARRIS_BRAIN_CANCER_PROGENITORS |
| — | GEORGES_CELL_CYCLE_MIR192_TARGETS |
| — | GEORGES_TARGETS_OF_MIR192_AND_MIR215 |
| — | HILLION_HMGA1_TARGETS |
| — | HILLION_HMGA1B_TARGETS |
| — | SHEN_SMARCA2_TARGETS_UP |
| — | SHEN_SMARCA2_TARGETS_DN |
| — | ENJUANES_SNPS_ASSOCIATED_WITH_RISK_OF_CLL |
| — | LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT |
| — | SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN |
| — | SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP |
| — | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN |
| — | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP |
| — | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP |
| — | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN |
| — | YAMASHITA_LIVER_CANCER_STEM_CELL_UP |
| — | YAMASHITA_LIVER_CANCER_STEM_CELL_DN |
| — | YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_UP |
| — | YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN |
| — | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 |
| — | HOSHIDA_LIVER_CANCER_SUBCLASS_S2 |
| — | HOSHIDA_LIVER_CANCER_SUBCLASS_S3 |
